Expandable intervertebral implant and related methods

Abstract
An expandable implant includes a first plate and a second plate spaced from each other along a first direction. The first plate defines a first bone-contacting surface configured to contact a superior vertebral body and the second plate defines a second bone-contacting surface opposed to the first bone contacting surface along the first direction. The second bone contacting surface is configured to contact an inferior vertebral body. The implant includes an actuation member at least partially disposed between the first and second plates with respect to the first direction. The actuation member defines a first axis, a first end and a second end spaced from the first end along a second direction along the first axis. The second direction is perpendicular to the first direction. The implant includes first and second wedge members carried by the actuation member and in engagement with the first and second plates, and also includes a drive member defining a second axis, a proximal end and a distal end spaced from the proximal end along a third direction along the second axis. The third direction is perpendicular to the first direction and offset from the second direction. The drive member is configured to communicate a driving force to the actuation member so as to cause the actuation member to rotate about the first axis, and at least one of the first and second wedge members is configured to translate along the second direction in response to rotation of the actuation member about the first axis so as to move at least one of the first and second plates with respect to the other of the first and second plates along the first direction.
Description
TECHNICAL FIELD

The present invention relates to an expandable intervertebral implant and related methods.


BACKGROUND

Removal of an intervertebral disc is often desired if the disc degenerates. Spinal fusion may be used to treat such a condition and involves replacing a degenerative disc with a device such as a cage or other spacer that restores the height of the disc space and allows bone growth through the device to fuse the adjacent vertebrae. Spinal fusion attempts to restore normal spinal alignment, stabilize the spinal segment for proper fusion, create an optimal fusion environment, and allows for early active mobilization by minimizing damage to spinal vasculature, dura, and neural elements. When spinal fusion meets these objectives, healing quickens and patient function, comfort and mobility improve. Spacer devices that are impacted into the disc space and allow growth of bone from adjacent vertebral bodies through the upper and lower surfaces of the implant are known in the art. Yet there continues to be a need for devices that minimize procedural invasiveness yet stabilize the spinal segment and create an optimum space for spinal fusion. There also continues to be a need for devices that can be inserted laterally (i.e., along a medial-lateral direction) into the intervertebral space.


SUMMARY

According to an embodiment of the present disclosure, an expandable implant includes a first plate and a second plate spaced from each other along a first direction. The first plate defines a first bone-contacting surface configured to contact a superior vertebral body and the second plate defines a second bone-contacting surface opposed to the first bone contacting surface along the first direction. The second bone contacting surface is configured to contact an inferior vertebral body. The implant includes an actuation member at least partially disposed between the first and second plates with respect to the first direction. The actuation member defines a first axis, a first end and a second end spaced from the first end along a second direction along the first axis. The second direction is perpendicular to the first direction. The implant includes first and second wedge members carried by the actuation member and in engagement with the first and second plates, and also includes a drive member defining a second axis, a proximal end and a distal end spaced from the proximal end along a third direction along the second axis. The third direction is perpendicular to the first direction and offset from the second direction. The drive member is configured to communicate a driving force to the actuation member so as to cause the actuation member to rotate about the first axis, and at least one of the first and second wedge members is configured to translate along the second direction in response to rotation of the actuation member about the first axis so as to move at least one of the first and second plates with respect to the other of the first and second plates along the first direction.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing summary, as well as the following detailed description of illustrative embodiments of the intervertebral implant of the present application, will be better understood when read in conjunction with the appended drawings. For the purposes of illustrating the expandable intervertebral implant of the present application, there is shown in the drawings illustrative embodiments. It should be understood, however, that the application is not limited to the precise arrangements and instrumentalities shown. In the drawings:



FIG. 1 illustrates an implant positioned between vertebral bodies, according to an embodiment of the present disclosure;



FIG. 2 is a perspective view of the implant shown in FIG. 1 in a collapsed configuration;



FIG. 3 is a perspective view of the implant shown in FIG. 1 in an expanded configuration;



FIG. 4 is a top view of the implant shown in FIG. 1 in the collapsed configuration;



FIG. 5 is a top view of the implant shown in FIG. 1 in the expanded configuration, with an upper plate of the implant removed illustrating an expansion mechanism of the implant;



FIG. 6A is an exploded perspective view of the expansion mechanism shown in FIG. 5;



FIG. 6B is perspective views of upper and lower plates of the implant shown in FIG. 1, wherein the upper and lower plates are shown at different perspectives to illustrate interior surfaces of the plates;



FIG. 7 is a bottom plan view of the upper plate of the implant shown in FIG. 6B;



FIG. 8 is sectional end view of the upper plate of the implant shown in FIG. 7, taken along section line 8-8 in FIG. 4;



FIG. 9 is a sectional end view of the bottom plate of the implant shown in FIG. 7, taken along section line 8-8 in FIG. 4;



FIG. 10 is a sectional view of a portion of the upper plate of the implant, taken along section line 10-10 in FIG. 4;



FIG. 11 is a perspective view of a wedge member of the expansion mechanism shown in FIGS. 5 and 6A;



FIG. 12 is a side view of the wedge member shown in FIG. 11;



FIGS. 13 and 14 are opposing ends views of the wedge member shown in FIG. 11;



FIG. 15 is a perspective view of another wedge member of the expansion mechanism shown in FIGS. 5 and 6A;



FIG. 16 is a side view of the wedge member shown in FIG. 15;



FIGS. 17 and 18 are opposing ends views of the wedge member shown in FIG. 15;



FIG. 19 is an exploded perspective view of an actuation member of the expansion mechanism shown in FIGS. 5 and 6A;



FIG. 20 is a side view of the actuation member shown in FIG. 19;



FIG. 21 is a sectional end view of the implant taken along section line 21-21 in FIG. 4, illustrating the implant in the collapsed configuration; and



FIG. 22 is a sectional end view of the implant shown in the expanded configuration.





DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

Referring to FIG. 1, a superior vertebral body 2 and an adjacent inferior vertebral body 4 define an intervertebral space 5 extending between the vertebral bodies 2, 4. The superior vertebral body 2 defines superior vertebral surface 6, and the adjacent inferior vertebral body 4 defines an inferior vertebral surface 8. The vertebral bodies 2, 4 can be anatomically adjacent, or can be remaining vertebral bodies after an intermediate vertebral body has been removed from a location between the vertebral bodies 2, 4. The intervertebral space 5 in FIG. 1 is illustrated after a discectomy, whereby the disc material has been removed or at least partially removed to prepare the intervertebral space 5 to receive an expandable intervertebral implant 10. The implant 10 can be configured for lateral insertion (i.e., along a medial-lateral trajectory) within the intervertebral space 5. Once inserted in the intervertebral space 5, the implant 10 can be expanded in a cranial-caudal direction to achieve appropriate height restoration and lordosis, as disclosed in more detail below. The intervertebral space 5 can be disposed anywhere along the spine as desired, including at the lumbar, thoracic, and cervical regions of the spine. It is to be appreciated that certain features of the implant 10 can be similar to those set forth in U.S. Patent Publication No. 2014/0243982 A1, published Aug. 28, 2014 in the name of Miller, the entire disclosure of which is incorporated herein by this reference.


Certain terminology is used in the following description for convenience only and is not limiting. The words “right”, “left”, “lower” and “upper” designate directions in the drawings to which reference is made. The words “inner”, “internal”, and “interior” refer to directions towards the geometric center of the implant, while the words “outer”, “external”, and “exterior” refer to directions away from the geometric center of the implant. The words, “anterior”, “posterior”, “superior,” “inferior,” “medial,” “lateral,” and related words and/or phrases are used to designate various positions and orientations in the human body to which reference is made. When these words are used in relation to the implant 10 or a component thereof, they are to be understood as referring to the relative positions of the implant 10 as implanted in the body as shown in FIG. 1. The terminology includes the above-listed words, derivatives thereof and words of similar import.


Referring now to FIG. 2, the implant 10 is described herein as extending horizontally along a longitudinal direction “L” and a transverse direction “T”, and vertically along a vertical direction “V”. Unless otherwise specified herein, the terms “longitudinal,” “transverse,” and “vertical” are used to describe the orthogonal directional components of various implant components and implant component axes. It should be appreciated that while the longitudinal and transverse directions L, T are illustrated as extending along and defining a horizontal plane (also referred to herein as a “longitudinal-transverse plane”), and that the vertical direction is illustrated as extending along a vertical plane (such as either a “vertical-longitudinal plane” or a “vertical-transverse plane,” as respectively referred to herein), the planes that encompass the various directions may differ during use. For instance, when the implant 10 is inserted into the intervertebral space 5, the vertical direction V extends generally along the superior-inferior (or caudal-cranial) direction, while the horizontal plane lies generally in the anatomical plane defined by the anterior-posterior direction and the medial-lateral direction. Accordingly, the directional terms “vertical” and “horizontal” may be used to describe the implant 10 and its components as illustrated merely for the purposes of clarity and illustration.


In FIG. 2, the implant 10 is shown in the collapsed configuration C. The implant 10 can extend between a proximal or trailing end 12 and a distal or leading end 14 that is spaced from the leading end 14 along a longitudinal implant axis X1 that extends along the longitudinal direction L. The leading and trailing ends 12, 14 may be respectively termed as such because the implant 10 can be inserted leading-end-first into the intervertebral space 5. The trailing end 12 can be configured to couple with one or more insertion instruments, which are configured to support and carry the implant 10 into the intervertebral space 5. The implant 10 can also extend between an anterior side 16 and a posterior side 18 along the transverse direction T.


The implant 10 can include a first or superior plate 100 and a second or inferior plate 200 opposing the superior plate 100 along the vertical direction V. The superior plate 100 can define a superior plate body 102 that defines a superior or first bone-contacting surface 104 and the inferior plate 200 can define an inferior plate body 202 that defines an inferior or second bone-contacting surface 204 spaced from the first bone-contacting surface 104 along the vertical direction V. The superior and inferior bone-contacting surfaces 104, 204 can be configured to engage the opposing superior and inferior vertebral bodies 4 and 6, respectively. Each bone-contacting surface 104, 204 can extend in a substantially planar fashion, as shown. Additionally, the superior and inferior bone-contacting surfaces 104, 204 can be angled with respect to each other in a vertical-transverse plane so as to define a lordotic angle α of the implant 10. Additionally, to facilitate insertion, the superior and inferior plate bodies 102, 202 can each define a tapered surface 106, 206 adjacent the leading end 14 of the implant 10, wherein each tapered surface 106, 206 tapers inwardly generally toward the vertical midpoint of the implant 10 in a distal direction to facilitate insertion of the implant 10.


While the superior and inferior bone-contacting surfaces 104, 204 are each shown as being substantially planar, in other embodiments, each bone-contacting surface 104, 204 can be substantially convex or at least partially convex, for instance, or can define a portion that is convex and another portion that is planar. The bone-contacting surfaces 104, 204 can also at least partially define a texture (not shown), such as spikes, ridges, cones, barbs, indentations, or knurls, which are configured to engage the respective vertebral bodies 4 and 6 when the implant 10 is inserted into the intervertebral space 5.


As used herein, the term “distal” and derivatives thereof refer to a direction from the trailing end 12 toward the leading end 14. As used herein, the term “proximal” and derivatives thereof refer to a direction from the leading end 14 toward the trailing end 12. Thus, as used herein, the term “longitudinal direction L” is bi-directional and is defined by the mono-directional distal and opposed proximal directions.


As used herein, the term “anterior” and derivatives thereof refer to a direction from the posterior side 18 of the implant 10 toward the anterior side 16 of the implant. As used herein, the term “posterior” and derivatives thereof refer to a direction from the anterior side 16 toward the posterior side 18. Thus, as used herein, the term “transverse direction L” is bi-directional and is defined by the mono-directional anterior and opposed posterior directions.


As used herein, the term “superior” and derivatives thereof refer to a direction from the second bone-contacting surface 204 toward the first bone-contacting surface 104. As used herein, the term “inferior” and derivatives thereof refer to a direction from the first bone-contacting surface 104 toward the second bone-contacting surface 204. Thus, as used herein, the term “vertical direction V” is bi-directional and is defined by the mono-directional superior and opposed inferior directions.


Referring to FIGS. 2 and 3, the implant 10 can include an expansion mechanism 300 interposed between portions of the superior and inferior plates 100, 200 and configured to separate the superior and inferior plates 100, 200 relative to each other in the vertical direction V. For example, the expansion mechanism 300 can be configured to actuate the implant 10 from the collapsed configuration C, as shown in FIG. 2, into an expanded configuration E, as shown in FIG. 3. The implant 10 can be configured to expand the vertical height and the lordotic angle α of the implant 10, each measured between the superior and inferior bone-contacting surfaces 104, 204. For example, when the implant 10 is in the collapsed configuration (FIG. 2), a collapsed anterior height HA′ of the implant 10 can be between about 4 mm and about 18 mm, a collapsed posterior height HP1 of the implant 10 can be between about 3 mm and about 17 mm, and a collapsed (i.e., “built-in”) lordotic angle α1 of the implant 10 can be between 0 degrees and about 15 degrees. When the implant 10 is in the expanded configuration E (FIG. 3), an expanded anterior height HA2 can be between about 8 mm and about 24 mm, the expanded posterior height HP2 can be between about 7 mm and about 21 mm, and the expanded lordotic angle α2 can be between about 15 degrees and about 45 degrees. It is to be appreciated that, in some embodiments, the implant 10 can be configured such that the expanded anterior height HA2 can be greater than the collapsed anterior height HA′ by a factor of about 3, and the expanded posterior height HP2 can also be greater than the collapsed posterior height HP1 by a factor of about 3.


The superior and inferior plates 100, 200 can each define features configured to house components of the expansion mechanism 300. For example, as shown in FIGS. 2 and 3, the superior plate body 102 can define a first lumen 108 and a second lumen 110 spaced from the first lumen 108 in the distal direction. Accordingly, the first lumen 108 may be termed a “proximal” lumen and the second lumen 210 may be termed a “distal” lumen. Additionally, while not visible in FIG. 2 or 3, the inferior plate body 202 can define a third lumen 208 and a fourth lumen 210 spaced from the third lumen 208 in the distal direction. Similarly, the third lumen 208 may be termed a “proximal” lumen and the fourth lumen 210 may be termed a “distal” lumen. The first and second lumens 108, 110 of the superior plate 100 can be respectively aligned with and opposite the third and fourth lumens 208, 210 of the inferior plate 200 along the vertical direction V. Each of the lumens 108, 110, 208, 210 can extend from a first or anterior lumen side 108a to a second or posterior lumen side 108b spaced from the first side 108a along the transverse direction T. The implant 10 is configured such that when the implant 10 is in the collapsed configuration C, various portions of the expansion mechanism 300 can be at least partially disposed within the lumens 108, 110, 208, 210, 210, as described in more detail below. For reference, the third and fourth lumens 208, 210 of the inferior plate 200 are both visible in FIGS. 5 and 6B, the third lumen 208 is also visible in FIGS. 21 and 22, and the fourth lumen 210 is also visible in FIG. 9.


With reference to FIG. 4, the implant 10 can define an implant length L0 between about 25 mm and about 70 mm, measured from the trailing end 12 to the leading end 14 of the implant 10 along the longitudinal direction L. The implant can also define an implant width W0 between about 20 mm and about 50 mm, measured from the anterior side 16 to the posterior side 18 of the implant 10 along the transverse direction T. The implant 10 can also define a central aperture 111 extending through the implant 10 (i.e., from the first to the second bone bone-contacting surface 104, 204) along the vertical direction V. With respect to the longitudinal direction L, the central aperture 111 can be located between the first and second lumens 108, 110 of the superior plate 100 and between the third and fourth lumens 208, 210 of the inferior plate 200. The central aperture 111 can define a first or anterior side 111a and a second or posterior side 111b spaced from the anterior side along the transverse direction T. The central aperture 111 can further define a third or proximal side 111c and a fourth or distal side 111d spaced from the proximal side along the longitudinal direction L. The central aperture 111 can extend substantially entirely un-occluded through the implant 10 along the vertical direction V. The central aperture 111 can occupy a significant volume of the implant 10 and can be pre-filled or packed with bone growth material prior to insertion of the implant 10 so as to enhance subsequent bone fusion between the superior and inferior vertebral bodies 2, 4.


Referring now to FIGS. 5 and 6A, the expansion mechanism 300 can include a drive assembly 301 and one or more actuation assemblies, such as first and second actuation assemblies 302a, 302b, that are configured to be driven by the drive assembly 301 and actuate movement of at least one of the superior and inferior plates 100, 200 with respect to the other of the plates 100, 200 along the vertical direction V. The second actuation assembly 302b can be spaced from the first actuation assembly 302a in the distal direction. Thus, the first actuation assembly 302a can be termed a “proximal” actuation assembly and the second actuation assembly 302b can be termed a “distal” actuation assembly. The first actuation assembly 302a can include a first or proximal pair of wedge members 303 and the second actuation assembly 302b can include a second or distal pair of wedge members 304. Each pair of wedge members 303, 304 can include a first wedge member 306 and a second wedge member 308 spaced from each other along the transverse direction T. The first wedge member 306 may be located adjacent the anterior side 16 and remote from the posterior side 18 of the implant 10. The second wedge member 308 can be located adjacent the posterior side 18 and remote from the anterior side 16 of the implant 10. Thus, the first wedge member 306 of each pair may be termed an “anterior” wedge member and the second wedge member 308 of each pair may be termed a “posterior” wedge member. The first and second wedge members 306, 308 of each pair 303, 304 can be configured to translate relative to one another in the transverse direction T. In other embodiments, only one of the wedge members 306, 308 of each pair need translate relative to the other wedge member along the transverse direction T.


The first and second pairs 303, 304 of wedge members can be configured such that translation of the first wedge members 306 relative to the second wedge members 308 along the transverse direction T drives expansion of the superior and inferior plates 100, 200 away from each other in the vertical direction V. In this manner, the implant 10 can be actuated from the collapsed configuration C into the expanded configuration E. For illustrative purposes, FIG. 5 illustrates the wedge members 306, 308 of each pair in a separated configuration, while the proximal pair 303 of wedge members of FIG. 6A are shown in a contracted configuration. The superior and inferior plates 100, 200 and the first and second wedge members 306, 308 of each pair 303, 304 can be respectively shaped, oriented and otherwise configured such that the contracted configuration of the wedge members 306, 308 corresponds to the collapsed configuration C of the implant 10 and the separated configuration of the wedge members 306, 308 corresponds to the expanded configuration E of the implant 10. However, it is to be appreciated that, in other embodiments, the separated configuration of the wedge members 306, 308 can correspond to the collapsed configuration of the implant 10 and the contracted configuration of the wedge members 306, 308 can correspond to the expanded configuration of the implant 10.


With continued reference to FIGS. 5 and 6A, the first actuation assembly 302a can include a first or proximal actuation member 310 coupled to the first pair of wedge members 303 and the second actuation assembly 302b can include a second or distal actuation member 312 coupled to the second pair of wedge members 304. The first and second actuation members 310, 312 can be configured similarly or even substantially identically to one another. Thus, it is to be appreciated that the following description and reference numbers set forth below in reference to the first actuation member 310 can also be used with reference to the second actuation member 312.


Each actuation member 310 can include an actuation rod 314 defining a central rod axis Y1 extending along the transverse direction T and a first end 318 spaced from an opposed second end 320 along the central rod axis Y1. The actuation rod 314 can further define an outer surface 321 extending between the first and second ends 318, 320. Each actuation rod 314 can further define a first portion 322 extending from the first end 318 toward the second end 320 and a second portion 324 extending from the second end 320 toward the first end 318. The first and second portions 322, 324 can be separated and spaced from one another along the transverse direction T. The first end 318 and the first portion 322 can each be located adjacent the anterior side 16 and remote from the posterior side 18 of the implant 10. The second end 320 and the second portion 324 can each be located adjacent the posterior side 18 and remote from the anterior side 16 of the implant 10. Thus, the first end 318, the first portion 322, or any component associated therewith, may be termed a respective “anterior” end, portion, or component, and the second end 320, the second portion 324, or any component associated therewith, may be termed a “posterior” end, portion, or component. The actuation rod 310 can further define a retention feature, such as an annular recess 326 formed in the outer surface 321 of the rod 310, located between and separating the first and second portions 322, 324 along the transverse direction T. The first portion 322 can define a first or anterior threaded region 328 and the second portion 324 can define a second or posterior threaded region 330. The first portion 322 can also optionally define a first unthreaded region 332 interposed between the first threaded region 328 and the retaining feature 326 along the transverse direction T. The second portion 324 can also optionally define a second unthreaded 334 region interposed between the retaining feature 326 and the second threaded region 330 along the transverse direction T, and a third unthreaded region 335 extending from the second threaded region 330 to the second end 320 of the actuation rod 314 in the posterior direction. The actuation rod 314 can also define an abutment surface 335a interposed between the second threaded region 330 and the third unthreaded region 335 along the transverse direction T. The abutment surface 335a can face in the posterior direction. The first wedge member 306 of each pair 303, 304 can be configured to translate along the first threaded region 328 of the associated actuation rod 314 and the second wedge member 308 of each pair 303, 304 can be configured to translate along the second threaded region 330 of the rod 314 responsive to rotation of the rod 314 about central rod axis Y1, as described in more detail below.


The first actuation assembly 302a can include a first transmission member, such as a first gear 336, for converting at least a portion of a driving force, as applied by a driving tool operated by a physician, into a first rotational force of the first actuation member 310 about the central rod axis Y1 thereof. Similarly, the second actuation assembly 302b can include a second transmission member, such as a second gear 338, for converting an additional portion of the driving force into a second rotational force of the second actuation member 312 about the central rod axis Y1 thereof. For example, as shown, the first and second gears 336, 338 can be bevel gears positioned adjacent the posterior ends 320 of the actuation rods 314. However, other gear types, including worm gears and helical gear, by way of non-limiting example, are within the scope of the present embodiments.


The drive assembly 301 can include a drive member, such as a drive shaft 340, rotationally coupled to each of the first and second actuation members 310, 312. The drive shaft 340 can include an engagement feature, such as a socket 342, for receiving a driving tool operated by the physician. The drive shaft 340 can further include a third transmission member, such as a third gear 344, and a fourth transmission member, such as a fourth gear 346, for transmitting the drive force to the respective first and second transmission members 336, 338 of the actuation assemblies 302a, 302b. The third and fourth gears 344, 346 can be coupled to the drive shaft 340 by welding, brazing, mechanical fasteners, or any other technique. In other embodiments, either or both of the third and fourth gears 344, 346 can be formed monolithically with the drive shaft 340.


As shown, the drive shaft 340 can define a central shaft axis X2, a shaft proximal end 350, and a shaft distal end 352 spaced from the shaft proximal end 350 along the longitudinal direction L along the central shaft axis X2. The third and fourth gears 344, 346 can comprise bevel gears that are configured to mesh with the respective first and second gears 336, 338. The fourth gear 346 can be spaced from the third gear 344 in the distal direction; accordingly, the third gear 344 can be termed a “proximal” gear and the fourth gear 346 can be termed a “distal” gear. When the gears 344, 346 are bevel gears, as shown, the first and third gears 336, 344 may be oriented at 90 degrees relative to each other, and the second and fourth gears 338, 346 may be oriented at 90 degrees relative to each other, although other relative orientations are within the scope of the disclosed embodiments.


The socket 342 can be recessed into the drive shaft 340 from the shaft proximal end 350. The socket 342 can be defined by a head 354 of the drive shaft 340 that extends from the shaft proximal end 350 in the distal direction. The socket 342 can be any one of hexagonal, pentagonal, square, triangular, cross-shaped, plus sign-shaped, linear, star-shaped, or any other shape configured to engage a driving tool. The head 354 of the drive shaft 340 can define a first outer shaft surface 356 and a portion of the shaft located distally of the head 354 can define a second shaft outer surface 358 such that the first outer shaft surface 356 has a diameter greater than a diameter of the second outer shaft surface 358.


The drive shaft 340 can further define a central bore 360 in fluid communication with the socket 342, and a plurality of apertures 362 in fluid communication with the central bore 360. The plurality of apertures 362 can extend from the second outer surface 358 radially inward (i.e., in a radial direction that is perpendicular to the central shaft axis X2) to the central bore 360, such that the socket 342, the central bore 360, and the apertures 362 define a continuous fluid pathway. The plurality of apertures 362 can be positioned adjacent the central aperture 111 of the implant 10 such that additional bone growth material can be injected into the socket 342 (optionally with the use of a funnel), through the central bore 360 and out the plurality of apertures of the drive shaft 340 and into the central aperture 111 of the implant 10, particularly when the implant is in the expanded configuration E.


Once the implant 10 is inserted into the intervertebral space 5 as desired, the physician can actuate the implant 10 from the collapsed configuration C to the expanded configuration E by inserting the driving tool into the socket 342 of the drive shaft 340 and rotating the driving tool. Rotating the driving tool can rotate the drive shaft 340 and the third and fourth gears 344, 346 which, in turn, rotate the first and second gears 336, 338 and the actuation rods 314 coupled thereto. As the actuation rods 314 rotate, the first wedge members 306 and the second wedge members 308 of each pair 303, 304 translate away from each other along the respective first and second threaded regions 328, 330 of the actuation rods 310, 312 along the transverse direction T, forcing the superior and inferior plates 100, 200 to separate from one another in the vertical direction V. With the implant 10 in the expanded configuration E, the physician can inject additional bone growth material into the central aperture 111 in the manner described above.


The expansion mechanism 300 can include a first mounting element, such as a first or proximal bracket 364, and a second mounting element, such as a second or distal bracket 366, for coupling the drive shaft 340 to the first and second actuation members 310, 312, respectively. For example, the first and second brackets 364, 366 can each be a square (i.e., “right-angle”) bracket in relation to the horizontal plane. In particular, each bracket 364, 366 can define a first bracket portion 368 configured to extend from a posterior bracket end 370 to a bend 372 spaced from the posterior bracket end 370 in the anterior direction. Each bracket 364, 366 can further define a second bracket portion 374 extending from the bend 372 to a holding element 376 spaced from the bend 372 in the longitudinal direction L. As shown more clearly in FIG. 6A, the first bracket portion 368 can define a bore coupling 378 adjacent the posterior bracket end 370 and sized and configured received the second outer surface 358 of the drive shaft 340. The bore coupling 378 can define a central coupling axis X3 that is configured to be coextensive with the central shaft axis X2 when the bracket 364, 366 is coupled to drive shaft 340. Each bore coupling 378 can be positioned adjacent an associated abutment flange of the drive shaft 340.


The holding element 376 of each bracket 364, 366 can be configured to engage the retention feature 326 of the associated actuation member 310, 312 in a manner at least partially retaining the actuation member 310, 312 in position relative to the drive shaft 340. The holding element 376 can define a pair of opposed arms 380a, 380b extending in the longitudinal direction L and spaced from one another in the vertical direction V so that inner surfaces 381a, 381b of the arms 380a, 380b can extend within the annular recess 326 of the associated actuation member 310, 312. The inner arm surfaces 381a, 381b can each be substantially linear and parallel with the longitudinal direction L. The arms 380a, 380b can further define outer arm surfaces 382a, 382b that are curved and convex so as to collectively define a C-shape in a vertical-longitudinal plane. The holding element 376 can further define a curved and concave intermediate surface 383 joining the inner arm surfaces 381a, 381b in the vertical direction V. The intermediate surface 383 can be contoured to match the contour of the outer surface 321 of the associated actuation rod 314 within the annular recess 326. When the brackets 364, 366 are coupled to their associated actuation members 310, 312, the inner arm surfaces 381a, 381b and the intermediate surface 383 of each holding element 376 can lightly abut or be in close proximity to the outer surface 321 of the associated actuation rod 314 within the annular recess 326 so as to substantially retain the actuation rod 314 in position relative to the drive shaft 340 in the transverse direction T, the vertical direction V, and at least one of the medial and lateral longitudinal directions. Stated differently, the holding element 376 of each bracket 364, 366 can be configured to act substantially as an axial bearing and at least partially as a journal bearing for the associated actuation rod 314.


As depicted, the proximal and distal brackets 364, 366 can be positioned on the drive shaft 340 such that first and second actuation members 310, 312 are positioned between the respective first bracket portions 368 with respect to the longitudinal direction L. In such embodiments, the arms 380a, 380b of the holding element 376 of the proximal bracket 364 can be open in the distal direction and the arms 380a, 380b of the holding element 376 of the distal bracket 366 can be open in the proximal direction. Thus, the arms 380a, 380b of each holding element 376 can be received on opposite vertical sides of the outer surface 321 of the rod 314 within the recess 326 during assembly of the implant 10. Alternatively, the proximal and distal brackets 364, 366 can be positioned on the drive shaft 340 such that respective first bracket portions 368 are positioned between the respective actuation members 310, 312 with respect to the longitudinal direction L. In such embodiments, the arms 380a, 380b of the proximal bracket 364 can be open in the proximal direction and the arms 380a, 380b of the distal bracket 366 can be open in the distal direction.


Referring now to FIG. 6B, the superior plate body 102 can define a first interior face 112 spaced from and located opposite the first bone-contacting surface 104 along the vertical direction V, and the inferior plate body 202 can define a second interior face 212 spaced from and located opposite the second bone-contacting surface 204 along the vertical direction V. The first and second interior faces 112, 212 can be located opposite one another and can substantially face one another along the vertical direction V. The first and second interior faces 112, 212 can each extend from the trailing end 12 to the leading end 14 of the implant 10 and from the anterior side 16 to the posterior side 18 of the implant 10. The first and second interior faces 112, 212 can each be configured to couple with the wedge members 306, 308, as set forth in more detail below.


The first interior face 112 can define a first interior plate contact surface 114 and the second interior 212 face can define a second interior plate contact surface 214. The first and second interior plate contact surfaces 114, 214 can be configured to abut one another when the implant 10 is in the collapsed configuration C. Each of the first and second interior plate contact surfaces 114, 214 can include a plurality of contact surfaces that are separated from one another along the longitudinal and transverse directions L, T.


The first interior face 112 of the superior plate body 102 can define a first cavity 116 and a second cavity 118 spaced from the first cavity 116 in the distal direction. Thus, the first cavity 116 can be termed a “proximal” cavity and the second cavity 118 can be termed a “distal” cavity. The first and second cavities 116, 118 can each extend along the vertical direction V from the first interior plate contact surface 114 toward the first bone-contacting surface 104, and can each extend along the transverse direction T from a location adjacent, or contiguous with, the anterior side 16 of the implant 10 to a location adjacent the posterior side 18 of the implant 10. The first cavity 116 can be contiguous with the first lumen 108 and the second cavity 118 can be contiguous with the second lumen 110. The second interior face 212 of the inferior plate body 202 can define a third cavity 216 and a fourth cavity 218 spaced from the third cavity 216 in the distal direction. Thus, the third cavity 216 can be termed a “proximal” cavity and the fourth cavity 218 can be termed a “distal” cavity. The third and fourth cavities 216, 218 can each extend along the vertical direction V from the second interior plate contact surface 214 toward the second bone-contacting surface 204, and can each extend along the transverse direction T from a location adjacent, or contiguous with, the anterior side 16 of the implant 10 to a location adjacent the posterior side 18 of the implant 10. The third cavity 216 can be contiguous with the third lumen 208 and the fourth cavity 218 can be contiguous with the fourth lumen 210.


The first and third cavities 116, 216 can be opposed to one another and face one another along the vertical direction V so that the first and third cavities 116, 216 can collectively house the first pair of wedge members 303, the first actuation member 310, and at least a portion of the first bracket 364 at least when the implant 10 is in the collapsed configuration C. Similarly, the second and fourth cavities 118, 218 can be opposed and facing one another along the vertical direction V so as to collectively house the second pair of wedge members 304, the second actuation member 312, and at least a portion of the second bracket 366 at least when the implant 10 is in the collapsed position C.


With reference to FIGS. 6B and 7, the first and second cavities 116, 118 of the superior plate body 102 can be similarly shaped. The first and second cavities 116, 118 can be configured similarly or even substantially identically to one another. Furthermore, the third and fourth cavities 216, 218 can be configured within the inferior plate body 202 in a manner similar or substantially identical to the manner in which the first and second cavities 116, 118 are configured within the superior plate body 102. Thus, it is to be appreciated that the following description and reference numbers set forth below in reference to the first cavity 116 can also be used with respect to any one of the second, third, and fourth cavities 118, 216, 218.


With reference to FIG. 7, each cavity 116, 118 can extend from a first or anterior cavity end 120 to a second or posterior cavity end 122 along a central cavity axis Y2 that extends along the transverse direction T. The anterior cavity end 120 can be contiguous with the anterior side 16 of the implant 10, and the posterior cavity end 122 can be located adjacent the posterior side 18 of the implant 10. Each cavity 116, 118 can also define a first or external side 124 and an opposed second or internal side 126 spaced from the first side along the longitudinal direction L. The first and second sides of each cavity 116 can face one another along the longitudinal direction L.


Each of the superior and inferior plates 100, 200 can include one or more engagement elements configured to engage corresponding engagement elements of the expansion mechanism 300 in a manner allowing the expansion mechanism 300 to separate the plates 100, 200 along the vertical direction V. For example, within each of the cavities 116, the plate body 102 can define engagement elements, such as a pair of ramp surfaces that are configured to mate with and slide along portions of the first and second wedge members 306, 308. The pair of ramp surfaces can include a first or anterior ramp surface 130 and a second or posterior ramp surface 132 spaced from the first ramp surface 130 along the transverse direction T. The first and second ramp surfaces 130, 132 can be positioned, with respect to the transverse direction T, on the opposite sides 108a, 108b of the lumen 108, 110 that is in communication with the cavity 116. The first ramp surface 130 can extend from the anterior cavity end 120 to the anterior side 108a of the lumen, and the second ramp surface 132 can extend from the posterior side 108b of the lumen to the posterior cavity end 122.


The first ramp surface 130 is inclined to abut and slidingly receive a portion of the first wedge member 306, and the second ramp surface 132 is inclined to abut and slidingly receive a portion of the second wedge member 308. The first ramp surface 130 can be inclined such that a vertical distance, measured from the interior plate contact surface 114 of the associated plate body 102 to the first ramp surface 130, increases from the anterior ramp end to the posterior ramp end along the transverse direction T. The second ramp surface 132 can be inclined such that a vertical distance, measured from the interior plate contact surface of the associated plate body to the second ramp surface 132, decreases from the anterior ramp end to the posterior ramp end along the transverse direction T. As shown in FIG. 8 with respect to the superior plate body 102, the first ramp surface 130 can be inclined at a first acute ramp angle βS1 between about 10 degrees and about 40 degrees with respect to the interior plate contact surface 114. The second ramp surface 132 can be inclined at a second acute ramp angle βS2 between about 10 degrees and about 60 degrees with respect to the interior plate contact surface 114. Similarly, as shown in FIG. 9 with respect to the inferior plate body 202, the first ramp surface 130 within the associated cavity 216 of the inferior plate body 202 can be inclined at a first acute ramp angle βI1 between about 10 degrees and about 40 degrees with respect to the interior plate contact surface 214. The second ramp surface 132 within the associated cavity 216 of the inferior plate body 202 can be inclined at a second acute ramp angles βI2 between about 10 degrees and about 60 degrees with respect to the interior plate contact surface 214. It is to be appreciated that the first and second ramp angles βS1, βS2 βI1, βI2 of the ramp surface 130, 132 within each cavity 116, 118, 216, 218 can vary as needed.


The plate body 102 can also define, within each cavity 116, 118, a first curvilinear portion 134 disposed at the anterior side 16 of the implant 10 and in communication with the first ramp surface 130, and a second curvilinear portion 136 disposed at the posterior end 122 of the cavity 116 and in communication with the second ramp surface 132. The first and second curvilinear portions 134, 136 can be recessed from the first and second ramp surface 130, 132, respectively, toward the bone-contacting surface 104 of the plate body 102 along the vertical direction V. The first and second curvilinear portions 134, 136 can each define a curvilinear profile in a vertical-longitudinal plane. When the superior and inferior plates 100, 200 are in the collapsed configuration C, the vertically opposed first curvilinear portions 134 of the superior and inferior plate bodies 102, 202 can collectively define a first or anterior access opening for the first portion 322 of the associated actuation member 310, 312, and the vertically opposed second curvilinear portions 136 of the plates bodies 102, 202 can collectively define a second or posterior access opening for the second portion 324 of the associated actuation member 310, 312.


At each of the external and internal sides 124, 126 of the cavity 116, the plate body 102 can define one or more projections 138 protruding inwardly toward the central cavity axis Y2 along the longitudinal direction L. The projections 138 can at least partially define one or more channels 140 located vertically between the one or more projections 138 and the associated ramp surface 130, 132 within the cavity 116. The projections 138 and channels 140 can be defined by various surfaces within the cavity 116. For example, as shown in FIG. 10, at each of the external and internal sides 124, 126 of the cavity 116, the plate body 102 can define a first surface 142 and a second surface 144 each extending in the vertical and transverse directions V, T. The first surface can be contiguous with the interior contact surface 114 of the plate body 102. The second surface 144 can be contiguous with one or more of the first and second ramp surface 130, 132 within the cavity 116, and can be located between the first surface 142 and the associated ramp surface 130, 132 with respect to the vertical direction V. With respect to the longitudinal direction L, the first surface 142 can be located between the second surface 144 and the central cavity axis Y2. The plate body 102 can define a third or overhang surface 146 extending between the first and second surfaces 142, 144 in the longitudinal direction L. The overhang surface 146 can be contiguous with one or both of the first and second surfaces 142, 144. The first and second surfaces 142, 144 can be substantially parallel with one another. The overhang surface 146 can be substantially orthogonal with respect to one or both of the first and second surfaces 142, 144. The one or more projections 138 can be at least partially defined by the overhang surface 146 and the first surface 142. Similarly, the one or more channels 140 can be at least partially defined by the second surface 144 and the overhang surface 146. Thus, the one or more projections 130 can overlap at least portions of the first and second ramp surface 130, 132 in the longitudinal direction L.


On each side of the cavity 116, the one or more protrusions 138 can include a first or anterior protrusion 138a that partially overlaps the first 146 ramp surface 130 in the longitudinal direction L and a second or posterior protrusion 138b that partially overlaps the second ramp surface 132 in the longitudinal direction L. Additionally, the one or more channels 140 can include a first or anterior channel 140a positioned vertically between the first protrusion 138a and the first ramp surface 130, and a second or posterior channel 140b positioned vertically between the second protrusion 138b and the second ramp surface 132. In this manner, the first and second channels 140a, 140b may be characterized as being positioned “underneath” the first and second protrusions 138a, 138b, respectively. The first channel 140a can be inclined so as to be parallel with the first ramp surface 130, and the second channel 140b can be inclined so as to be parallel with the second ramp surface 132. Thus, as shown in FIGS. 8 and 9, the first channels 140a within the associated cavities 116, 118, 216, 218 of the superior and inferior plate bodies 102, 202 can each be inclined at a first acute channel angle δS1, δI1 between about 10 degrees and about 40 degrees with respect to their interior plate contact surface 114, 214, and the second channels 140b can each be inclined at a second acute channel angle δS2, δI2 between about 10 degrees and about 60 degrees with respect to their interior plate contact surface 114, 214.


It is to be appreciated that the protrusions 138 and channels 140 on the interior side 126 of the cavity 116 can be sized, shaped and oriented similarly to those on the exterior 124 side of the cavity 116. Stated differently, the features on the external and internal sides 124, 126 of the cavity 116 can virtually be mirror images of each other about a vertical plane that extends along the central cavity axis Y2.


In association with each cavity 116, 118, the plate body 102 can also define a first or external longitudinal slot 148 and a second or internal longitudinal slot 150 aligned with each other on the opposite sides 124, 126 of the cavity. The first slot 148 can extend from the exterior of the plate body 102 to the cavity along the longitudinal direction L, and the second slot 150 can extend from the cavity toward the interior of the plate body 102 along the longitudinal direction L. The anterior and posterior protrusions 138a, 138b on the exterior side 124 of each cavity 116 can be separated from one another along the transverse direction T by the first slot 148, and the anterior and posterior protrusions 138a, 138b on the interior side 126 of each cavity 116 can be separated from one another along the transverse direction T by the second slot 150. Additionally, the anterior and posterior channels 140a, 140b on each side 124, 126 of each cavity 116 can also be located on opposite sides of the respective slots 148, 150 with respect to the transverse direction T.


The plate body can also define a first or proximal landing surface 152 associated with the first cavity 116, and a second or distal landing surface 154 associated with the second cavity 118. The first and second landing surfaces 152, 154 can each be recessed into the plate body 102 from the interior plate contact surface 114 thereof in the vertical direction V. The second landing surface 154 can be spaced from the first landing surface 152 in the distal direction, such that the first and second cavities 116, 118 are both positioned between the first and second landing surfaces 152, 154 along the longitudinal direction L. The first landing surface 152 can be adjacent to and optionally contiguous with the trailing end 12 of the implant 10, and the second landing surface 154 can be adjacent to and optionally contiguous with the leading end 14 of the implant 10. The first and second landing surfaces 152, 154 can each be adjacent the posterior side 18 and remote from the anterior side 16 of the implant 10. The first and second landing surfaces 152, 154 can each extend in the posterior direction from the external slot 148 of the associated cavity 116, 118.


With respect to the longitudinal direction L, the first landing surface 152 can be separated from the external side 124 of the first cavity 116 by a first wall 156 defined by the plate body 102, and the second landing surface 154 can be separated from the external side 124 of the second cavity 118 by a second wall 158 defined by the plate body 102.


Each cavity 116, 118 and its associated first and second slots 148, 150 and associated landing surface 152, 154 is configured to receive the associated bracket 364, 366. For example, with respect to the first cavity 116, the first portion 368 of the first bracket 364 can extend across the first landing surface 152 in the transverse direction T, and the second portion 374 of the bracket 364 can extend along the longitudinal direction L across the first cavity 116 and within the external and internal slots 148, 150 associated therewith. Similarly, the first portion 368 of the second bracket 366 can extend across the second landing surface 154 in the transverse direction T, and the second portion 374 of the bracket 366 can extend along the longitudinal direction L across the second cavity 118 and within the external and internal slots 148, 150 associated therewith. In this manner, the brackets 364, 366 can be at least partially retained in position relative to the associated plate body 102, as shown in FIG. 5, for example. The internal slots 150 can optionally each have a curved and concave profile in a vertical-longitudinal plane so as to correspond to the curved and convex profile of the outer arm surfaces 382a, 382b of the holding element 378 of the associated bracket 364, 366. The external and internal slots 148, 150 can each have a width in the transverse direction T that is greater than a transverse width of the second portions 374 of the brackets 364, 366 so that the brackets 364, 366 can adjust their position relative to the superior and inferior plate bodies 102, 202 along the transverse direction T during expansion of the implant 10 from the collapsed configuration C to the expanded configuration E.


The interior face 112 of the plate body 102 can also define a third landing surface 160 adjacent to and optionally contiguous with the posterior side 18 of the implant 10. The third landing surface 160 can extend from the proximal end 12 to the distal end 14 of the implant 10 along the longitudinal direction L, and can extend from the first and second cavities 116, 118 to the posterior side 18 of the implant 10 in the posterior direction. The third landing surface 160 can be contiguous with one or more of the first and second cavities 116, 118, the first and second landing surfaces 152, 154, and the first and second walls 156, 158 of the plate body 102. The third landing surface 160 can be configured to at least partially house the drive shaft 340 and the first and second transmission members 336, 338 of the expansion mechanism 300. Accordingly, the third landing surface 160 can be sloped so that a vertical distance measured from the third landing surface 160 to the bone-contacting surface 104 of the plate body 102 decreases along the posterior direction. A portion of the third landing surface 160 that is contiguous with the first and second cavities 116, 118 can define a curved and concave slope profile in the vertical-transverse plane. The interior face 112 of the plate body 102 can further define first and second recesses 162, 164 adjacent to, or optionally contiguous with, the posterior ends 122 of the first and second cavities 116, 118, respectively, so as to at least partially house the first and second transmission members 336, 338.


The inferior plate 200 can be configured similarly to the superior plate 100. For example, as shown in the illustrated embodiments, the superior and inferior plate bodies 102, 202 can be mirror images of each other about a horizontal plane extending through the geometric center of the implant 10. Accordingly, the inferior plate 200 can include structural features that correspond to those described above with respect to the superior plate 100. Thus, reference numbers of features of the superior plate body 102 can be used with reference to the corresponding features of the inferior plate body 202. For example, the third and fourth cavities 216, 218 defined by the inferior plate body 202 can be configured similarly to the first and second cavities 116, 118 of the superior plate body 102. Therefore, while certain features of the third and fourth cavities 216, 218 may not have been explicitly discussed herein, such as the posterior and anterior ramp surface 130, 132, protrusions 138 and channels 140, by way of non-limiting example, it is to be appreciated that such features of the third and fourth cavities 216, 218 can be configured substantially the same as those of the first and second cavities 116, 118, and the reference numbers of those features can be used interchangeably.


Referring now to FIGS. 11 through 14, various view of the first or anterior wedge member 306 are illustrated. The first wedge members 306 of each of the proximal and distal pairs 303, 304 can be configured similarly. The first wedge member 306 can define a first wedge body 400 extending along a first central wedge axis Y3 between an outer end 402 and an inner end 404 spaced from the outer end 402 with respect to the first central wedge axis Y3. The outer end 402 can define an outer face 406, and the inner 404 and can define an inner face 408, and each face 406, 408 can optionally be planar and oriented normal to the first central wedge axis Y3. The first central wedge axis Y3 is generally aligned with the central rod axis Y2 of the actuation rod 314 that carries the first wedge member 306. Thus, the first central wedge axis Y3 and the central rod axis Y2 can each extend along the transverse direction T. As show in FIGS. 5 and 6A, the outer end 402 of the first wedge body 400 is positioned to face in the anterior direction, and the inner end 404 is positioned to face in the posterior direction. The first wedge body 400 can define a first wedge length L1 between about 1.5 mm and about 10 mm measured from the outer end 402 to the inner end 404 of the first wedge body 400.


The first wedge body 400 can define one or more engagement elements configured to engage the corresponding engagement elements of the superior and inferior plates 100, 200 in a manner driving separation between the plates 100, 200 in the vertical direction V. The one or more engagement elements of the first wedge body 400 can include a first or superior inclined surface 410 and a second or inferior inclined surface 412 opposite and spaced from one another along the vertical direction V. The superior and inferior inclined surfaces 410, 412 can extend along the transverse direction T from the outer end 402 to the inner end 404 of the first wedge body 400. The superior and inferior inclined surfaces 410, 412 can each be inclined relative to the first central wedge axis Y3 such that the outer end is narrower than the inner end in the vertical direction V, thus providing the first wedge body 400 with its wedge shape. A height H1 of the outer end 402 of the first wedge body 400 in the vertical direction V can be in the range of about 2 mm and about 15 mm, and a height H2 of the inner end 404 of the first wedge body 400 in the vertical direction V can be in the range of about 3.5 mm and about 17.5 mm. The superior inclined surface 410 can slidably mate with the first ramp surface 130 within the associated cavity 116, 118 of the superior plate body 102, and the second inferior inclined surface 78 can slidably mate with the first ramp surface 130 within the associated cavity 216, 218 of the inferior plate body 202.


The first wedge body 400 can further define a first side surface 414 and an opposed second side surface 416 spaced from one another along the longitudinal direction L. The first and second side surfaces 414, 416 can extend from the outer end 402 to the inner end 404 of the first wedge body 400 along the transverse direction T and between the superior and inferior inclined surfaces 410, 412 along the vertical direction V. The first and second side surfaces 414, 416 can each be planar and parallel with one another, although other orientations are within the scope of the present disclosure.


The first wedge body 400 can also define one or more ridges 420 protruding from the first and second side surfaces 414, 416 along the longitudinal direction L. The ridges 420 are configured to interlock the first wedge member 306 with one or both of the superior and inferior plates 100, 200 so as to couple the superior and inferior plates 100, 200 together. For instance, the one or more ridges 420 are configured to be slidably received within one or more of the anterior channels 140a within the associated cavity 116. Accordingly, each of the ridges 420 of the first wedge body 400 can generally be parallel with the associated channels 140a in which they are received.


The one or more ridges 420 can include a first ridge 420a and a second ridge 420b protruding outwardly from the first side surface 414 of the first wedge body 400 along the longitudinal direction L, and can further include a third ridge 420c and a fourth ridge 420d protruding outwardly from the second side surface 416 of the first wedge body 400 along the longitudinal direction L. The first and third ridges 420a, 420 may each be located adjacent to or optionally contiguous with the superior inclined surface 410 of the first wedge body 400. Thus, the first and third ridges 420a, 420c may each be termed a superior ridge. The second and fourth ridges 420b, 420d may each be located adjacent to or optionally contiguous with the inferior inclined surface 412 of the first wedge body 400, and can thus each be termed an inferior ridge. One or both of the first and third ridges 420a, 420c can extend from the inner end 404 to the outer end 402 of the first wedge body 400 and can be parallel with the superior inclined surface 410 of the wedge body 400. Similarly, one or both of the second and fourth ridges 420b, 420d can extend from the inner end 404 to the outer end 402 of the first wedge body 400 and can be parallel with the inferior inclined surface 412 of the wedge body 400. However, in other embodiments, any one of the ridges 420 can extend less than the full distance between the outer and inner ends 402, 404 of the first wedge body 400.


Each of the ridges 420a, 420b, 420c, 420d can define a superior ridge surface 422, an opposed inferior ridge surface 424, and an outer ridge surface 426 extending between the superior and inferior ridge surfaces 422, 424 in the vertical direction V. The superior ridge surfaces 422 of the first and third ridges 420a, 420c can be adjacent to, contiguous with, or, as shown in the illustrated embodiments, can define a part of, the superior inclined surface 410 of the first wedge body 400. Similarly, the inferior ridge surfaces 424 of the second and fourth ridges 420b, 420d can be adjacent to, contiguous with, or, as shown, can define a part of, the inferior inclined surface 412 of the first wedge body 400. It is to be appreciated that the superior and inferior inclined surfaces 410, 412 of the first wedge body 400 can be planar, or, as depicted in FIGS. 6A and 11 through 14, can define one or more curved profiles in a vertical-transverse plane. For example, the superior and inferior inclined surfaces 410, 412 can each define a first region 428 adjacent or contiguous with the outer end 402, a second region 430 adjacent or contiguous with the inner end 404, and a third, intermediate region 432 located between the first and second regions 428, 430 with respect to the transverse direction T. As shown, the first and second regions 428, 430 can define first and second curved convex profiles, respectively, and the intermediate region 432 can define a linear profile, in the vertical-transverse plane. The curved profiles of the first and second regions 428, 430 can define the same radius of curvature or different radii of curvature, as needed. It is to be appreciated that the foregoing first, second and intermediate profiles can also be present on the superior ridge surfaces 422 of the first and third ridges 420a, 420c and the inferior ridges surfaces 424 of the second and fourth ridges 420b, 420d, particularly when the superior and inferior ridge surfaces 422, 424 define a part of the superior and inferior inclined surfaces 410, 412 of the first wedge body 400.


The curved profiles of the first and second regions 428, 430 of each of the superior and inferior inclined surfaces 410, 412 can reduce friction between the first wedge body 400 and the superior and inferior plate bodies 102, 202 during translation of the first wedge body 400 along the transverse direction T. The curved profiles can also provide for a smoother transition between the various lordotic angles α of the superior and inferior bone-contacting surfaces 104, 204, as well as reduce internal stresses imparted to the first wedge body 400 and the plate bodies 102, 202, respectively, during expansion of the implant 10.


As best shown in FIGS. 13 and 14, the first wedge body 400 can define a first maximum wedge width W1 between about 4 mm and about 7 mm measured from the outer surfaces 426 of the first and third ridges 420a, 420c (or the second and fourth ridges 420b, 420d) along the longitudinal direction L. Additionally, the superior inclined surface 410 can define a linear profile in a vertical-longitudinal plane, optionally with respect to each location along the first central wedge axis Y3.


With particular reference to FIG. 12, a first edge 434a between the outer and inferior ridge surfaces 426, 424 of the first ridge 420a and a second edge 434b between the outer and superior surfaces 426, 422 of the second ridge 420b can each define a linear profile in a vertical-transverse plane. Similarly, respective third and fourth edges 434c, 434d between the outer and inferior ridge surfaces 426, 424 of the third ridge 420c and between the outer and superior surfaces 426, 422 of the fourth ridge 420d, respectively, can each define a linear profile in a vertical-transverse plane. Each of these edges 434a, 434b, 434c, 434d can extend parallel with the respective channel 140a in which it is received. It is to be appreciated that the first, second, third, and fourth edges 434a, 434b, 434c, 434d can be considered as defining the incline angles θ of the first, second, third, and fourth ridges 420a, 420b, 420c, 420d, respectively. This is so even considering that the superior surfaces 422 of the first and third ridges 420a, 420c and the inferior surfaces 424 of the second and fourth ridges 420b, 420d can each define one or more curved profiles in the vertical-transverse plane. Accordingly, the first and third edges 434a, 434c can be parallel with one another and with the anterior channels 140a on opposite sides of the associated cavity 116, 118 of the superior plate body 102, and can each be inclined at a first or superior ridge incline angle θS between about 10 and 40 degrees with respect to the first central wedge axis Y3 (or with respect to the central rod axis Y1 of the actuation member 310 on which the first wedge body 400 is received). Similarly, the second and fourth edges 434b, 434d can be parallel with one another and with the anterior channels 140a on opposite sides of the associated cavity 216, 218 of the inferior plate body 202, and can each be inclined at a second or inferior ridge incline angle θI between about 10 and 40 degrees with respect to the first central wedge axis Y3 (or with respect to the central rod axis Y1 of the actuation member 310 on which the first wedge body 400 is received). The first and second ridge incline angles θS, θI can vary as needed. It is to be appreciated that, while the superior and inferior inclined surfaces 410, 412 of the first wedge body 400 can define one or more curved profiles in a vertical-transverse plane, the general incline angles of the superior and inferior surfaces 410, 412 can be defined or at least approximated by the superior and inferior ridge incline angles θS, θI, respectively.


The inferior ridge surface 424 of the first ridge 420a and the superior ridge surface 422 of the second ridge 420b can each be adjacent to or contiguous with the first side surface 414 of the first wedge body 400, and the inferior ridge surface 424 of the third ridge 420c and the superior ridge surface 422 of the fourth ridge 420d can each be adjacent to or contiguous with the second side surface 416 of the first wedge body 400. The outer ridge surfaces 426 of the first and third ridges 420a, 420c can be opposite one another along the longitudinal direction L, and outer ridge surfaces 426 of the second and fourth ridges 420b, 420d can be opposite one another along the longitudinal direction L. The inferior ridge surface 424 of the first ridge 420a and the superior ridge surface 422 of the second ridge 420b can be opposite and facing one another with respect to the vertical direction V such that the first central wedge axis Y3 is positioned between the inferior ridge surface 424 of the first ridge 420a and the superior ridge surface 422 of the second ridge 420b with respect to the vertical direction V. Similarly, the inferior ridge surface 424 of the third ridge 420c and the superior ridge surface 422 of the fourth ridge 420d can be opposite and facing one another with respect to the vertical direction V such that the first central wedge axis Y3 is positioned between the inferior ridge surface 424 of the third ridge 420c and the superior ridge surface 422 of the fourth ridge 420d with respect to the vertical direction V.


The inferior ridge surface 424 of the first ridge 420a, the superior ridge surface 422 of the second ridge 420b, and the first side surface 424 can collectively define a first recess portion 436 of the first wedge body 400, which can receive the anterior protrusions 138a defined on the associated side 124, 126 of the associated cavities 116, 216 of the superior and inferior plate bodies 102, 202, respectively. Similarly, the inferior ridge surface 424 of the third ridge 420c, the superior ridge surface 422 of the fourth ridge 420d, and the second side surface 416 can collectively define a second recess portion 438 of the first wedge body 400 which can receive the anterior protrusions 138a defined on the associated opposite side 126, 124 of the associated cavities 116, 216 of the superior and inferior plate bodies 102, 202, respectively. Simultaneously, the first and third ridges 420a, 420c can be received within the anterior channels 140a of the superior plate body 102, and the second and fourth ridges 420b, 420d can be received within the anterior channels 140a of the inferior plate body 202. Accordingly, the protrusions 138 of the plate bodies 102, 202 can overlap with the associated ridges 420 in the longitudinal direction L. Stated differently, the overhang surface 146 of each protrusion 138 can extend between the edge 434 of the associated ridge 420 and the associated side surface 414, 416 of the first wedge body 400 in the longitudinal direction L in manner providing mechanical interference resisting separation between the first wedge body 400 and the superior and inferior plate bodies 102, 202 along the vertical direction V. In this manner, the ridges 420 can interlock the first wedge body 400 to each of the superior and inferior plates 100, 200 so as to couple the superior and inferior plates 100, 200 together.


The first wedge body 400 can also define a first bore 440 extending therethrough from the outer end 402 to the inner end 404 along the first central wedge axis Y3. The first bore 440 can be configured to receive at least a portion of the associated actuation member 310. For example, the first bore 440 can be internally threaded to mate with the first or anterior threaded region 328 of the actuation member 310.


Referring now to FIGS. 15 through 18, various view of the second or posterior wedge member 308 are illustrated. The second wedge members 308 of the proximal and distal pairs 303, 304 of wedge members can be configured similarly. Furthermore, it is also to be appreciated that the second wedge member 308 can be configured substantially similarly, or optionally virtually identically, to the first wedge member 306. Accordingly, it is to be appreciated that each of the features and reference numbers described above in relation to the first wedge member 306 can be replicated in relation to the second wedge member 308, indicated herein with a “prime” notation when used in reference to the second wedge member 308. Thus, the second wedge body 400′ can define one or more engagement elements, such as the superior and inferior inclined surfaces 410′, 412′, that are configured to engage the corresponding engagement elements of the superior and inferior plates 100, 200 in a manner driving separation between the plates 100, 200 along the vertical direction V. For the sake of brevity, the following description of the second wedge body 400′ will focus on the differences between the first and second wedge members 306, 308 of the illustrated embodiment.


The superior and inferior inclined surfaces 410′, 412′ of the second wedge body 400′ can each define a linear profile in a vertical-transverse plane from the outer end 402′ to the inner end 404′. The superior and inferior inclined surfaces 410′, 412′ of the second wedge body 400′ can each be oriented at an incline angle θS′, θI′ between about 10 degrees and about 60 degrees from the second central wedge axis Y3′ (or from the central rod axis Y1 of the actuation member 310 on which the second wedge body 400′ is received) to the respective superior and inferior inclined surface 410′, 412′. The second wedge body 400′ can define a second wedge length L1′ between about 1.5 mm and about 10 mm, a second maximum wedge width W1′ between about 4 mm and about 7 mm, an outer end height H1′ between about 2 mm and about 15 mm, and an inner end height H2′ between about 3.5 mm and about 17.5 mm. The superior inclined surface 410′ can slidably mate with the second or posterior ramp surface 132 within the associated cavity 116, 118 of the superior plate body 102, and the second inferior inclined surface 412′ can slidably mate with the second or posterior ramp surface 132 within the associated cavity 216, 218 of the inferior plate body 202.


The one or more ridges 420′ of the second wedge body 400′ are configured to be slidably received within, and generally parallel with, the corresponding posterior channels 140b within the associated cavities 116, 118, 216, 218 of the superior and inferior plate bodies 102, 202. On the second wedge body 400′, the superior inclined surface 410′ can be parallel with each of the superior and inferior surfaces 422′, 424′ and the edges 434a′, 434c′ of the first and third (superior) ridges 420a′, 420c, while the inferior inclined surface 412′ can be parallel with each of the superior and inferior surfaces 422′, 424′ and the edges 434a′, 434c′ of the second and fourth (inferior) ridges 420b′, 420d.


The first recess portion 436′ of the second wedge body 400′ can receive the posterior protrusions 138b defined on the associated side 124, 126 of the associated cavities 116, 118, 216, 218 of the superior and inferior plate bodies 102, 202, and the second recess portion 438′ of the second wedge body 400′ can receive the posterior protrusions 138b defined on the associated opposite side 126, 124 of the associated cavities 116, 118, 216, 218 of the superior and inferior plate bodies 102, 202, respectively. Simultaneously, the ridges 420′ of the second wedge body 400′ can be received within the posterior channels 140b of the associated cavity 116, 118, 216, 218. Thus, the protrusions 138 of the plate bodies 102, 202 can overlap in the longitudinal direction L with the associated ridges 420′ of the second wedge body 400′ so as to interlock the second wedge body 400′ to each of the superior and inferior plates 100, 200. The second bore 440′ defined by the second wedge body 400′ can be internally threaded to mate with the second or posterior threaded region 330 of the associated actuation member 310. Further, one or both of the first and second wedge bodies 400, 400′ can include a radiographic marker embedded therein (not shown).


Referring now to FIGS. 19 and 20, the first and second (i.e., proximal and distal) actuation members 310, 312 are configured to couple the first and second wedge members 306, 308 of each pair 303, 304 together while also providing stability to the superior plate 100 and inferior plate 200 during expansion of the implant 10. The first and second actuation members 310, 312 can be configured substantially similarly, or even optionally virtually identically, to each other. Accordingly, while only the first actuation member 310 is shown in FIGS. 19 and 20, it is to be understood that the following description and reference numbers can also be used with reference to the second actuation member 312.


The first or anterior threaded region 328 can have a length L2 that is greater than a length L6 of the second or posterior threaded region 330 by a factor between about 1.5 to 4. The first or anterior unthreaded region 332 can have a length L3 that is less than the length L1 of the anterior wedge 306. Similarly, the second or posterior unthreaded region 334 can have a length L5 that is less than the length L1′ of the second or posterior wedge 308. In some embodiments, the lengths L3, L5 of the first and second unthreaded regions 332, 334 can each be as small as zero. The annular recess 326 can have a length L4 of in the range of about 0.25 mm and about 2 mm. The third unthreaded region 335 can have a length L7 of at least about 3 mm. The actuation rod 314 can have a total length L8 of between about 18 mm and about 48 mm. Each of the foregoing lengths L2-L8 are measured along the central rod axis Y1. The outer surface 321 of the actuation rod 314 within the annular recess 326 can define a diameter D1 greater than about 1 mm.


The posterior threaded region 330 can be located adjacent to the associated first or second transmission member 336, 338. For example, in the illustrated embodiments, the posterior threaded region 330 can be contiguous with a rear face 384 of the associated bevel gear 336. Additionally, the third unthreaded region 335 of the actuation rod 310 can define a mounting formation, such as a keyed connector 386, that is configured to be matingly received within a central keyed slot 388 defined in the rear face 384 of the bevel gear 336. In this manner, to assemble at least the second or posterior wedge member 308 on the actuation rod 314, a technician can insert the second threaded region 330 into the second bore 440′ of the second wedge member 308 and rotate the actuation rod 314 with respect to the second wedge member 308 until the second wedge member 308 translates along the second threaded portion 330 until the outer face 402′ of the second wedge body 400′ is positioned remote from, or at least spaced from, the abutment surface 335a in the anterior direction. Once the second wedge member 308 is so positioned on the actuation rod 314, the technician can insert the keyed connector 386 into the central keyed slot 388 of the bevel gear 336 until the rear face 384 of the bevel gear 336 abuts the abutment surface 335a. The central keyed slot 388 can extend from the rear face 384 to a front face 390 of the bevel gear 336 along the transverse direction T. The bevel gear 336 and the central keyed slot 388 can each have a length L9 that is substantially equivalent to the length L7 of the third unthreaded region 335 so that the posterior end 320 of the actuation rod 314 is at least substantially flush with the front face 390 of the bevel gear 336 when the rear face 384 of the gear 336 abuts the abutment surface 355a. Thus, once the rear face 384 of the bevel gear 336 abuts the abutment surface 355a, the technician can weld the bevel gear 336 to the actuation rod 314. For example, a weld can be formed at a joint between the posterior end 320 of the actuation rod 314 and the front face 390 of the bevel gear 336. It is to be appreciated, however, that other methods or techniques of affixing the bevel gear 336 to the actuation rod 314 are within the scope of the present disclosure.


Each actuation rod 314 is configured to extend through the first and second bores 440, 440′ of the first and second wedge bodies 400, 400′, respectively, and into the first and second curvilinear portions 134, 136 of the associated, vertically opposed cavities 116, 216 and 118, 218 of the superior and inferior plates 100, 200 when the implant 10 is in the collapsed configuration C.


The first threaded region 328 of the actuation rod 314 can have a thread pattern that is oriented in the opposite direction of a thread pattern formed on the second threaded region 330. Accordingly, the internal threads of the first and second bores 440, 440′ can be in opposing orientations such that when the actuation rod 314 rotates, the first and second wedge members 306, 308 translate along the actuation rod 314 toward each other or away from each depending on the rotation direction of the actuation rod 314. The thread pattern on each threaded region 328, 330 can have a different thread pitch so that the first and second wedge members 306, 308 translate along the first and second threaded regions 328, 330 at different respective rates. For example, in the illustrated embodiments, the thread pitch of the first threaded region 328 may be greater than the thread pitch of the second threaded region 330 so that the first wedge member 306 translates a greater transverse distance along the first threaded region 328 than a distance by which the second wedge member 308 translates along the second threaded region 330 responsive to rotation of the actuation rod 314 about the central rod axis Y1. In this manner, the lordotic angle α of the implant 10 can be increased as the implant 10 expands from the collapsed configuration C to the expanded configuration E. The actuation rod 314 can define a pitch ratio of about 3:1 between the first and second threaded regions 328, 330. In other embodiments, the pitch ratio can range from about 1:1 to about 6:1.


It is to be appreciated, however, that the lordotic angle of the implant 10 can also be increased during expansion of the implant 10 by adjusting any one or a combination of additional factors, such as: the respective incline angles θS, θI, θS′, θI′ of the superior and inferior inclined surfaces 410, 412 of the first and second wedge bodies 400, 400′; the ramp angles βS1, βI1, βS2, βI2 of the anterior and posterior ramps 130, β2 within the vertically opposed cavities 116, 216 and 118, 218 of the superior and inferior plate bodies 102, 202; the relative heights H1, H2, H1′, H2′ of the outer and inner ends 402, 404 of the first and second wedge bodies 400, 400′, by way of non-limiting example. Any of the foregoing factors, alone or in combination, can be adjusted or tailored as desired to provide a predetermined lordotic distraction profile when the implant 10 is in the expanded configuration E. It is also to be appreciated that the physician can achieve a kyphotic distraction profile by rotating the implant 10 by 180 degrees about the longitudinal implant axis X1 (i.e., flipping the implant 10 upside down) prior to insertion within the intervertebral space 5. Thus, the simple design of the implant 10 disclosed herein provides the benefit of allowing lordotic or kyphotic distraction of adjacent vertebral bodies 2, 4 as needed.


Referring to FIGS. 21 and 22, a sectional end view of the implant 10 is provide for both the collapsed configuration C (FIG. 21) and the expanded configuration E (FIG. 22), each view taken along the external side 124 of the first and third (i.e., proximal) cavities 116, 216 of the bone plates 100, 200 and facing the distal direction. While FIGS. 21 and 22 depict various aspects, features, and relative positions of each of the first and third cavities 116, 216, the first actuation member 310, the first pair 303 of wedge members, and the first bracket 364, it is to be appreciated that the following descriptions thereof can also be consistent with the second and fourth cavities 118, 218, the second actuation member 312, the second pair 304 of wedge members, and the second bracket 366.


Referring now to FIG. 21, in the collapsed configuration C, the interior plate contact surfaces 114, 214 of the superior and inferior plates 100, 200 can abut one another. The first and third cavities 116, 216 can provide space sufficient to house the first actuation member 310, the first pair 303 of wedge members, and at least a portion of the holding element 376 of the first bracket 364. The inner ends 404, 404′ of the first and second wedge members 306, 308 face one another and are spaced apart from each other to define a gap therebetween. The holding element 376 of the first bracket 364 can be positioned between the inner ends 404, 404′ of the first and second wedge members 306, 308 along the transverse direction T. At least one of the inner ends 404, 404′ can be adjacent to, or can optionally abut, the holding element 376. While not visible in FIG. 21, the first threaded region 328 of the actuation rod 314 can be disposed within the first bore 440 of the first wedge member 306 and the second threaded region 330 of the rod 314 can be disposed within the second bore 440′ of the second wedge member 308. The third landing surfaces 160 of the superior and inferior plate bodies 102, 202 can at least partially conform to an outer radius of the third gear 344.


Additionally, when the implant 10 is in the collapsed configuration C, the superior inclined surfaces 410, 410′ of the wedge members 306, 308 can be adjacent to or abut the respective first and second ramp surface 130, β2 within the first cavity 116 while the inferior inclined surfaces 412, 412′ of the wedge members 306, 308 can be adjacent to or abut the respective first and second ramp surface 130, β2 within the third cavity 216. The first ridges 420a, 420a′ of the wedges can be disposed in the respective anterior and posterior channels 140a, 140b within the first cavity 116, and the second ridges 420b, 420b′ can be disposed in the respective anterior and posterior channels 140a, 140b within the third cavity 216. While not visible in FIG. 21, it is to be appreciated that the third 420c, 420c′ and fourth ridges 420d, 420d′ of the wedge members 306, 308 can also be disposed within the channels 140a, 140b associated therewith. With continued reference to FIG. 21, portions of the first and second wedge members 306, 308 can extend into the first lumen 108 in communication with the first cavity 116 and into the third lumen 208 in communication with the third cavity 216, which enhances the compactness and reduces the overall transverse width W0 of the implant 10. The lumens 108, 208 have the additional benefit of promoting bone growth after the implant 10 is implanted in the intervertebral space 5.


During expansion of the implant 10 (i.e., between the respective configurations shown in FIGS. 21 and 22), the drive shaft 340 can be rotated about the central shaft axis X2, which rotates the third and fourth gears 344, 346, which, in turn, rotate the first and second gears 336, 338 and the actuation rods 314 about their central rod axes Y1. Rotation of the actuation rods 314 causes the first wedge member 306 of each pair 302, 304 to translate in the anterior direction (i.e., toward the anterior side 16 of the implant 10) along the first threaded region 328 and the second wedge member 308 of each pair 302, 304 to translate in the posterior direction (i.e., toward the posterior side 18 of the implant 10) along the second threaded region 330. The superior and inferior inclined surfaces 410, 412, 410′, 412′ of the first and second wedge members 306, 308 bear against the associated ramp surfaces 130, β2 of the plate bodies 102, 202 to separate the superior plate body 102 from the inferior plate body 202 along the vertical direction V. The ridges 420a, 420c, 420a′, 420c′ slide along the associated channels 140a, 140b. The holding element 376 of the bracket 364 can remain disposed within the annular recess 326 of the actuation rod 214 and can also remain within the exterior and interior slots 148, 150. As shown in FIG. 22, in the expanded configuration E, the outer end 404′ of the second wedge member 308 can abut the rear face 384 of the first bevel gear 336, which affectively causes a braking action of the expansion mechanism 300. Additionally, in the expanded configuration E, the outer ends 404 of the first wedge members 306 of each pair 303, 304 can protrude marginally from the anterior side 16 of the implant 10. However, in other embodiments, the outer ends 404 of the first wedge members 306 can be spaced from the anterior side 16 of the implant 10 in the posterior direction when the implant 10 is in the expanded configuration E. It is to be appreciated that the actuation rod 314, the first and second bevel gears 336, 338, and the first and second wedge members 306, 308 can be collectively configured such that a stop surface or feature is not required for the first wedge member 306.


The embodiments set forth herein prove the implant 10 with numerous benefits. For example, the longitudinal length L0 of the implant 10 can be consistent regardless of whether the implant 10 is in the collapsed configuration C or the expanded configuration E. In embodiments wherein the first wedge members 306 do not protrude from the anterior side 16 of the implant 10 in the expanded configuration E, the width W0 of the implant 10 can also be consistent regardless of whether the implant 10 is in the collapsed or expanded configuration C, E.


It is to be appreciated that portions of any of the superior and inferior plate bodies 102, 202 and/or any component of the expansion mechanism 300 can include features configured to engage one or more tools for inserting, positioning, and/or expanding the implant 10. The superior and inferior plate bodies 102, 202 can each include one or more radiographic markers (not shown) aligned with one another along the vertical direction so that, with image analysis, the extent of plate separation can be determined or indicated by observing the relative vertical positions of the aligned radiographic markers.


It is also to be appreciated that the relative orientations of the actuation members 310, 312 and the drive shaft 340 in relation to each other and in relation to the superior and inferior plates 100, 200 can be altered. For example, the central rod axis Y1 of each actuation member 310, 312 could be oriented at an obtuse angle with respect to the central shaft axis X2 of the drive shaft 340. Additionally, in other embodiments, the implant can include only one actuation member 310 and one associated pair of wedge members 303.


It is yet also to be appreciated that the features of the implant 10 disclosed herein can be modified such that, for example, only one of the wedge members 306, 308 translates along the transverse direction in response to rotation of the drive shaft 340, or that only one of the superior and inferior plates 100, 200 moves along the vertical direction during expansion of the implant 10.


It is further to be appreciated that the dimensions set forth above in regards to various components of the implant 10 represent mere examples of the sizes of the foregoing components. The dimensions of the foregoing components can be adjusted as needed. Furthermore, the implant 10, and its various components, can also be scaled larger or smaller than the sizes disclosed herein.


Each of the components described herein can be formed of a biocompatible metal, such as titanium, steel, or any alloy thereof, such as a titanium-molybdenum alloy, for example, or any biocompatible polymeric material, such as polyether ether ketone (PEEK), or any other suitable biocompatible material.


Although the disclosure has been described in detail, it should be understood that various changes, substitutions, and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims. Moreover, the scope of the present disclosure is not intended to be limited to the particular embodiments described in the specification. As one of ordinary skill in the art will readily appreciate from that processes, machines, manufacture, composition of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present disclosure.

Claims
  • 1. An expandable implant, comprising: a first plate and a second plate spaced from each other along a first direction, the first plate defining a first bone-contacting surface configured to contact a superior vertebral body, the second plate defining a second bone-contacting surface opposed to the first bone contacting surface along the first direction, the second bone contacting surface configured to contact an inferior vertebral body;an actuation member at least partially disposed between the first and second plates with respect to the first direction, the actuation member defining a first axis, a first end and a second end spaced from the first end along a second direction along the first axis, wherein the second direction is perpendicular to the first direction;first and second wedge members carried by the actuation member and in engagement with the first and second plates;a first transmission member carried by the actuation member;a drive member defining a second axis, a proximal end and a distal end spaced from the proximal end along a third direction along the second axis, the third direction perpendicular to the first direction and offset from the second direction; anda second transmission member carried by the drive member,wherein the drive member is configured to communicate a driving force to the actuation member so as to cause the actuation member to rotate about the first axis, and at least one of first and second wedge members is configured to translate along the second direction in response to rotation of the actuation member about the first axis so as to move at least one of the first and second plates with respect to the other of the first and second plates along the first direction,wherein the first and second transmission members are configured to engage one another so as to transfer at least a portion of the driving force to the actuation member so as to rotate the actuation member about the first axis, andwherein the first transmission member is a first gear, and the second transmission member is a second gear.
  • 2. The implant of claim 1, wherein first gear is configured to rotate about the first axis and the second gear is configured to rotate about the second axis.
  • 3. The implant of claim 2, wherein the first and second gears are both bevel gears.
  • 4. The implant of claim 2, wherein the first and second axes are perpendicular to one another.
  • 5. The implant of claim 4, wherein the first and second axes are each perpendicular to the first direction.
  • 6. An expandable implant, comprising: a first plate and a second plate spaced from each other along a first direction, the first plate defining a first bone-contacting surface configured to contact a superior vertebral body, the second plate defining a second bone-contacting surface opposed to the first bone contacting surface along the first direction, the second bone contacting surface configured to contact an inferior vertebral body,a first actuation member at least partially disposed between the first and second plates with respect to the first direction, the actuation member defining a first axis, a first end and a second end spaced from the first end along a second direction along the first axis, wherein the second direction is perpendicular to the first direction;first and second wedge members carried by the actuation member and in engagement with the first and second plates;a first transmission member carried by the actuation member;a drive member defining a second axis, a proximal end and a distal end spaced from the proximal end along a third direction along the second axis, the third direction perpendicular to the first direction and offset from the second direction; anda second transmission member carried by the drive member,wherein the drive member is configured to communicate a driving force to the actuation member so as to cause the actuation member to rotate about the first axis, and at least one of first and second wedge members is configured to translate along the second direction in response to rotation of the actuation member about the first axis so as to move at least one of the first and second plates with respect to the other of the first and second plates along the first direction,wherein the first and second transmission members are configured to engage one another so as to transfer at least a portion of the driving force to the actuation member so as to rotate the actuation member about the first axis, andwherein the implant further comprises a second actuation member that is spaced from the first actuation member along the third direction.
  • 7. The implant of claim 6, wherein the second actuation member defines a third axis extending along the second direction, the second actuation member further defining a first end and a second end spaced from the first end along the second direction.
  • 8. The implant of claim 7, further comprising third and fourth wedge members carried by the second actuation member, wherein the third and fourth wedge members are in engagement with the first and second plates, the third and fourth wedge members are configured to translate at least one of toward and away from each other along the third axis responsive to rotation of the second actuation member about the third axis so as to at least partially move the first and second plates away from one another in the first direction.
  • 9. The implant of claim 8, further comprising: a third transmission member carried by the second actuation member;a fourth transmission member carried by the drive member, wherein the third and fourth transmission members are configured to engage one another so as to transfer at least a second portion of the driving force to the second actuation member so as to rotate the second actuation member about the third axis.
  • 10. The implant of claim 9, wherein the first transmission member is a first gear, the second transmission member is a second gear, the third transmission member is a third gear, and the fourth transmission member is a fourth gear.
  • 11. The implant of claim 10, wherein each of the first, second, third, and fourth gears is a bevel gear.
  • 12. The implant of claim 11, wherein the first bevel gear is configured to rotate about the first axis, the third bevel gear configured to rotate about the third axis, and the second and fourth bevel gears are each configured to rotate about the second axis.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/519,470, filed Jun. 14, 2017, in the name of Luu, the entire disclosure of which is hereby incorporated by reference into this patent application.

US Referenced Citations (2783)
Number Name Date Kind
1802560 Kerwin Apr 1931 A
1924695 Olson Aug 1933 A
1965653 Kennedy Jul 1934 A
2077804 Morrison Apr 1937 A
2115250 Bruson Apr 1938 A
2121193 Hanicke Jun 1938 A
2170111 Bruson Aug 1939 A
2173655 Neracher et al. Sep 1939 A
2229024 Bruson Jan 1941 A
2243717 Moreira May 1941 A
2381050 Hardinge Aug 1945 A
2388056 Hendricks Oct 1945 A
2485531 William et al. Oct 1949 A
2489870 Dzus Nov 1949 A
2570465 Lundholm Oct 1951 A
2677369 Knowles May 1954 A
2706701 Hans et al. Apr 1955 A
2710277 Shelanski et al. Jun 1955 A
2826532 Hosmer Mar 1958 A
2900305 Siggia Aug 1959 A
2977315 Scheib et al. Mar 1961 A
3091237 Skinner May 1963 A
3112743 Cochran et al. Dec 1963 A
3115804 Johnson Dec 1963 A
3228828 Romano Jan 1966 A
3312139 Di Cristina Apr 1967 A
3486505 Morrison Dec 1969 A
3489143 Halloran Jan 1970 A
3648294 Shahrestani Mar 1972 A
3698391 Mahony Oct 1972 A
3717655 Godefroi et al. Feb 1973 A
3760802 Fischer et al. Sep 1973 A
3800788 White Apr 1974 A
3805775 Fischer et al. Apr 1974 A
3811449 Gravlee et al. May 1974 A
3842825 Wagner Oct 1974 A
3848601 Ma et al. Nov 1974 A
3855638 Pilliar Dec 1974 A
3867728 Stubstad et al. Feb 1975 A
3875595 Froning Apr 1975 A
3889665 Ling et al. Jun 1975 A
3964480 Froning Jun 1976 A
3986504 Avila Oct 1976 A
4013071 Rosenberg Mar 1977 A
4052988 Doddi et al. Oct 1977 A
4091806 Aginsky May 1978 A
4175555 Herbert Nov 1979 A
4236512 Aginsky Dec 1980 A
4249435 Smith et al. Feb 1981 A
4262665 Roalstad et al. Apr 1981 A
4262676 Jamshidi Apr 1981 A
4274163 Malcom et al. Jun 1981 A
4275717 Bolesky Jun 1981 A
4312337 Donohue Jan 1982 A
4312353 Shahbabian Jan 1982 A
4313434 Segal Feb 1982 A
4341206 Perrett et al. Jul 1982 A
4349921 Kuntz Sep 1982 A
4350151 Scott Sep 1982 A
4351069 Ballintyn et al. Sep 1982 A
4352883 Lim Oct 1982 A
4369790 McCarthy Jan 1983 A
4399814 Pratt et al. Aug 1983 A
4401112 Rezaian Aug 1983 A
4401433 Luther Aug 1983 A
4409974 Freedland Oct 1983 A
4440921 Allcock et al. Apr 1984 A
4449532 Storz May 1984 A
4451256 Weikl et al. May 1984 A
4456005 Lichty Jun 1984 A
4462394 Jacobs Jul 1984 A
4463753 Gustilo Aug 1984 A
4466435 Murray Aug 1984 A
4467479 Brody Aug 1984 A
4488543 Tornier Dec 1984 A
4488549 Lee et al. Dec 1984 A
4494535 Haig Jan 1985 A
4495174 Allcock et al. Jan 1985 A
4532660 Field Aug 1985 A
4537185 Stednitz Aug 1985 A
4538612 Patrick, Jr. Sep 1985 A
4542539 Rowe et al. Sep 1985 A
4545374 Jacobson Oct 1985 A
4562598 Kranz Jan 1986 A
4573448 Kambin Mar 1986 A
4595006 Burke et al. Jun 1986 A
4601710 Moll Jul 1986 A
4625722 Murray Dec 1986 A
4625725 Davison et al. Dec 1986 A
4627434 Murray Dec 1986 A
4628945 Johnson, Jr. Dec 1986 A
4629450 Suzuki et al. Dec 1986 A
4630616 Tretinyak Dec 1986 A
4632101 Freedland Dec 1986 A
4640271 Lower Feb 1987 A
4641640 Griggs Feb 1987 A
4645503 Lin et al. Feb 1987 A
4646741 Smith Mar 1987 A
4651717 Jakubczak Mar 1987 A
4653489 Tronzo Mar 1987 A
4665906 Jervis May 1987 A
4667663 Miyata May 1987 A
4686973 Frisch Aug 1987 A
4686984 Bonnet Aug 1987 A
4688561 Reese Aug 1987 A
4697584 Haynes Oct 1987 A
4706670 Andersen et al. Nov 1987 A
4714469 Kenna Dec 1987 A
4714478 Fischer Dec 1987 A
4721103 Freedland Jan 1988 A
4723544 Moore et al. Feb 1988 A
4743256 Brantigan May 1988 A
4743257 Toermaelae et al. May 1988 A
4759766 Buettner-Janz et al. Jul 1988 A
4760843 Fischer et al. Aug 1988 A
4772287 Ray et al. Sep 1988 A
4790304 Rosenberg Dec 1988 A
4790817 Luther Dec 1988 A
4796612 Reese Jan 1989 A
4802479 Haber et al. Feb 1989 A
4815909 Simons Mar 1989 A
4827917 Brumfield May 1989 A
4834069 Umeda May 1989 A
4834757 Brantigan May 1989 A
4838282 Strasser et al. Jun 1989 A
4856950 Bushnell Aug 1989 A
4858601 Glisson Aug 1989 A
4862891 Smith Sep 1989 A
4863476 Shepperd Sep 1989 A
4870153 Matzner et al. Sep 1989 A
4871366 Von et al. Oct 1989 A
4873976 Schreiber Oct 1989 A
4878915 Brantigan Nov 1989 A
4880622 Allcock et al. Nov 1989 A
4888022 Huebsch Dec 1989 A
4888024 Powlan Dec 1989 A
4889119 Jamiolkowski et al. Dec 1989 A
4892550 Huebsch Jan 1990 A
4896662 Noble Jan 1990 A
4898186 Ikada et al. Feb 1990 A
4898577 Badger et al. Feb 1990 A
4903692 Reese Feb 1990 A
4904261 Dove et al. Feb 1990 A
4911718 Lee et al. Mar 1990 A
4917554 Bronn Apr 1990 A
4932969 Frey et al. Jun 1990 A
4940467 Tronzo Jul 1990 A
4941466 Romano Jul 1990 A
4946378 Hirayama et al. Aug 1990 A
4959064 Engelhardt Sep 1990 A
4961740 Ray et al. Oct 1990 A
4963144 Huene Oct 1990 A
4966587 Baumgart Oct 1990 A
4968317 Toermaelae et al. Nov 1990 A
4969888 Scholten et al. Nov 1990 A
4978334 Toye et al. Dec 1990 A
4978349 Frigg Dec 1990 A
4981482 Ichikawa Jan 1991 A
4988351 Paulos et al. Jan 1991 A
4994027 Farrell Feb 1991 A
4995200 Eberhart Feb 1991 A
5002557 Hasson Mar 1991 A
5006121 Hafeli Apr 1991 A
5011484 Breard Apr 1991 A
5013315 Barrows May 1991 A
5013316 Goble et al. May 1991 A
5015247 Michelson May 1991 A
5015255 Kuslich May 1991 A
5019082 Frey et al. May 1991 A
5030233 Ducheyne Jul 1991 A
5051189 Farrah Sep 1991 A
5053035 McLaren Oct 1991 A
5055104 Ray Oct 1991 A
5059193 Kuslich Oct 1991 A
5062849 Schelhas Nov 1991 A
5071435 Fuchs et al. Dec 1991 A
5071437 Steffee Dec 1991 A
5080662 Paul Jan 1992 A
5084043 Hertzmann et al. Jan 1992 A
5092891 Kummer et al. Mar 1992 A
5098241 Aldridge et al. Mar 1992 A
5098433 Freedland Mar 1992 A
5098435 Stednitz et al. Mar 1992 A
5102413 Poddar Apr 1992 A
5108404 Scholten et al. Apr 1992 A
5114407 Burbank May 1992 A
5116336 Frigg May 1992 A
5120171 Lasner Jun 1992 A
5122130 Keller Jun 1992 A
5122133 Evans Jun 1992 A
5122141 Simpson et al. Jun 1992 A
5123926 Pisharodi Jun 1992 A
5133719 Winston Jul 1992 A
5133755 Brekke Jul 1992 A
5134477 Knauer et al. Jul 1992 A
5139486 Moss Aug 1992 A
5147366 Arroyo et al. Sep 1992 A
5158543 Lazarus Oct 1992 A
5163939 Winston Nov 1992 A
5163989 Campbell et al. Nov 1992 A
5167663 Brumfield Dec 1992 A
5167664 Hodorek Dec 1992 A
5169400 Muehling et al. Dec 1992 A
5169402 Elloy Dec 1992 A
5171278 Pisharodi Dec 1992 A
5171279 Mathews Dec 1992 A
5171280 Baumgartner Dec 1992 A
5176651 Allgood et al. Jan 1993 A
5176683 Kimsey et al. Jan 1993 A
5176692 Wilk et al. Jan 1993 A
5176697 Hasson et al. Jan 1993 A
5178501 Carstairs Jan 1993 A
5183052 Terwilliger Feb 1993 A
5183464 Dubrul et al. Feb 1993 A
5188118 Terwilliger Feb 1993 A
5192327 Brantigan Mar 1993 A
5195506 Hulfish Mar 1993 A
5201742 Hasson Apr 1993 A
5217462 Asnis et al. Jun 1993 A
5217475 Kuber Jun 1993 A
5217486 Rice et al. Jun 1993 A
5224952 Deniega et al. Jul 1993 A
5228441 Lundquist Jul 1993 A
5234431 Keller Aug 1993 A
5241972 Bonati Sep 1993 A
5242410 Melker Sep 1993 A
5242447 Borzone Sep 1993 A
5242448 Pettine et al. Sep 1993 A
5242879 Abe et al. Sep 1993 A
5246441 Ross et al. Sep 1993 A
5250049 Michael Oct 1993 A
5250061 Michelson Oct 1993 A
5257632 Turkel et al. Nov 1993 A
5263953 Bagby Nov 1993 A
5269797 Bonati et al. Dec 1993 A
5280782 Wilk Jan 1994 A
5285795 Ryan et al. Feb 1994 A
5286001 Rafeld Feb 1994 A
5290243 Chodorow et al. Mar 1994 A
5290312 Kojimoto et al. Mar 1994 A
5300074 Frigg Apr 1994 A
5303718 Krajicek Apr 1994 A
5304142 Liebl et al. Apr 1994 A
5306307 Senter et al. Apr 1994 A
5306308 Gross et al. Apr 1994 A
5306309 Wagner et al. Apr 1994 A
5306310 Siebels Apr 1994 A
5308327 Heaven et al. May 1994 A
5308352 Koutrouvelis May 1994 A
5312410 Miller et al. May 1994 A
5312417 Wilk May 1994 A
5314477 Marnay May 1994 A
5320644 Baumgartner Jun 1994 A
5322505 Krause et al. Jun 1994 A
5324261 Amundson et al. Jun 1994 A
5330429 Noguchi et al. Jul 1994 A
5331975 Bonutti Jul 1994 A
5334184 Bimman Aug 1994 A
5334204 Clewett et al. Aug 1994 A
5342365 Waldman Aug 1994 A
5342382 Brinkerhoff et al. Aug 1994 A
5344252 Kakimoto Sep 1994 A
5361752 Moll et al. Nov 1994 A
5364398 Chapman et al. Nov 1994 A
5370646 Reese et al. Dec 1994 A
5370647 Graber et al. Dec 1994 A
5370661 Branch Dec 1994 A
5370697 Baumgartner Dec 1994 A
5372660 Davidson et al. Dec 1994 A
5374267 Siegal Dec 1994 A
5382248 Jacobson et al. Jan 1995 A
5383932 Wilson et al. Jan 1995 A
5385151 Scarfone et al. Jan 1995 A
5387213 Breard et al. Feb 1995 A
5387215 Fisher Feb 1995 A
5390683 Pisharodi Feb 1995 A
5395317 Kambin Mar 1995 A
5395371 Miller et al. Mar 1995 A
5397364 Kozak et al. Mar 1995 A
5401269 Buettner-Janz et al. Mar 1995 A
5407430 Peters Apr 1995 A
5410016 Hubbell et al. Apr 1995 A
5415661 Holmes May 1995 A
5423816 Lin Jun 1995 A
5423817 Lin Jun 1995 A
5423850 Berger Jun 1995 A
5424773 Saito Jun 1995 A
5425773 Boyd et al. Jun 1995 A
5431658 Moskovich Jul 1995 A
5441538 Bonutti Aug 1995 A
5443514 Steffee Aug 1995 A
5449359 Groiso Sep 1995 A
5449361 Preissman Sep 1995 A
5452748 Simmons et al. Sep 1995 A
5454365 Bonutti Oct 1995 A
5454790 Dubrul Oct 1995 A
5454815 Geisser et al. Oct 1995 A
5454827 Aust et al. Oct 1995 A
5456686 Klapper et al. Oct 1995 A
5458641 Ramirez Jimenez Oct 1995 A
5458643 Oka et al. Oct 1995 A
5462563 Shearer et al. Oct 1995 A
5464427 Curtis et al. Nov 1995 A
5468245 Vargas, III Nov 1995 A
5470333 Ray Nov 1995 A
5472426 Bonati et al. Dec 1995 A
5474539 Costa et al. Dec 1995 A
5480400 Berger Jan 1996 A
5484437 Michelson Jan 1996 A
5486190 Green Jan 1996 A
5496318 Howland et al. Mar 1996 A
5498265 Asnis et al. Mar 1996 A
5501695 Anspach et al. Mar 1996 A
5505710 Dorsey, III Apr 1996 A
5507816 Bullivant Apr 1996 A
5509923 Middleman et al. Apr 1996 A
5512037 Russell et al. Apr 1996 A
5514143 Bonutti et al. May 1996 A
5514153 Bonutti May 1996 A
5514180 Heggeness et al. May 1996 A
5520690 Errico et al. May 1996 A
5520896 De et al. May 1996 A
5522398 Goldenberg et al. Jun 1996 A
5522790 Moll et al. Jun 1996 A
5522846 Bonutti Jun 1996 A
5522895 Mikos Jun 1996 A
5522899 Michelson Jun 1996 A
5527312 Ray Jun 1996 A
5527343 Bonutti Jun 1996 A
5527624 Higgins et al. Jun 1996 A
5531856 Moll et al. Jul 1996 A
5534023 Henley Jul 1996 A
5534029 Shima Jul 1996 A
5534030 Navarro et al. Jul 1996 A
5536127 Pennig Jul 1996 A
5538009 Byrne et al. Jul 1996 A
5540688 Navas Jul 1996 A
5540693 Fisher Jul 1996 A
5540711 Kieturakis et al. Jul 1996 A
5545164 Howland Aug 1996 A
5545222 Bonutti Aug 1996 A
5549610 Russell et al. Aug 1996 A
5549679 Kuslich Aug 1996 A
5554191 Lahille et al. Sep 1996 A
5556431 Buttner-Janz Sep 1996 A
5558674 Heggeness et al. Sep 1996 A
D374287 Goble et al. Oct 1996 S
5562736 Ray et al. Oct 1996 A
5562738 Boyd et al. Oct 1996 A
5564926 Braanemark Oct 1996 A
5569248 Mathews Oct 1996 A
5569251 Baker et al. Oct 1996 A
5569290 McAfee Oct 1996 A
5569548 Koike et al. Oct 1996 A
5571109 Bertagnoli Nov 1996 A
5571189 Kuslich Nov 1996 A
5571190 Ulrich et al. Nov 1996 A
5575790 Chen et al. Nov 1996 A
5591168 Judet et al. Jan 1997 A
5593409 Michelson Jan 1997 A
5601556 Pisharodi Feb 1997 A
5601561 Ferry et al. Feb 1997 A
5601572 Middleman et al. Feb 1997 A
5609634 Voydeville Mar 1997 A
5609635 Michelson Mar 1997 A
5613950 Yoon Mar 1997 A
5618142 Sonden et al. Apr 1997 A
5618314 Harwin et al. Apr 1997 A
5624447 Myers Apr 1997 A
5626613 Schmieding May 1997 A
5628751 Sander et al. May 1997 A
5628752 Asnis et al. May 1997 A
5632746 Middleman et al. May 1997 A
5639276 Weinstock et al. Jun 1997 A
5643320 Lower et al. Jul 1997 A
5645589 Li Jul 1997 A
5645596 Kim et al. Jul 1997 A
5645597 Krapiva Jul 1997 A
5645599 Samani Jul 1997 A
5647857 Anderson et al. Jul 1997 A
5649931 Bryant et al. Jul 1997 A
5653763 Errico et al. Aug 1997 A
5658335 Allen Aug 1997 A
5662683 Kay Sep 1997 A
5665095 Jacobson et al. Sep 1997 A
5665122 Kambin Sep 1997 A
5667508 Errico et al. Sep 1997 A
5669915 Caspar et al. Sep 1997 A
5669926 Aust et al. Sep 1997 A
5674294 Bainville et al. Oct 1997 A
5674295 Ray et al. Oct 1997 A
5674296 Bryan et al. Oct 1997 A
5676701 Yuan et al. Oct 1997 A
5679723 Cooper et al. Oct 1997 A
5681263 Flesch Oct 1997 A
5683465 Shinn et al. Nov 1997 A
5693100 Pisharodi Dec 1997 A
5695513 Johnson et al. Dec 1997 A
5697977 Pisharodi Dec 1997 A
5700239 Yoon Dec 1997 A
5702391 Lin Dec 1997 A
5702449 McKay Dec 1997 A
5702450 Bisserie Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5702454 Baumgartner Dec 1997 A
5707359 Bufalini Jan 1998 A
5713870 Yoon Feb 1998 A
5713903 Sander et al. Feb 1998 A
5716415 Steffee Feb 1998 A
5716416 Lin Feb 1998 A
5720753 Sander et al. Feb 1998 A
5725531 Shapiro Mar 1998 A
5725541 Anspach et al. Mar 1998 A
5725588 Errico et al. Mar 1998 A
5728097 Mathews Mar 1998 A
5728116 Rosenman Mar 1998 A
5735853 Olerud Apr 1998 A
5741253 Michelson Apr 1998 A
5741282 Anspach et al. Apr 1998 A
5743881 Demco Apr 1998 A
5743912 Lahille et al. Apr 1998 A
5743914 Skiba Apr 1998 A
5749879 Middleman et al. May 1998 A
5749889 Bacich et al. May 1998 A
5752969 Cunci et al. May 1998 A
5755797 Baumgartner May 1998 A
5755798 Papavero et al. May 1998 A
5756127 Grisoni et al. May 1998 A
5762500 Lazarof Jun 1998 A
5762629 Kambin Jun 1998 A
5766252 Henry et al. Jun 1998 A
5772661 Michelson Jun 1998 A
5772662 Chapman et al. Jun 1998 A
5772678 Thomason et al. Jun 1998 A
5776156 Shikhman Jul 1998 A
5782800 Yoon Jul 1998 A
5782832 Larsen et al. Jul 1998 A
5782865 Grotz Jul 1998 A
5788703 Mittelmeier et al. Aug 1998 A
5792044 Foley et al. Aug 1998 A
5800549 Bao et al. Sep 1998 A
5807275 Jamshidi Sep 1998 A
5807327 Green et al. Sep 1998 A
5810721 Mueller et al. Sep 1998 A
5810821 Vandewalle Sep 1998 A
5810866 Yoon Sep 1998 A
5814084 Grivas et al. Sep 1998 A
5820628 Middleman et al. Oct 1998 A
5823979 Mezo Oct 1998 A
5824084 Muschler Oct 1998 A
5824093 Ray et al. Oct 1998 A
5824094 Serhan et al. Oct 1998 A
5827289 Reiley et al. Oct 1998 A
5833657 Reinhardt et al. Nov 1998 A
5836948 Zucherman et al. Nov 1998 A
5837752 Shastri et al. Nov 1998 A
5846259 Berthiaume Dec 1998 A
5848986 Lundquist et al. Dec 1998 A
5849004 Bramlet Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5851216 Allen Dec 1998 A
5857995 Thomas et al. Jan 1999 A
5860973 Michelson Jan 1999 A
5860977 Zucherman et al. Jan 1999 A
5865846 Bryan et al. Feb 1999 A
5865848 Baker Feb 1999 A
5871485 Rao et al. Feb 1999 A
5873854 Wolvek Feb 1999 A
5876404 Zucherman et al. Mar 1999 A
5888220 Felt et al. Mar 1999 A
5888223 Bray, Jr. Mar 1999 A
5888224 Beckers et al. Mar 1999 A
5888226 Rogozinski Mar 1999 A
5888227 Cottle Mar 1999 A
5888228 Knothe et al. Mar 1999 A
5893850 Cachia Apr 1999 A
5893889 Harrington Apr 1999 A
5893890 Pisharodi Apr 1999 A
5895428 Berry Apr 1999 A
5902231 Foley et al. May 1999 A
5904690 Middleman et al. May 1999 A
5904696 Rosenman May 1999 A
5908422 Bresina Jun 1999 A
5916228 Ripich et al. Jun 1999 A
5916267 Prakit Jun 1999 A
5919235 Husson et al. Jul 1999 A
5925056 Thomas et al. Jul 1999 A
5925074 Gingras et al. Jul 1999 A
5928235 Friedl Jul 1999 A
5928244 Tovey et al. Jul 1999 A
5928422 Uchiyama et al. Jul 1999 A
5931870 Cuckler et al. Aug 1999 A
5935129 McDevitt et al. Aug 1999 A
5947999 Groiso Sep 1999 A
5948000 Larsen et al. Sep 1999 A
5954722 Bono Sep 1999 A
5954747 Clark Sep 1999 A
5957902 Teves Sep 1999 A
5957924 Toermaelae et al. Sep 1999 A
5961554 Janson et al. Oct 1999 A
5964730 Williams et al. Oct 1999 A
5964761 Kambin Oct 1999 A
5967783 Ura Oct 1999 A
5967970 Cowan et al. Oct 1999 A
5968044 Nicholson et al. Oct 1999 A
5968098 Winslow Oct 1999 A
5972015 Scribner et al. Oct 1999 A
5972385 Liu et al. Oct 1999 A
5976139 Bramlet Nov 1999 A
5976146 Ogawa et al. Nov 1999 A
5976186 Bao et al. Nov 1999 A
5976187 Richelsoph Nov 1999 A
5980522 Koros et al. Nov 1999 A
5984927 Wenstrom et al. Nov 1999 A
5984966 Kiema et al. Nov 1999 A
5985307 Hanson et al. Nov 1999 A
5989255 Pepper et al. Nov 1999 A
5989291 Ralph et al. Nov 1999 A
5993459 Larsen et al. Nov 1999 A
5997510 Schwemberger Dec 1999 A
5997538 Asnis et al. Dec 1999 A
5997541 Schenk Dec 1999 A
6001100 Sherman et al. Dec 1999 A
6001101 Augagneur et al. Dec 1999 A
6004327 Asnis et al. Dec 1999 A
6005161 Brekke Dec 1999 A
6007519 Rosselli Dec 1999 A
6007566 Wenstrom, Jr. Dec 1999 A
6007580 Lehto et al. Dec 1999 A
6010508 Bradley Jan 2000 A
6010513 Toermaelae et al. Jan 2000 A
6012494 Balazs Jan 2000 A
6015410 Toermaelae et al. Jan 2000 A
6015436 Schoenhoeffer Jan 2000 A
6019762 Cole Feb 2000 A
6019792 Cauthen Feb 2000 A
6019793 Perren et al. Feb 2000 A
6022350 Ganem Feb 2000 A
6022352 Vandewalle Feb 2000 A
6030162 Huebner Feb 2000 A
6030364 Durgin et al. Feb 2000 A
6030401 Marino Feb 2000 A
6033406 Mathews Mar 2000 A
6033412 Losken et al. Mar 2000 A
6036701 Rosenman Mar 2000 A
6039740 Olerud Mar 2000 A
6039761 Li et al. Mar 2000 A
6039763 Shelokov Mar 2000 A
6045552 Zucherman et al. Apr 2000 A
6045579 Hochschuler et al. Apr 2000 A
6048309 Flom et al. Apr 2000 A
6048342 Zucherman et al. Apr 2000 A
6048346 Reiley et al. Apr 2000 A
6048360 Khosravi et al. Apr 2000 A
6053922 Krause et al. Apr 2000 A
6053935 Brenneman et al. Apr 2000 A
6056763 Parsons May 2000 A
6063121 Xavier et al. May 2000 A
6066142 Serbousek et al. May 2000 A
6066154 Reiley et al. May 2000 A
6068630 Zucherman et al. May 2000 A
6068648 Cole et al. May 2000 A
6071982 Wise et al. Jun 2000 A
6073051 Sharkey et al. Jun 2000 A
6074390 Zucherman et al. Jun 2000 A
6080158 Lin Jun 2000 A
6080193 Hochschuler et al. Jun 2000 A
6083225 Winslow et al. Jul 2000 A
6083244 Lubbers et al. Jul 2000 A
6090112 Zucherman et al. Jul 2000 A
6090143 Meriwether et al. Jul 2000 A
6096080 Nicholson et al. Aug 2000 A
6099531 Bonutti Aug 2000 A
6102914 Bulstra et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6106557 Robioneck et al. Aug 2000 A
6110210 Norton et al. Aug 2000 A
6113624 Bezwada et al. Sep 2000 A
6113637 Gill et al. Sep 2000 A
6113638 Williams et al. Sep 2000 A
6113640 Toermaelae et al. Sep 2000 A
6117174 Nolan Sep 2000 A
6119044 Kuzma Sep 2000 A
6120508 Gruenig et al. Sep 2000 A
6123705 Michelson Sep 2000 A
6123711 Winters Sep 2000 A
6126660 Dietz Oct 2000 A
6126661 Faccioli et al. Oct 2000 A
6126663 Hair Oct 2000 A
6126686 Badylak et al. Oct 2000 A
6126689 Brett Oct 2000 A
6127597 Beyar et al. Oct 2000 A
6129762 Li Oct 2000 A
6129763 Chauvin et al. Oct 2000 A
6132435 Young Oct 2000 A
6136031 Middleton Oct 2000 A
6139558 Wagner Oct 2000 A
6139579 Steffee et al. Oct 2000 A
6146384 Lee et al. Nov 2000 A
6146387 Trott et al. Nov 2000 A
6146420 McKay Nov 2000 A
6146421 Gordon et al. Nov 2000 A
6147135 Yuan et al. Nov 2000 A
6149652 Zucherman et al. Nov 2000 A
6152926 Zucherman et al. Nov 2000 A
6156038 Zucherman et al. Dec 2000 A
6159179 Simonson Dec 2000 A
6159211 Boriani et al. Dec 2000 A
6159244 Suddaby Dec 2000 A
6161350 Espinosa Dec 2000 A
6162234 Freedland et al. Dec 2000 A
6162236 Osada Dec 2000 A
6162252 Kuras et al. Dec 2000 A
6165218 Husson et al. Dec 2000 A
6165486 Marra et al. Dec 2000 A
6168595 Durham et al. Jan 2001 B1
6168597 Biedermann et al. Jan 2001 B1
6171610 Vacanti et al. Jan 2001 B1
6174337 Keenan Jan 2001 B1
6175758 Kambin Jan 2001 B1
6176882 Biedermann et al. Jan 2001 B1
6179794 Burras Jan 2001 B1
6179873 Zientek Jan 2001 B1
6183471 Zucherman et al. Feb 2001 B1
6183472 Lutz Feb 2001 B1
6183474 Bramlet et al. Feb 2001 B1
6183517 Suddaby Feb 2001 B1
6187043 Ledergerber Feb 2001 B1
6187048 Milner et al. Feb 2001 B1
6190387 Zucherman et al. Feb 2001 B1
6190414 Young et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6197033 Haid et al. Mar 2001 B1
6197041 Shichman et al. Mar 2001 B1
6197065 Martin et al. Mar 2001 B1
6197325 MacPhee et al. Mar 2001 B1
6200322 Branch et al. Mar 2001 B1
6203565 Bonutti et al. Mar 2001 B1
6206826 Mathews et al. Mar 2001 B1
6206922 Zdeblick et al. Mar 2001 B1
D439980 Reiley et al. Apr 2001 S
6213957 Milliman et al. Apr 2001 B1
6214368 Lee et al. Apr 2001 B1
6217509 Foley et al. Apr 2001 B1
6217579 Koros Apr 2001 B1
6221082 Marino et al. Apr 2001 B1
6224603 Marino May 2001 B1
6224631 Kohrs May 2001 B1
6224894 Jamiolkowski et al. May 2001 B1
6228058 Dennis et al. May 2001 B1
6231606 Graf et al. May 2001 B1
6235030 Zucherman et al. May 2001 B1
6235043 Reiley et al. May 2001 B1
6238397 Zucherman et al. May 2001 B1
6238491 Davidson et al. May 2001 B1
6241733 Nicholson et al. Jun 2001 B1
6241734 Scribner et al. Jun 2001 B1
6241769 Nicholson et al. Jun 2001 B1
6245107 Ferree Jun 2001 B1
6248108 Toermaelae et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6248131 Felt et al. Jun 2001 B1
6251111 Barker et al. Jun 2001 B1
6251140 Marino et al. Jun 2001 B1
6258093 Edwards et al. Jul 2001 B1
6261289 Levy Jul 2001 B1
6264676 Gellman et al. Jul 2001 B1
6264695 Stoy Jul 2001 B1
6267763 Castro Jul 2001 B1
6267765 Taylor et al. Jul 2001 B1
6267767 Strobel et al. Jul 2001 B1
6277149 Boyle et al. Aug 2001 B1
6280444 Zucherman et al. Aug 2001 B1
6280456 Scribner et al. Aug 2001 B1
6280474 Cassidy et al. Aug 2001 B1
6280475 Bao et al. Aug 2001 B1
6287313 Sasso Sep 2001 B1
6290724 Marino Sep 2001 B1
6293909 Chu et al. Sep 2001 B1
6293952 Brosens et al. Sep 2001 B1
D449691 Reiley et al. Oct 2001 S
6296644 Saurat et al. Oct 2001 B1
6296647 Robioneck et al. Oct 2001 B1
6302914 Michelson Oct 2001 B1
6306136 Baccelli Oct 2001 B1
6306177 Felt et al. Oct 2001 B1
D450676 Huttner Nov 2001 S
6312443 Stone Nov 2001 B1
6319252 McDevitt et al. Nov 2001 B1
6319254 Giet et al. Nov 2001 B1
6319272 Brenneman et al. Nov 2001 B1
6331312 Lee et al. Dec 2001 B1
6332882 Zucherman et al. Dec 2001 B1
6332883 Zucherman et al. Dec 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6332895 Suddaby Dec 2001 B1
6346092 Leschinsky Feb 2002 B1
6348053 Cachia Feb 2002 B1
6355043 Adam Mar 2002 B1
6361537 Anderson Mar 2002 B1
6361538 Fenaroli et al. Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6364828 Yeung et al. Apr 2002 B1
6364897 Bonutti Apr 2002 B1
6368325 McKinley et al. Apr 2002 B1
6368350 Erickson et al. Apr 2002 B1
6368351 Glenn et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6374971 Siciliano et al. Apr 2002 B1
6375681 Truscott Apr 2002 B1
6375682 Fleischmann et al. Apr 2002 B1
6375683 Crozet et al. Apr 2002 B1
6379355 Zucherman et al. Apr 2002 B1
6379363 Herrington et al. Apr 2002 B1
6387130 Stone et al. May 2002 B1
6398793 McGuire Jun 2002 B1
6402750 Atkinson et al. Jun 2002 B1
6409766 Brett Jun 2002 B1
6409767 Perice et al. Jun 2002 B1
6413278 Marchosky Jul 2002 B1
6416551 Keller Jul 2002 B1
6419641 Mark et al. Jul 2002 B1
6419676 Zucherman et al. Jul 2002 B1
6419677 Zucherman et al. Jul 2002 B2
6419704 Ferree Jul 2002 B1
6419705 Erickson Jul 2002 B1
6419706 Graf Jul 2002 B1
6423061 Bryant Jul 2002 B1
6423067 Eisermann Jul 2002 B1
6423071 Lawson Jul 2002 B1
6423083 Reiley et al. Jul 2002 B2
6423089 Gingras et al. Jul 2002 B1
6425887 McGuckin et al. Jul 2002 B1
6425919 Lambrecht Jul 2002 B1
6425920 Hamada Jul 2002 B1
6428541 Boyd et al. Aug 2002 B1
6428556 Chin Aug 2002 B1
6436101 Hamada Aug 2002 B1
6436140 Liu et al. Aug 2002 B1
6436143 Ross et al. Aug 2002 B1
6440138 Reiley et al. Aug 2002 B1
6440154 Gellman et al. Aug 2002 B2
6440169 Elberg et al. Aug 2002 B1
6443989 Jackson Sep 2002 B1
6447518 Krause et al. Sep 2002 B1
6447527 Thompson et al. Sep 2002 B1
6447540 Fontaine et al. Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6451019 Zucherman et al. Sep 2002 B1
6451020 Zucherman et al. Sep 2002 B1
6454806 Cohen et al. Sep 2002 B1
6454807 Jackson Sep 2002 B1
6458134 Songer et al. Oct 2002 B1
6461359 Tribus et al. Oct 2002 B1
6468277 Justin et al. Oct 2002 B1
6468279 Reo Oct 2002 B1
6468309 Lieberman Oct 2002 B1
6468310 Ralph et al. Oct 2002 B1
6471724 Zdeblick et al. Oct 2002 B2
6475226 Belef et al. Nov 2002 B1
6478029 Boyd et al. Nov 2002 B1
6478796 Zucherman et al. Nov 2002 B2
6478805 Marino et al. Nov 2002 B1
6482235 Lambrecht et al. Nov 2002 B1
6485491 Farris et al. Nov 2002 B1
6485518 Cornwall et al. Nov 2002 B1
D467657 Scribner Dec 2002 S
6488693 Gannoe et al. Dec 2002 B2
6488710 Besselink Dec 2002 B2
6489309 Singh et al. Dec 2002 B1
6491626 Stone et al. Dec 2002 B1
6491695 Roggenbuck Dec 2002 B1
6491714 Bennett Dec 2002 B1
6491724 Ferree Dec 2002 B1
6494860 Rocamora et al. Dec 2002 B2
6494883 Ferree Dec 2002 B1
6494893 Dubrul et al. Dec 2002 B2
6498421 Oh et al. Dec 2002 B1
6500178 Zucherman et al. Dec 2002 B2
6500205 Michelson Dec 2002 B1
6506192 Gertzman et al. Jan 2003 B1
6508839 Lambrecht et al. Jan 2003 B1
6511471 Rosenman et al. Jan 2003 B2
6511481 Von et al. Jan 2003 B2
6512958 Swoyer et al. Jan 2003 B1
D469871 Sand Feb 2003 S
6514256 Zucherman et al. Feb 2003 B2
6517543 Berrevoets et al. Feb 2003 B1
6517580 Ramadan et al. Feb 2003 B1
6520907 Foley et al. Feb 2003 B1
6520991 Huene Feb 2003 B2
D472323 Sand Mar 2003 S
6527774 Lieberman Mar 2003 B2
6527803 Crozet et al. Mar 2003 B1
6527804 Gauchet et al. Mar 2003 B1
6530930 Marino et al. Mar 2003 B1
6533791 Betz et al. Mar 2003 B1
6533797 Stone et al. Mar 2003 B1
6533818 Weber et al. Mar 2003 B1
6540747 Marino Apr 2003 B1
6544265 Lieberman Apr 2003 B2
6547793 McGuire Apr 2003 B1
6547795 Schneiderman Apr 2003 B2
6547823 Scarborough et al. Apr 2003 B2
6551319 Lieberman Apr 2003 B2
6551322 Lieberman Apr 2003 B1
6554831 Rivard et al. Apr 2003 B1
6554833 Levy et al. Apr 2003 B2
6554852 Oberlander Apr 2003 B1
6558389 Clark et al. May 2003 B2
6558390 Cragg May 2003 B2
6558424 Thalgott May 2003 B2
6562046 Sasso May 2003 B2
6562049 Norlander et al. May 2003 B1
6562072 Fuss et al. May 2003 B1
6562074 Gerbec et al. May 2003 B2
6575919 Reiley et al. Jun 2003 B1
6575979 Cragg Jun 2003 B1
6576016 Hochshuler et al. Jun 2003 B1
6579291 Keith et al. Jun 2003 B1
6579293 Chandran Jun 2003 B1
6579320 Gauchet et al. Jun 2003 B1
6579321 Gordon et al. Jun 2003 B1
6582390 Sanderson Jun 2003 B1
6582431 Ray Jun 2003 B1
6582433 Yun Jun 2003 B2
6582437 Dorchak et al. Jun 2003 B2
6582441 He et al. Jun 2003 B1
6582453 Tran et al. Jun 2003 B1
6582466 Gauchet Jun 2003 B1
6582467 Teitelbaum et al. Jun 2003 B1
6582468 Gauchet Jun 2003 B1
6585730 Foerster Jul 2003 B1
6585740 Schlapfer et al. Jul 2003 B2
6589240 Hinchliffe Jul 2003 B2
6589249 Sater et al. Jul 2003 B2
6592553 Zhang et al. Jul 2003 B2
6592624 Fraser et al. Jul 2003 B1
6592625 Cauthen Jul 2003 B2
6595998 Johnson et al. Jul 2003 B2
6596008 Kambin Jul 2003 B1
6599294 Fuss et al. Jul 2003 B2
6599297 Carlsson et al. Jul 2003 B1
6602293 Biermann et al. Aug 2003 B1
6607530 Carl et al. Aug 2003 B1
6607544 Boucher et al. Aug 2003 B1
6607558 Kuras Aug 2003 B2
6610066 Dinger et al. Aug 2003 B2
6610091 Reiley Aug 2003 B1
6610094 Husson Aug 2003 B2
6613050 Wagner et al. Sep 2003 B1
6613054 Scribner et al. Sep 2003 B2
6616678 Nishtala et al. Sep 2003 B2
6620196 Trieu Sep 2003 B1
6623505 Scribner et al. Sep 2003 B2
6626943 Eberlein et al. Sep 2003 B2
6626944 Taylor Sep 2003 B1
6629998 Lin Oct 2003 B1
6632224 Cachia et al. Oct 2003 B2
6632235 Weikel et al. Oct 2003 B2
6635059 Randall et al. Oct 2003 B2
6635060 Hanson et al. Oct 2003 B2
6635362 Zheng Oct 2003 B2
RE38335 Aust et al. Nov 2003 E
D482787 Reiss Nov 2003 S
6641564 Kraus Nov 2003 B1
6641582 Hanson et al. Nov 2003 B1
6641587 Scribner et al. Nov 2003 B2
6641614 Wagner et al. Nov 2003 B1
6645213 Sand et al. Nov 2003 B2
6645248 Casutt Nov 2003 B2
6648890 Culbert et al. Nov 2003 B2
6648893 Dudasik Nov 2003 B2
6648917 Gerbec et al. Nov 2003 B2
6652527 Zucherman et al. Nov 2003 B2
6652592 Grooms et al. Nov 2003 B1
D483495 Sand Dec 2003 S
6655962 Kennard Dec 2003 B1
6656178 Veldhuizen et al. Dec 2003 B1
6656180 Stahurski Dec 2003 B2
6660004 Barker et al. Dec 2003 B2
6660037 Husson et al. Dec 2003 B1
6663647 Reiley et al. Dec 2003 B2
6666890 Michelson Dec 2003 B2
6666891 Boehm et al. Dec 2003 B2
6669698 Tromanhauser et al. Dec 2003 B1
6669729 Chin Dec 2003 B2
6669732 Serhan et al. Dec 2003 B2
6673074 Shluzas Jan 2004 B2
6676663 Higueras et al. Jan 2004 B2
6676664 Al-Assir Jan 2004 B1
6676665 Foley et al. Jan 2004 B2
6679833 Smith et al. Jan 2004 B2
6679915 Cauthen Jan 2004 B1
6682535 Hoogland Jan 2004 B2
6682561 Songer et al. Jan 2004 B2
6682562 Viart et al. Jan 2004 B2
6685706 Padget et al. Feb 2004 B2
6685742 Jackson Feb 2004 B1
6689125 Keith et al. Feb 2004 B1
6689152 Balceta et al. Feb 2004 B2
6689168 Lieberman Feb 2004 B2
6692499 Toermaelae et al. Feb 2004 B2
6692563 Zimmermann Feb 2004 B2
6695842 Zucherman et al. Feb 2004 B2
6695851 Zdeblick et al. Feb 2004 B2
6699246 Zucherman et al. Mar 2004 B2
6699247 Zucherman et al. Mar 2004 B2
6706070 Wagner et al. Mar 2004 B1
6709458 Michelson Mar 2004 B2
6712819 Zucherman et al. Mar 2004 B2
6716216 Boucher et al. Apr 2004 B1
6716247 Michelson Apr 2004 B2
6716957 Tunc Apr 2004 B2
6719760 Dorchak et al. Apr 2004 B2
6719761 Reiley et al. Apr 2004 B1
6719773 Boucher et al. Apr 2004 B1
6719796 Cohen et al. Apr 2004 B2
6723096 Dorchak et al. Apr 2004 B1
6723126 Berry Apr 2004 B1
6723127 Ralph et al. Apr 2004 B2
6723128 Uk Apr 2004 B2
6726691 Osorio et al. Apr 2004 B2
D490159 Sand May 2004 S
6730126 Boehm et al. May 2004 B2
6733093 Deland et al. May 2004 B2
6733460 Ogura May 2004 B2
6733532 Gauchet et al. May 2004 B1
6733534 Sherman May 2004 B2
6733535 Michelson May 2004 B2
6733635 Ozawa et al. May 2004 B1
6740090 Cragg et al. May 2004 B1
6740093 Hochschuler et al. May 2004 B2
6740117 Ralph et al. May 2004 B2
D492032 Muller et al. Jun 2004 S
6743166 Berci et al. Jun 2004 B2
6743255 Ferree Jun 2004 B2
6746451 Middleton et al. Jun 2004 B2
6749560 Konstorum et al. Jun 2004 B1
6752831 Sybert et al. Jun 2004 B2
6755837 Ebner Jun 2004 B2
6755841 Fraser et al. Jun 2004 B2
D492775 Doelling et al. Jul 2004 S
D493533 Blain Jul 2004 S
6758673 Fromovich et al. Jul 2004 B2
6758847 Maguire Jul 2004 B2
6758861 Ralph et al. Jul 2004 B2
6758862 Berry et al. Jul 2004 B2
6761720 Senegas Jul 2004 B1
6764491 Frey et al. Jul 2004 B2
6764514 Li et al. Jul 2004 B1
D495417 Doelling et al. Aug 2004 S
6770075 Howland Aug 2004 B2
6773460 Jackson Aug 2004 B2
6780151 Grabover et al. Aug 2004 B2
6783530 Levy Aug 2004 B1
6790210 Cragg et al. Sep 2004 B1
6793656 Mathews Sep 2004 B1
6793678 Hawkins Sep 2004 B2
6793679 Michelson Sep 2004 B2
6796983 Zucherman et al. Sep 2004 B1
6805685 Taylor Oct 2004 B2
6805695 Keith et al. Oct 2004 B2
6805697 Helm et al. Oct 2004 B1
6805714 Sutcliffe Oct 2004 B2
6808526 Magerl et al. Oct 2004 B1
6808537 Michelson Oct 2004 B2
6814736 Reiley et al. Nov 2004 B2
6814756 Michelson Nov 2004 B1
6821298 Jackson Nov 2004 B1
6830589 Erickson Dec 2004 B2
6835205 Atkinson et al. Dec 2004 B2
6835206 Jackson Dec 2004 B2
6835208 Marchosky Dec 2004 B2
6840941 Rogers et al. Jan 2005 B2
6840944 Suddaby Jan 2005 B2
6852126 Ahlgren Feb 2005 B2
6852127 Varga et al. Feb 2005 B2
6852129 Gerbec et al. Feb 2005 B2
6855167 Shimp et al. Feb 2005 B2
6863668 Gillespie et al. Mar 2005 B2
6863672 Reiley et al. Mar 2005 B2
6863673 Gerbec et al. Mar 2005 B2
6866682 An et al. Mar 2005 B1
6875215 Taras et al. Apr 2005 B2
6878167 Ferree Apr 2005 B2
6881228 Zdeblick et al. Apr 2005 B2
6881229 Khandkar et al. Apr 2005 B2
6883520 Lambrecht et al. Apr 2005 B2
6887243 Culbert May 2005 B2
6887248 McKinley et al. May 2005 B2
6890333 Von et al. May 2005 B2
6893464 Kiester May 2005 B2
6893466 Trieu May 2005 B2
6899716 Cragg May 2005 B2
6899719 Reiley et al. May 2005 B2
6899735 Coates et al. May 2005 B2
D506828 Layne et al. Jun 2005 S
6902566 Zucherman et al. Jun 2005 B2
6905512 Paes et al. Jun 2005 B2
6908465 Von et al. Jun 2005 B2
6908506 Zimmermann Jun 2005 B2
6916323 Kitchens Jul 2005 B2
6921403 Cragg et al. Jul 2005 B2
6923810 Michelson Aug 2005 B1
6923811 Carl et al. Aug 2005 B1
6923813 Phillips et al. Aug 2005 B2
6923814 Hildebrand et al. Aug 2005 B1
6929606 Ritland Aug 2005 B2
6929647 Cohen Aug 2005 B2
6936071 Marnay et al. Aug 2005 B1
6936072 Lambrecht et al. Aug 2005 B2
6942668 Padget et al. Sep 2005 B2
6945973 Bray Sep 2005 B2
6945975 Dalton Sep 2005 B2
6946000 Senegas et al. Sep 2005 B2
6949100 Venturini Sep 2005 B1
6949108 Holmes Sep 2005 B2
6951561 Warren et al. Oct 2005 B2
6952129 Lin et al. Oct 2005 B2
6953477 Berry Oct 2005 B2
6955691 Chae et al. Oct 2005 B2
6962606 Michelson Nov 2005 B2
6964674 Matsuura et al. Nov 2005 B1
6964686 Gordon Nov 2005 B2
6966910 Ritland Nov 2005 B2
6966912 Michelson Nov 2005 B2
6969404 Ferree Nov 2005 B2
6969405 Suddaby Nov 2005 B2
D512506 Layne et al. Dec 2005 S
6972035 Michelson Dec 2005 B2
6974479 Trieu Dec 2005 B2
6979341 Scribner et al. Dec 2005 B2
6979352 Reynolds Dec 2005 B2
6979353 Bresina Dec 2005 B2
6981981 Reiley et al. Jan 2006 B2
6997929 Manzi et al. Feb 2006 B2
7004945 Boyd et al. Feb 2006 B2
7004971 Serhan et al. Feb 2006 B2
7008453 Michelson Mar 2006 B1
7014633 Cragg Mar 2006 B2
7018089 Wenz et al. Mar 2006 B2
7018412 Ferreira et al. Mar 2006 B2
7018415 McKay Mar 2006 B1
7018416 Hanson et al. Mar 2006 B2
7018453 Klein et al. Mar 2006 B2
7022138 Mashburn Apr 2006 B2
7025746 Tal Apr 2006 B2
7025787 Bryan et al. Apr 2006 B2
7029473 Zucherman et al. Apr 2006 B2
7029498 Boehm et al. Apr 2006 B2
7037339 Houfburg May 2006 B2
7041107 Pohjonen et al. May 2006 B2
7044954 Reiley et al. May 2006 B2
7048694 Mark et al. May 2006 B2
7048736 Robinson et al. May 2006 B2
7060068 Tromanhauser et al. Jun 2006 B2
7060073 Frey et al. Jun 2006 B2
7063701 Michelson Jun 2006 B2
7063702 Michelson Jun 2006 B2
7063703 Reo Jun 2006 B2
7063725 Foley Jun 2006 B2
7066960 Dickman Jun 2006 B1
7066961 Michelson Jun 2006 B2
7069087 Sharkey et al. Jun 2006 B2
7070598 Lim et al. Jul 2006 B2
7070601 Culbert et al. Jul 2006 B2
7074203 Johanson et al. Jul 2006 B1
7074226 Roehm et al. Jul 2006 B2
7081120 Li et al. Jul 2006 B2
7081122 Reiley et al. Jul 2006 B1
7083650 Moskowitz et al. Aug 2006 B2
7087053 Vanney Aug 2006 B2
7087055 Lim et al. Aug 2006 B2
7087083 Pasquet et al. Aug 2006 B2
7089063 Lesh et al. Aug 2006 B2
7094239 Michelson Aug 2006 B1
7094257 Mujwid et al. Aug 2006 B2
7094258 Lambrecht et al. Aug 2006 B2
7101375 Zucherman et al. Sep 2006 B2
7114501 Johnson et al. Oct 2006 B2
7115128 Michelson Oct 2006 B2
7115163 Zimmermann Oct 2006 B2
7118572 Bramlet et al. Oct 2006 B2
7118579 Michelson Oct 2006 B2
7118580 Beyersdorff et al. Oct 2006 B1
7118598 Michelson Oct 2006 B2
7124761 Lambrecht et al. Oct 2006 B2
7125424 Banick et al. Oct 2006 B2
7128760 Michelson Oct 2006 B2
7135424 Worley et al. Nov 2006 B2
7153304 Robie et al. Dec 2006 B2
7153305 Johnson et al. Dec 2006 B2
7153306 Ralph et al. Dec 2006 B2
7153307 Scribner et al. Dec 2006 B2
D536096 Hoogland et al. Jan 2007 S
7156874 Paponneau et al. Jan 2007 B2
7156875 Michelson Jan 2007 B2
7156876 Moumene et al. Jan 2007 B2
7156877 Lotz et al. Jan 2007 B2
7163558 Senegas et al. Jan 2007 B2
7166107 Anderson Jan 2007 B2
7172612 Ishikawa Feb 2007 B2
7179293 McKay Feb 2007 B2
7179294 Eisermann et al. Feb 2007 B2
7189242 Boyd et al. Mar 2007 B2
7201751 Zucherman et al. Apr 2007 B2
7204851 Trieu et al. Apr 2007 B2
7207991 Michelson Apr 2007 B2
7211112 Baynham et al. May 2007 B2
7214227 Colleran et al. May 2007 B2
7217291 Zucherman et al. May 2007 B2
7217293 Branch, Jr. May 2007 B2
7220280 Kast et al. May 2007 B2
7220281 Lambrecht et al. May 2007 B2
7223227 Pflueger May 2007 B2
7223292 Messerli et al. May 2007 B2
7226481 Kuslich Jun 2007 B2
7226483 Gerber et al. Jun 2007 B2
7235101 Berry et al. Jun 2007 B2
7241297 Shaolian et al. Jul 2007 B2
7244273 Pedersen et al. Jul 2007 B2
7250060 Trieu Jul 2007 B2
7252671 Scribner et al. Aug 2007 B2
7267683 Sharkey et al. Sep 2007 B2
7267687 McGuckin, Jr. Sep 2007 B2
7270679 Istephanous et al. Sep 2007 B2
7276062 McDaniel et al. Oct 2007 B2
7282061 Sharkey et al. Oct 2007 B2
7291173 Richelsoph et al. Nov 2007 B2
7306628 Zucherman et al. Dec 2007 B2
7309357 Kim Dec 2007 B2
7311713 Johnson et al. Dec 2007 B2
7316714 Gordon et al. Jan 2008 B2
7318840 McKay Jan 2008 B2
7320689 Keller Jan 2008 B2
7320708 Bernstein Jan 2008 B1
7322962 Forrest Jan 2008 B2
7326211 Padget et al. Feb 2008 B2
7326248 Michelson Feb 2008 B2
7335203 Winslow et al. Feb 2008 B2
7351262 Bindseil et al. Apr 2008 B2
7361140 Ries et al. Apr 2008 B2
7371238 Soboleski et al. May 2008 B2
7377942 Berry May 2008 B2
7383639 Malandain Jun 2008 B2
7400930 Sharkey et al. Jul 2008 B2
7406775 Funk et al. Aug 2008 B2
7410501 Michelson Aug 2008 B2
7413576 Sybert et al. Aug 2008 B2
7422594 Zander Sep 2008 B2
7434325 Foley et al. Oct 2008 B2
7442211 De et al. Oct 2008 B2
7445637 Taylor Nov 2008 B2
7470273 Dougherty-Shah Dec 2008 B2
D584812 Ries Jan 2009 S
7473256 Assell et al. Jan 2009 B2
7473268 Zucherman et al. Jan 2009 B2
7476251 Zucherman et al. Jan 2009 B2
7485134 Simonson Feb 2009 B2
7488326 Elliott Feb 2009 B2
7500991 Bartish et al. Mar 2009 B2
7503920 Siegal Mar 2009 B2
7503933 Michelson Mar 2009 B2
7507241 Levy et al. Mar 2009 B2
7517363 Rogers et al. Apr 2009 B2
7520888 Trieu Apr 2009 B2
7547317 Cragg Jun 2009 B2
7556629 Von et al. Jul 2009 B2
7556651 Humphreys et al. Jul 2009 B2
7569074 Eisermann et al. Aug 2009 B2
7572279 Jackson Aug 2009 B2
7575580 Lim et al. Aug 2009 B2
7575599 Villiers et al. Aug 2009 B2
7578820 Moore et al. Aug 2009 B2
7588574 Assell et al. Sep 2009 B2
7608083 Lee et al. Oct 2009 B2
7618458 Biedermann et al. Nov 2009 B2
7621950 Globerman et al. Nov 2009 B1
7621960 Boyd et al. Nov 2009 B2
7625377 Veldhuizen et al. Dec 2009 B2
7625378 Foley Dec 2009 B2
7625394 Molz et al. Dec 2009 B2
7637905 Saadat et al. Dec 2009 B2
7641657 Cragg Jan 2010 B2
7641670 Davison et al. Jan 2010 B2
7641692 Bryan et al. Jan 2010 B2
7647123 Sharkey et al. Jan 2010 B2
7648523 Mirkovic et al. Jan 2010 B2
7655010 Serhan et al. Feb 2010 B2
7666186 Harp Feb 2010 B2
7666266 Izawa et al. Feb 2010 B2
7670354 Davison et al. Mar 2010 B2
7670374 Schaller Mar 2010 B2
7674265 Smith et al. Mar 2010 B2
7674273 Davison et al. Mar 2010 B2
7682370 Pagliuca et al. Mar 2010 B2
7682400 Zwirkoski Mar 2010 B2
7691120 Shluzas et al. Apr 2010 B2
7691147 Guetlin et al. Apr 2010 B2
7699878 Pavlov et al. Apr 2010 B2
7703727 Selness Apr 2010 B2
7704280 Lechmann et al. Apr 2010 B2
7717944 Foley et al. May 2010 B2
7722530 Davison May 2010 B2
7722612 Sala et al. May 2010 B2
7722674 Grotz May 2010 B1
7727263 Cragg Jun 2010 B2
7731751 Butler et al. Jun 2010 B2
7740633 Assell et al. Jun 2010 B2
7744599 Cragg Jun 2010 B2
7744650 Lindner et al. Jun 2010 B2
7749270 Peterman Jul 2010 B2
7762995 Eversull et al. Jul 2010 B2
7763025 Ainsworth Jul 2010 B2
7763028 Lim et al. Jul 2010 B2
7763038 O'Brien Jul 2010 B2
7763055 Foley Jul 2010 B2
7766930 DiPoto et al. Aug 2010 B2
7771473 Thramann Aug 2010 B2
7771479 Humphreys et al. Aug 2010 B2
7785368 Schaller Aug 2010 B2
7789914 Michelson Sep 2010 B2
7794463 Cragg Sep 2010 B2
7799032 Assell et al. Sep 2010 B2
7799033 Assell et al. Sep 2010 B2
7799036 Davison et al. Sep 2010 B2
7799080 Doty Sep 2010 B2
7799081 McKinley Sep 2010 B2
7799083 Smith et al. Sep 2010 B2
7803161 Foley et al. Sep 2010 B2
D626233 Cipoletti et al. Oct 2010 S
7814429 Buffet et al. Oct 2010 B2
7819921 Grotz Oct 2010 B2
7824410 Simonson et al. Nov 2010 B2
7824429 Culbert et al. Nov 2010 B2
7824445 Biro et al. Nov 2010 B2
7828807 LeHuec et al. Nov 2010 B2
7837734 Zucherman Nov 2010 B2
7846183 Blain Dec 2010 B2
7846206 Oglaza et al. Dec 2010 B2
7850695 Pagliuca et al. Dec 2010 B2
7850733 Baynham et al. Dec 2010 B2
7854766 Moskowitz et al. Dec 2010 B2
7857832 Culbert et al. Dec 2010 B2
7862590 Lim et al. Jan 2011 B2
7862595 Foley et al. Jan 2011 B2
7867259 Foley et al. Jan 2011 B2
7874980 Sonnenschein et al. Jan 2011 B2
7875077 Humphreys et al. Jan 2011 B2
7879098 Simmons, Jr. Feb 2011 B1
7887589 Glenn et al. Feb 2011 B2
7892171 Davison et al. Feb 2011 B2
7892249 Davison et al. Feb 2011 B2
7901438 Culbert et al. Mar 2011 B2
7901459 Hodges et al. Mar 2011 B2
7909870 Kraus Mar 2011 B2
7909874 Zielinski Mar 2011 B2
7918874 Siegal Apr 2011 B2
7922719 Ralph et al. Apr 2011 B2
7922729 Michelson Apr 2011 B2
7931674 Zucherman et al. Apr 2011 B2
7931689 Hochschuler et al. Apr 2011 B2
7935051 Miles et al. May 2011 B2
7938832 Culbert et al. May 2011 B2
7942903 Moskowitz et al. May 2011 B2
7947078 Siegal May 2011 B2
7951199 Miller May 2011 B2
7955391 Schaller Jun 2011 B2
7959675 Gately Jun 2011 B2
7963967 Woods Jun 2011 B1
7963993 Schaller Jun 2011 B2
7967864 Schaller Jun 2011 B2
7967865 Schaller Jun 2011 B2
7985231 Sankaran Jul 2011 B2
7993403 Foley et al. Aug 2011 B2
7998176 Culbert Aug 2011 B2
8007535 Hudgins et al. Aug 2011 B2
8012212 Link et al. Sep 2011 B2
8021424 Beger et al. Sep 2011 B2
8021426 Segal et al. Sep 2011 B2
8025697 McClellan et al. Sep 2011 B2
8034109 Zwirkoski Oct 2011 B2
8034110 Garner et al. Oct 2011 B2
8038703 Dobak et al. Oct 2011 B2
8043293 Warnick Oct 2011 B2
8043381 Hestad et al. Oct 2011 B2
8052754 Froehlich Nov 2011 B2
8057544 Schaller Nov 2011 B2
8057545 Hughes et al. Nov 2011 B2
8062375 Glerum et al. Nov 2011 B2
8075621 Michelson Dec 2011 B2
8097036 Cordaro et al. Jan 2012 B2
8100978 Bass Jan 2012 B2
8105382 Olmos Jan 2012 B2
8109972 Zucherman et al. Feb 2012 B2
8109977 Culbert et al. Feb 2012 B2
8118871 Gordon Feb 2012 B2
8128700 Delurio et al. Mar 2012 B2
8128702 Zucherman et al. Mar 2012 B2
8133232 Levy et al. Mar 2012 B2
8147549 Metcalf et al. Apr 2012 B2
8177812 Sankaran May 2012 B2
8187327 Edidin et al. May 2012 B2
8187332 McLuen May 2012 B2
8192495 Simpson et al. Jun 2012 B2
8202322 Doty Jun 2012 B2
8206423 Siegal Jun 2012 B2
8216312 Gray Jul 2012 B2
8216314 Richelsoph Jul 2012 B2
8216317 Thibodeau Jul 2012 B2
8221501 Eisermann et al. Jul 2012 B2
8221502 Branch, Jr. Jul 2012 B2
8221503 Garcia et al. Jul 2012 B2
8231675 Rhoda Jul 2012 B2
8231681 Castleman et al. Jul 2012 B2
8236029 Siegal Aug 2012 B2
8236058 Fabian et al. Aug 2012 B2
8241328 Siegal Aug 2012 B2
8241358 Butler et al. Aug 2012 B2
8241361 Link Aug 2012 B2
8241364 Hansell et al. Aug 2012 B2
8246622 Siegal et al. Aug 2012 B2
8257440 Gordon et al. Sep 2012 B2
8257442 Edie Sep 2012 B2
8262666 Baynham et al. Sep 2012 B2
8262736 Michelson Sep 2012 B2
8267939 Cipoletti et al. Sep 2012 B2
8267965 Gimbel et al. Sep 2012 B2
8273128 Oh et al. Sep 2012 B2
8273129 Baynham et al. Sep 2012 B2
8287599 McGuckin, Jr. Oct 2012 B2
8292959 Webb et al. Oct 2012 B2
8303663 Jimenez et al. Nov 2012 B2
8317866 Palmatier et al. Nov 2012 B2
8323345 Sledge Dec 2012 B2
8328812 Siegal et al. Dec 2012 B2
8328852 Zehavi et al. Dec 2012 B2
8337559 Hansell et al. Dec 2012 B2
8343193 Johnson et al. Jan 2013 B2
8343222 Cope Jan 2013 B2
8353961 McClintock et al. Jan 2013 B2
8361154 Reo Jan 2013 B2
8366777 Matthis et al. Feb 2013 B2
8377098 Landry et al. Feb 2013 B2
8377133 Yuan et al. Feb 2013 B2
8382842 Greenhalgh et al. Feb 2013 B2
8394129 Morgenstern et al. Mar 2013 B2
8398712 De et al. Mar 2013 B2
8398713 Weiman Mar 2013 B2
8403990 Dryer et al. Mar 2013 B2
8409282 Kim Apr 2013 B2
8409290 Zamani et al. Apr 2013 B2
8409291 Blackwell et al. Apr 2013 B2
8414650 Bertele et al. Apr 2013 B2
8425559 Tebbe et al. Apr 2013 B2
8435298 Weiman May 2013 B2
8454617 Schaller et al. Jun 2013 B2
8454698 De et al. Jun 2013 B2
8465524 Siegal Jun 2013 B2
8470043 Schaller et al. Jun 2013 B2
8480715 Gray Jul 2013 B2
8480742 Pisharodi Jul 2013 B2
8480748 Poulos Jul 2013 B2
8486109 Siegal Jul 2013 B2
8486148 Butler et al. Jul 2013 B2
8491591 Fuerderer Jul 2013 B2
8491653 Zucherman et al. Jul 2013 B2
8491657 Attia et al. Jul 2013 B2
8491659 Weiman Jul 2013 B2
8506635 Palmatier et al. Aug 2013 B2
8518087 Lopez Aug 2013 B2
8518120 Glerum et al. Aug 2013 B2
8523909 Hess Sep 2013 B2
8523944 Jimenez et al. Sep 2013 B2
8535380 Greenhalgh et al. Sep 2013 B2
8545567 Krueger Oct 2013 B1
8551092 Morgan et al. Oct 2013 B2
8551173 Lechmann et al. Oct 2013 B2
8556978 Schaller Oct 2013 B2
8556979 Glerum et al. Oct 2013 B2
8568481 Olmos Oct 2013 B2
8579977 Fabian Nov 2013 B2
8579981 Lim et al. Nov 2013 B2
8591583 Schaller et al. Nov 2013 B2
8591585 McLaughlin et al. Nov 2013 B2
8597330 Siegal Dec 2013 B2
8597333 Morgenstern et al. Dec 2013 B2
8597360 McLuen Dec 2013 B2
8603168 Gordon et al. Dec 2013 B2
8603170 Cipoletti et al. Dec 2013 B2
8603177 Gray Dec 2013 B2
8610091 Matsumoto Dec 2013 B2
8623091 Suedkamp et al. Jan 2014 B2
8628576 Triplett et al. Jan 2014 B2
8628577 Jimenez Jan 2014 B1
8628578 Miller et al. Jan 2014 B2
8632595 Weiman Jan 2014 B2
8636746 Jimenez et al. Jan 2014 B2
8641764 Gately Feb 2014 B2
8663329 Ernst Mar 2014 B2
8663331 McClellan et al. Mar 2014 B2
8668740 Rhoda et al. Mar 2014 B2
8672977 Siegal et al. Mar 2014 B2
8679161 Malandain et al. Mar 2014 B2
8679183 Glerum et al. Mar 2014 B2
8685095 Miller et al. Apr 2014 B2
8685098 Glerum et al. Apr 2014 B2
8696751 Ashley et al. Apr 2014 B2
8702757 Thommen et al. Apr 2014 B2
8702798 Matthis et al. Apr 2014 B2
8709086 Glerum Apr 2014 B2
8709088 Kleiner et al. Apr 2014 B2
8715351 Pinto May 2014 B1
8721723 Hansell et al. May 2014 B2
8728160 Globerman et al. May 2014 B2
8728166 Schwab May 2014 B2
8740954 Ghobrial et al. Jun 2014 B2
8753398 Gordon et al. Jun 2014 B2
8758349 Germain et al. Jun 2014 B2
8758441 Hovda et al. Jun 2014 B2
8764806 Abdou Jul 2014 B2
8771360 Jimenez et al. Jul 2014 B2
8777993 Siegal et al. Jul 2014 B2
8778025 Ragab et al. Jul 2014 B2
8795366 Varela Aug 2014 B2
8795374 Chee Aug 2014 B2
8801787 Schaller Aug 2014 B2
8801792 De et al. Aug 2014 B2
8808376 Schaller Aug 2014 B2
8828085 Jensen Sep 2014 B1
8845638 Siegal et al. Sep 2014 B2
8845728 Abdou Sep 2014 B1
8845731 Weiman Sep 2014 B2
8845732 Weiman Sep 2014 B2
8845733 O'Neil et al. Sep 2014 B2
8845734 Weiman Sep 2014 B2
8852242 Morgenstern et al. Oct 2014 B2
8852243 Morgenstern et al. Oct 2014 B2
8852279 Weiman Oct 2014 B2
8864833 Glerum et al. Oct 2014 B2
8888853 Glerum et al. Nov 2014 B2
8888854 Glerum et al. Nov 2014 B2
8900235 Siegal Dec 2014 B2
8900307 Hawkins et al. Dec 2014 B2
8906098 Siegal Dec 2014 B2
8920506 McGuckin, Jr. Dec 2014 B2
8926704 Glerum et al. Jan 2015 B2
8936641 Cain Jan 2015 B2
8940049 Jimenez et al. Jan 2015 B1
8940050 Laurence et al. Jan 2015 B2
8940052 Lechmann et al. Jan 2015 B2
8961609 Schaller Feb 2015 B2
8968408 Schaller et al. Mar 2015 B2
8974508 Stephan et al. Mar 2015 B2
8979929 Schaller Mar 2015 B2
8986387 To et al. Mar 2015 B1
8986388 Siegal et al. Mar 2015 B2
8986389 Lim et al. Mar 2015 B2
9005291 Loebl et al. Apr 2015 B2
9017408 Siegal et al. Apr 2015 B2
9017413 Siegal et al. Apr 2015 B2
9039767 Raymond et al. May 2015 B2
9039771 Glerum et al. May 2015 B2
9044334 Siegal et al. Jun 2015 B2
9044338 Schaller Jun 2015 B2
9060876 To et al. Jun 2015 B1
9066808 Schaller Jun 2015 B2
9078767 McLean Jul 2015 B1
9089428 Bertele et al. Jul 2015 B2
9095446 Landry et al. Aug 2015 B2
9095447 Barreiro et al. Aug 2015 B2
9101488 Malandain Aug 2015 B2
9101489 Protopsaltis et al. Aug 2015 B2
9101491 Rodgers et al. Aug 2015 B2
9101492 Mangione et al. Aug 2015 B2
9107766 McLean et al. Aug 2015 B1
9119730 Glerum Sep 2015 B2
9237956 Jensen Jan 2016 B1
9254138 Siegal et al. Feb 2016 B2
9259326 Schaller Feb 2016 B2
9271846 Lim et al. Mar 2016 B2
9277928 Morgenstern Lopez Mar 2016 B2
9282979 O'Neil et al. Mar 2016 B2
9283092 Siegal et al. Mar 2016 B2
9295562 Lechmann et al. Mar 2016 B2
9314348 Emstad Apr 2016 B2
9326866 Schaller et al. May 2016 B2
9333091 Dimauro May 2016 B2
9387087 Tyber Jul 2016 B2
9402732 Gabelberger Aug 2016 B2
9402739 Weiman et al. Aug 2016 B2
9408712 Siegal et al. Aug 2016 B2
9414923 Studer et al. Aug 2016 B2
9414934 Cain Aug 2016 B2
9414936 Miller et al. Aug 2016 B2
9433510 Lechmann et al. Sep 2016 B2
9439776 Dimauro et al. Sep 2016 B2
9439777 Dimauro Sep 2016 B2
9445825 Belaney et al. Sep 2016 B2
9445918 Lin et al. Sep 2016 B1
9445919 Palmatier et al. Sep 2016 B2
9463099 Levy et al. Oct 2016 B2
9474623 Cain Oct 2016 B2
9492288 Wagner Nov 2016 B2
9510954 Glerum et al. Dec 2016 B2
9532884 Siegal et al. Jan 2017 B2
9566165 Lee et al. Feb 2017 B2
9566167 Barrus et al. Feb 2017 B2
9579215 Suedkamp et al. Feb 2017 B2
9592129 Slivka et al. Mar 2017 B2
9597197 Lechmann et al. Mar 2017 B2
9662223 Matthis et al. May 2017 B2
9662224 Weiman May 2017 B2
9675470 Packer et al. Jun 2017 B2
9724207 Dimauro et al. Aug 2017 B2
9730803 Dimauro et al. Aug 2017 B2
9750552 Stephan et al. Sep 2017 B2
9750618 Daffinson et al. Sep 2017 B1
9788962 Gabelberger Oct 2017 B2
9788963 Aquino et al. Oct 2017 B2
9788971 Stein Oct 2017 B1
9801639 O'Neil et al. Oct 2017 B2
9801640 O'Neil et al. Oct 2017 B2
9801729 Dimauro et al. Oct 2017 B2
9801734 Stein et al. Oct 2017 B1
9808351 Kelly et al. Nov 2017 B2
9808353 Suddaby et al. Nov 2017 B2
9814589 Dimauro Nov 2017 B2
9814590 Serhan et al. Nov 2017 B2
9833334 Voellmicke et al. Dec 2017 B2
9839528 Weiman Dec 2017 B2
9839530 Hawkins et al. Dec 2017 B2
9848991 Boehm et al. Dec 2017 B2
9872779 Miller et al. Jan 2018 B2
9907670 Deridder et al. Mar 2018 B2
9918851 Willis et al. Mar 2018 B2
9924978 Thommen et al. Mar 2018 B2
9925060 Dimauro et al. Mar 2018 B2
9931223 Cain Apr 2018 B2
9931226 Kurtaliaj et al. Apr 2018 B2
9937053 Melkent et al. Apr 2018 B2
9949769 Serhan et al. Apr 2018 B2
9962272 Daffinson et al. May 2018 B1
9974664 Emerick et al. May 2018 B2
9980823 Matthis et al. May 2018 B2
9987142 McConnell Jun 2018 B2
9993350 Cain Jun 2018 B2
10004607 Weiman et al. Jun 2018 B2
10058433 Lechmann et al. Aug 2018 B2
10085843 Dimauro Oct 2018 B2
10092417 Weiman et al. Oct 2018 B2
10137009 Weiman et al. Nov 2018 B2
10143569 Weiman et al. Dec 2018 B2
10166117 Daffinson et al. Jan 2019 B1
10219915 Stein Mar 2019 B1
10238500 Rogers et al. Mar 2019 B2
10265191 Lim et al. Apr 2019 B2
10307254 Levy et al. Jun 2019 B2
10363142 McClintock et al. Jul 2019 B2
10376372 Serhan et al. Aug 2019 B2
10398563 Engstrom Sep 2019 B2
10398566 Olmos et al. Sep 2019 B2
10405986 Kelly et al. Sep 2019 B2
10405989 O'Neil et al. Sep 2019 B2
10420651 Serhan et al. Sep 2019 B2
10433971 Dimauro et al. Oct 2019 B2
10433974 O'Neil Oct 2019 B2
10433977 Lechmann et al. Oct 2019 B2
10449056 Cain Oct 2019 B2
10449058 Lechmann et al. Oct 2019 B2
10470894 Foley et al. Nov 2019 B2
10492918 Dimauro Dec 2019 B2
10492924 Stein et al. Dec 2019 B2
10512489 Serhan et al. Dec 2019 B2
10537436 Maguire et al. Jan 2020 B2
10548741 Suedkamp et al. Feb 2020 B2
10555817 Dimauro et al. Feb 2020 B2
10575959 Dimauro et al. Mar 2020 B2
10583013 Dimauro et al. Mar 2020 B2
10583015 Olmos et al. Mar 2020 B2
10639164 Dimauro et al. May 2020 B2
10639166 Weiman May 2020 B2
10682241 Glerum et al. Jun 2020 B2
10743914 Lopez et al. Aug 2020 B2
10842644 Weiman et al. Nov 2020 B2
10888433 Frasier et al. Jan 2021 B2
10966840 Voellmicke et al. Apr 2021 B2
10973652 Hawkins et al. Apr 2021 B2
11051954 Greenhalgh et al. Jul 2021 B2
20010011174 Reiley et al. Aug 2001 A1
20010012950 Nishtala et al. Aug 2001 A1
20010016741 Burkus et al. Aug 2001 A1
20010016775 Scarborough et al. Aug 2001 A1
20010027320 Sasso Oct 2001 A1
20010037126 Stack et al. Nov 2001 A1
20010039452 Zucherman et al. Nov 2001 A1
20010039453 Gresser et al. Nov 2001 A1
20010049529 Cachia et al. Dec 2001 A1
20010049530 Culbert et al. Dec 2001 A1
20010049531 Reiley et al. Dec 2001 A1
20010056302 Boyer Dec 2001 A1
20020001476 Nagamine et al. Jan 2002 A1
20020010070 Cales et al. Jan 2002 A1
20020016583 Cragg Feb 2002 A1
20020026195 Layne et al. Feb 2002 A1
20020026244 Trieu Feb 2002 A1
20020029084 Paul et al. Mar 2002 A1
20020032462 Houser et al. Mar 2002 A1
20020032483 Nicholson et al. Mar 2002 A1
20020035400 Bryan et al. Mar 2002 A1
20020037799 Li et al. Mar 2002 A1
20020045904 Fuss et al. Apr 2002 A1
20020045942 Ham Apr 2002 A1
20020045943 Uk Apr 2002 A1
20020055740 Lieberman May 2002 A1
20020055781 Sazy May 2002 A1
20020058947 Hochschuler et al. May 2002 A1
20020068974 Kuslich et al. Jun 2002 A1
20020068976 Jackson Jun 2002 A1
20020068977 Jackson Jun 2002 A1
20020072801 Michelson Jun 2002 A1
20020077700 Varga et al. Jun 2002 A1
20020077701 Kuslich Jun 2002 A1
20020082584 Rosenman et al. Jun 2002 A1
20020082608 Reiley et al. Jun 2002 A1
20020087152 Mikus et al. Jul 2002 A1
20020087163 Dixon et al. Jul 2002 A1
20020091387 Hoogland Jul 2002 A1
20020091390 Michelson Jul 2002 A1
20020099385 Ralph et al. Jul 2002 A1
20020107519 Dixon et al. Aug 2002 A1
20020107573 Steinberg Aug 2002 A1
20020120335 Angelucci et al. Aug 2002 A1
20020128713 Ferree Sep 2002 A1
20020128715 Bryan et al. Sep 2002 A1
20020128716 Cohen et al. Sep 2002 A1
20020138078 Chappuis Sep 2002 A1
20020138146 Jackson Sep 2002 A1
20020143331 Zucherman et al. Oct 2002 A1
20020143334 Hoffmann et al. Oct 2002 A1
20020143335 Von et al. Oct 2002 A1
20020151895 Soboleski et al. Oct 2002 A1
20020151976 Foley et al. Oct 2002 A1
20020156482 Scribner et al. Oct 2002 A1
20020161444 Choi Oct 2002 A1
20020165612 Gerber et al. Nov 2002 A1
20020169471 Ferdinand Nov 2002 A1
20020172851 Corey et al. Nov 2002 A1
20020173796 Cragg Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020173851 McKay Nov 2002 A1
20020183761 Johnson et al. Dec 2002 A1
20020183778 Reiley et al. Dec 2002 A1
20020183848 Ray et al. Dec 2002 A1
20020191487 Sand Dec 2002 A1
20020193883 Wironen Dec 2002 A1
20020198526 Shaolian et al. Dec 2002 A1
20030004575 Erickson Jan 2003 A1
20030004576 Thalgott Jan 2003 A1
20030006942 Searls et al. Jan 2003 A1
20030014112 Ralph et al. Jan 2003 A1
20030014113 Ralph et al. Jan 2003 A1
20030014116 Ralph et al. Jan 2003 A1
20030018390 Husson Jan 2003 A1
20030023305 McKay Jan 2003 A1
20030028250 Reiley et al. Feb 2003 A1
20030028251 Mathews Feb 2003 A1
20030032963 Reiss et al. Feb 2003 A1
20030040796 Ferree Feb 2003 A1
20030040799 Boyd et al. Feb 2003 A1
20030045937 Ginn Mar 2003 A1
20030045939 Casutt Mar 2003 A1
20030050644 Boucher et al. Mar 2003 A1
20030063582 Mizell et al. Apr 2003 A1
20030065330 Zucherman et al. Apr 2003 A1
20030065396 Michelson Apr 2003 A1
20030069582 Culbert Apr 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030069642 Ralph et al. Apr 2003 A1
20030073998 Pagliuca et al. Apr 2003 A1
20030074063 Gerbec et al. Apr 2003 A1
20030074075 Thomas et al. Apr 2003 A1
20030078667 Manasas et al. Apr 2003 A1
20030083642 Boyd et al. May 2003 A1
20030083688 Simonson May 2003 A1
20030108588 Chen et al. Jun 2003 A1
20030130664 Boucher et al. Jul 2003 A1
20030130739 Gerbec et al. Jul 2003 A1
20030135275 Garcia et al. Jul 2003 A1
20030139648 Foley et al. Jul 2003 A1
20030139812 Garcia et al. Jul 2003 A1
20030139813 Messerli et al. Jul 2003 A1
20030153874 Tal Aug 2003 A1
20030171812 Grunberg et al. Sep 2003 A1
20030187431 Simonson Oct 2003 A1
20030187445 Keith et al. Oct 2003 A1
20030187506 Ross et al. Oct 2003 A1
20030191414 Reiley et al. Oct 2003 A1
20030191489 Reiley et al. Oct 2003 A1
20030191531 Berry et al. Oct 2003 A1
20030195518 Cragg Oct 2003 A1
20030195547 Scribner et al. Oct 2003 A1
20030195630 Ferree Oct 2003 A1
20030199979 McGuckin Oct 2003 A1
20030204261 Eisermann et al. Oct 2003 A1
20030208122 Melkent et al. Nov 2003 A1
20030208136 Mark et al. Nov 2003 A1
20030208220 Worley et al. Nov 2003 A1
20030208270 Michelson Nov 2003 A9
20030220643 Ferree Nov 2003 A1
20030220648 Osorio et al. Nov 2003 A1
20030220695 Sevrain Nov 2003 A1
20030229350 Kay Dec 2003 A1
20030229372 Reiley et al. Dec 2003 A1
20030233096 Osorio et al. Dec 2003 A1
20030233102 Nakamura et al. Dec 2003 A1
20030233145 Landry et al. Dec 2003 A1
20030233146 Grinberg et al. Dec 2003 A1
20040002761 Rogers et al. Jan 2004 A1
20040006391 Reiley Jan 2004 A1
20040008949 Liu et al. Jan 2004 A1
20040010251 Pitaru et al. Jan 2004 A1
20040010260 Scribner et al. Jan 2004 A1
20040010263 Boucher et al. Jan 2004 A1
20040010318 Ferree Jan 2004 A1
20040019354 Johnson et al. Jan 2004 A1
20040019359 Worley et al. Jan 2004 A1
20040024408 Burkus et al. Feb 2004 A1
20040024409 Sand et al. Feb 2004 A1
20040024410 Olson et al. Feb 2004 A1
20040024463 Thomas et al. Feb 2004 A1
20040024465 Lambrecht et al. Feb 2004 A1
20040030387 Landry et al. Feb 2004 A1
20040034343 Gillespie et al. Feb 2004 A1
20040034429 Lambrecht et al. Feb 2004 A1
20040049190 Biedermann et al. Mar 2004 A1
20040049203 Scribner et al. Mar 2004 A1
20040049223 Nishtala et al. Mar 2004 A1
20040049270 Gewirtz Mar 2004 A1
20040054412 Gerbec et al. Mar 2004 A1
20040059333 Carl et al. Mar 2004 A1
20040059337 Hanson et al. Mar 2004 A1
20040059339 Roehm et al. Mar 2004 A1
20040059350 Gordon et al. Mar 2004 A1
20040059418 McKay et al. Mar 2004 A1
20040064144 Johnson et al. Apr 2004 A1
20040068269 Bonati et al. Apr 2004 A1
20040073308 Kuslich et al. Apr 2004 A1
20040073310 Moumene et al. Apr 2004 A1
20040082953 Petit Apr 2004 A1
20040083000 Keller et al. Apr 2004 A1
20040087947 Lim et al. May 2004 A1
20040088055 Hanson May 2004 A1
20040092933 Shaolian et al. May 2004 A1
20040092948 Stevens et al. May 2004 A1
20040092988 Shaolian et al. May 2004 A1
20040093083 Branch May 2004 A1
20040097924 Lambrecht et al. May 2004 A1
20040097930 Justis et al. May 2004 A1
20040097932 Ray et al. May 2004 A1
20040097941 Weiner et al. May 2004 A1
20040097973 Loshakove et al. May 2004 A1
20040098131 Bryan et al. May 2004 A1
20040102774 Trieu May 2004 A1
20040102784 Pasquet et al. May 2004 A1
20040102846 Keller et al. May 2004 A1
20040106925 Culbert Jun 2004 A1
20040106940 Shaolian et al. Jun 2004 A1
20040111161 Trieu Jun 2004 A1
20040116997 Taylor et al. Jun 2004 A1
20040117019 Trieu et al. Jun 2004 A1
20040117022 Marnay et al. Jun 2004 A1
20040127906 Culbert et al. Jul 2004 A1
20040127990 Bartish et al. Jul 2004 A1
20040127991 Ferree Jul 2004 A1
20040133124 Bates et al. Jul 2004 A1
20040133229 Lambrecht et al. Jul 2004 A1
20040133279 Krueger et al. Jul 2004 A1
20040133280 Trieu Jul 2004 A1
20040138748 Boyer et al. Jul 2004 A1
20040143284 Chin Jul 2004 A1
20040143332 Krueger et al. Jul 2004 A1
20040143734 Buer et al. Jul 2004 A1
20040147129 Rolfson Jul 2004 A1
20040147877 Heuser Jul 2004 A1
20040147950 Mueller et al. Jul 2004 A1
20040148027 Errico et al. Jul 2004 A1
20040153064 Foley et al. Aug 2004 A1
20040153065 Lim Aug 2004 A1
20040153115 Reiley et al. Aug 2004 A1
20040153156 Cohen Aug 2004 A1
20040153160 Carrasco Aug 2004 A1
20040158206 Aboul-Hosn et al. Aug 2004 A1
20040158258 Bonati et al. Aug 2004 A1
20040162617 Zucherman et al. Aug 2004 A1
20040162618 Mujwid et al. Aug 2004 A1
20040167561 Boucher et al. Aug 2004 A1
20040167562 Osorio et al. Aug 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040172133 Gerber et al. Sep 2004 A1
20040172134 Berry Sep 2004 A1
20040176775 Burkus et al. Sep 2004 A1
20040186052 Iyer et al. Sep 2004 A1
20040186471 Trieu Sep 2004 A1
20040186482 Kolb et al. Sep 2004 A1
20040186528 Ries et al. Sep 2004 A1
20040186570 Rapp Sep 2004 A1
20040186573 Ferree Sep 2004 A1
20040186577 Ferree Sep 2004 A1
20040193271 Fraser et al. Sep 2004 A1
20040193277 Long et al. Sep 2004 A1
20040199162 Von et al. Oct 2004 A1
20040210231 Boucher et al. Oct 2004 A1
20040210310 Trieu Oct 2004 A1
20040215343 Hochschuler et al. Oct 2004 A1
20040215344 Hochschuler et al. Oct 2004 A1
20040220580 Johnson et al. Nov 2004 A1
20040220668 Eisermann et al. Nov 2004 A1
20040220669 Studer Nov 2004 A1
20040220672 Shadduck Nov 2004 A1
20040225292 Sasso et al. Nov 2004 A1
20040225296 Reiss et al. Nov 2004 A1
20040225361 Glenn et al. Nov 2004 A1
20040230191 Frey et al. Nov 2004 A1
20040230309 DiMauro et al. Nov 2004 A1
20040243229 Vidlund et al. Dec 2004 A1
20040243239 Taylor Dec 2004 A1
20040243241 Istephanous et al. Dec 2004 A1
20040249377 Kaes et al. Dec 2004 A1
20040249461 Ferree Dec 2004 A1
20040249466 Liu et al. Dec 2004 A1
20040254520 Porteous et al. Dec 2004 A1
20040254575 Obenchain et al. Dec 2004 A1
20040254643 Jackson Dec 2004 A1
20040254644 Taylor Dec 2004 A1
20040260297 Padget et al. Dec 2004 A1
20040260300 Gorensek et al. Dec 2004 A1
20040260397 Lambrecht et al. Dec 2004 A1
20040266257 Ries et al. Dec 2004 A1
20040267271 Scribner et al. Dec 2004 A9
20040267367 O'Neil Dec 2004 A1
20050004578 Lambrecht et al. Jan 2005 A1
20050010293 Zucherman et al. Jan 2005 A1
20050010298 Zucherman et al. Jan 2005 A1
20050015148 Jansen et al. Jan 2005 A1
20050015152 Sweeney Jan 2005 A1
20050019365 Frauchiger et al. Jan 2005 A1
20050021041 Michelson Jan 2005 A1
20050033289 Warren et al. Feb 2005 A1
20050033295 Wisnewski Feb 2005 A1
20050033434 Berry Feb 2005 A1
20050033440 Lambrecht et al. Feb 2005 A1
20050038431 Bartish et al. Feb 2005 A1
20050038515 Kunzler Feb 2005 A1
20050038517 Carrison et al. Feb 2005 A1
20050043737 Reiley et al. Feb 2005 A1
20050043796 Grant et al. Feb 2005 A1
20050043800 Paul et al. Feb 2005 A1
20050054948 Goldenberg Mar 2005 A1
20050055097 Grunberg et al. Mar 2005 A1
20050060036 Schultz et al. Mar 2005 A1
20050060038 Lambrecht et al. Mar 2005 A1
20050065519 Michelson Mar 2005 A1
20050065609 Wardlaw Mar 2005 A1
20050065610 Pisharodi Mar 2005 A1
20050069571 Slivka et al. Mar 2005 A1
20050070908 Cragg Mar 2005 A1
20050070911 Carrison et al. Mar 2005 A1
20050070913 Milbocker et al. Mar 2005 A1
20050071011 Ralph et al. Mar 2005 A1
20050080443 Fallin et al. Apr 2005 A1
20050080488 Schultz Apr 2005 A1
20050085912 Arnin et al. Apr 2005 A1
20050090443 Michael John Apr 2005 A1
20050090833 DiPoto Apr 2005 A1
20050090852 Layne et al. Apr 2005 A1
20050090899 DiPoto Apr 2005 A1
20050096745 Andre et al. May 2005 A1
20050102202 Linden et al. May 2005 A1
20050107880 Shimp et al. May 2005 A1
20050113916 Branch, Jr. May 2005 A1
20050113917 Chae et al. May 2005 A1
20050113918 Messerli et al. May 2005 A1
20050113919 Cragg et al. May 2005 A1
20050113927 Malek May 2005 A1
20050113928 Cragg et al. May 2005 A1
20050118228 Trieu Jun 2005 A1
20050118550 Turri Jun 2005 A1
20050119657 Goldsmith Jun 2005 A1
20050119662 Reiley et al. Jun 2005 A1
20050119750 Studer Jun 2005 A1
20050119751 Lawson Jun 2005 A1
20050119752 Williams et al. Jun 2005 A1
20050119754 Trieu et al. Jun 2005 A1
20050124989 Suddaby Jun 2005 A1
20050124992 Ferree Jun 2005 A1
20050124999 Teitelbaum et al. Jun 2005 A1
20050125061 Zucherman et al. Jun 2005 A1
20050125062 Biedermann et al. Jun 2005 A1
20050125066 McAfee Jun 2005 A1
20050130929 Boyd Jun 2005 A1
20050131267 Talmadge Jun 2005 A1
20050131268 Talmadge Jun 2005 A1
20050131269 Talmadge Jun 2005 A1
20050131406 Reiley et al. Jun 2005 A1
20050131409 Chervitz et al. Jun 2005 A1
20050131411 Culbert Jun 2005 A1
20050131536 Eisermann et al. Jun 2005 A1
20050131538 Chervitz et al. Jun 2005 A1
20050131540 Trieu Jun 2005 A1
20050131541 Trieu Jun 2005 A1
20050137595 Hoffmann et al. Jun 2005 A1
20050137602 Assell et al. Jun 2005 A1
20050142211 Wenz Jun 2005 A1
20050143734 Cachia et al. Jun 2005 A1
20050143763 Ortiz et al. Jun 2005 A1
20050143827 Globerman et al. Jun 2005 A1
20050149022 Shaolian et al. Jul 2005 A1
20050149030 Serhan et al. Jul 2005 A1
20050149034 Assell et al. Jul 2005 A1
20050149191 Cragg et al. Jul 2005 A1
20050149194 Ahlgren Jul 2005 A1
20050149197 Cauthen Jul 2005 A1
20050154396 Foley et al. Jul 2005 A1
20050154463 Trieu Jul 2005 A1
20050154467 Peterman et al. Jul 2005 A1
20050165398 Reiley Jul 2005 A1
20050165406 Assell et al. Jul 2005 A1
20050165420 Cha Jul 2005 A1
20050165484 Ferree Jul 2005 A1
20050165485 Trieu Jul 2005 A1
20050171539 Braun et al. Aug 2005 A1
20050171541 Boehm et al. Aug 2005 A1
20050171552 Johnson et al. Aug 2005 A1
20050171608 Peterman et al. Aug 2005 A1
20050171610 Humphreys et al. Aug 2005 A1
20050177173 Aebi et al. Aug 2005 A1
20050177235 Baynham et al. Aug 2005 A1
20050177240 Blain Aug 2005 A1
20050182412 Johnson et al. Aug 2005 A1
20050182413 Johnson et al. Aug 2005 A1
20050182414 Manzi et al. Aug 2005 A1
20050182418 Boyd et al. Aug 2005 A1
20050187556 Stack et al. Aug 2005 A1
20050187558 Johnson et al. Aug 2005 A1
20050187559 Raymond et al. Aug 2005 A1
20050187564 Jayaraman Aug 2005 A1
20050197702 Coppes et al. Sep 2005 A1
20050197707 Trieu et al. Sep 2005 A1
20050203512 Hawkins et al. Sep 2005 A1
20050216018 Sennett Sep 2005 A1
20050216026 Culbert Sep 2005 A1
20050216081 Taylor Sep 2005 A1
20050216087 Zucherman et al. Sep 2005 A1
20050222681 Richley et al. Oct 2005 A1
20050222684 Ferree Oct 2005 A1
20050228383 Zucherman et al. Oct 2005 A1
20050228391 Levy et al. Oct 2005 A1
20050228397 Malandain et al. Oct 2005 A1
20050234425 Miller et al. Oct 2005 A1
20050234451 Markworth Oct 2005 A1
20050234452 Malandain Oct 2005 A1
20050234456 Malandain Oct 2005 A1
20050240182 Zucherman et al. Oct 2005 A1
20050240189 Rousseau et al. Oct 2005 A1
20050240193 Layne et al. Oct 2005 A1
20050240269 Lambrecht et al. Oct 2005 A1
20050251142 Hoffmann et al. Nov 2005 A1
20050251149 Wenz Nov 2005 A1
20050251260 Gerber et al. Nov 2005 A1
20050256525 Culbert et al. Nov 2005 A1
20050256576 Moskowitz et al. Nov 2005 A1
20050261682 Ferree Nov 2005 A1
20050261684 Shaolian et al. Nov 2005 A1
20050261695 Cragg et al. Nov 2005 A1
20050261769 Moskowitz et al. Nov 2005 A1
20050261781 Sennett et al. Nov 2005 A1
20050267471 Biedermann et al. Dec 2005 A1
20050273166 Sweeney Dec 2005 A1
20050273173 Gordon et al. Dec 2005 A1
20050277938 Parsons Dec 2005 A1
20050278023 Zwirkoski Dec 2005 A1
20050278026 Gordon et al. Dec 2005 A1
20050278027 Hyde, Jr. Dec 2005 A1
20050278029 Trieu Dec 2005 A1
20050283238 Reiley Dec 2005 A1
20050283244 Gordon et al. Dec 2005 A1
20050287071 Wenz Dec 2005 A1
20060004326 Collins et al. Jan 2006 A1
20060004456 McKay Jan 2006 A1
20060004457 Collins et al. Jan 2006 A1
20060004458 Collins et al. Jan 2006 A1
20060009778 Collins et al. Jan 2006 A1
20060009779 Collins et al. Jan 2006 A1
20060009851 Collins et al. Jan 2006 A1
20060015105 Warren et al. Jan 2006 A1
20060015119 Plassky et al. Jan 2006 A1
20060020284 Foley et al. Jan 2006 A1
20060030850 Keegan et al. Feb 2006 A1
20060030872 Culbert et al. Feb 2006 A1
20060030933 Delegge et al. Feb 2006 A1
20060030943 Peterman Feb 2006 A1
20060036241 Siegal Feb 2006 A1
20060036244 Spitler et al. Feb 2006 A1
20060036246 Carl et al. Feb 2006 A1
20060036256 Carl et al. Feb 2006 A1
20060036259 Carl et al. Feb 2006 A1
20060036261 McDonnell Feb 2006 A1
20060036273 Siegal Feb 2006 A1
20060036323 Carl et al. Feb 2006 A1
20060036324 Sachs et al. Feb 2006 A1
20060041258 Galea Feb 2006 A1
20060041314 Millard Feb 2006 A1
20060045904 Aronson Mar 2006 A1
20060058790 Carl et al. Mar 2006 A1
20060058807 Landry et al. Mar 2006 A1
20060058876 McKinley Mar 2006 A1
20060058880 Wysocki et al. Mar 2006 A1
20060064101 Arramon Mar 2006 A1
20060064102 Ebner Mar 2006 A1
20060064171 Trieu Mar 2006 A1
20060064172 Trieu Mar 2006 A1
20060069436 Sutton et al. Mar 2006 A1
20060069439 Zucherman et al. Mar 2006 A1
20060069440 Zucherman et al. Mar 2006 A1
20060074429 Ralph et al. Apr 2006 A1
20060079908 Lieberman Apr 2006 A1
20060084867 Tremblay et al. Apr 2006 A1
20060084977 Lieberman Apr 2006 A1
20060084988 Kim Apr 2006 A1
20060085002 Trieu et al. Apr 2006 A1
20060085009 Truckai et al. Apr 2006 A1
20060085010 Lieberman Apr 2006 A1
20060089642 Diaz et al. Apr 2006 A1
20060089646 Bonutti Apr 2006 A1
20060089654 Lins et al. Apr 2006 A1
20060089715 Truckai et al. Apr 2006 A1
20060089718 Zucherman et al. Apr 2006 A1
20060089719 Trieu Apr 2006 A1
20060095045 Trieu May 2006 A1
20060095046 Trieu et al. May 2006 A1
20060095134 Trieu et al. May 2006 A1
20060095138 Truckai et al. May 2006 A1
20060100622 Jackson May 2006 A1
20060100706 Shadduck et al. May 2006 A1
20060100707 Stinson et al. May 2006 A1
20060106381 Ferree et al. May 2006 A1
20060106397 Lins May 2006 A1
20060106459 Truckai et al. May 2006 A1
20060111715 Jackson May 2006 A1
20060111728 Abdou May 2006 A1
20060111785 O'Neil May 2006 A1
20060119629 An et al. Jun 2006 A1
20060122609 Mirkovic et al. Jun 2006 A1
20060122610 Culbert et al. Jun 2006 A1
20060122701 Kiester Jun 2006 A1
20060122703 Aebi et al. Jun 2006 A1
20060122704 Vresilovic et al. Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060136062 Dinello et al. Jun 2006 A1
20060136064 Sherman Jun 2006 A1
20060142759 Arnin et al. Jun 2006 A1
20060142765 Dixon et al. Jun 2006 A9
20060142776 Iwanari Jun 2006 A1
20060142858 Colleran et al. Jun 2006 A1
20060142864 Cauthen Jun 2006 A1
20060149136 Seto et al. Jul 2006 A1
20060149229 Kwak et al. Jul 2006 A1
20060149237 Markworth et al. Jul 2006 A1
20060149252 Markworth et al. Jul 2006 A1
20060149379 Kuslich et al. Jul 2006 A1
20060149380 Lotz et al. Jul 2006 A1
20060149385 McKay Jul 2006 A1
20060155379 Heneveld et al. Jul 2006 A1
20060161162 Lambrecht et al. Jul 2006 A1
20060161166 Johnson et al. Jul 2006 A1
20060167547 Suddaby Jul 2006 A1
20060167553 Cauthen et al. Jul 2006 A1
20060173545 Cauthen et al. Aug 2006 A1
20060178743 Carter Aug 2006 A1
20060178745 Bartish et al. Aug 2006 A1
20060178746 Bartish et al. Aug 2006 A1
20060184192 Markworth et al. Aug 2006 A1
20060184247 Edidin et al. Aug 2006 A1
20060184248 Edidin et al. Aug 2006 A1
20060189999 Zwirkoski Aug 2006 A1
20060190083 Arnin et al. Aug 2006 A1
20060190085 Cauthen Aug 2006 A1
20060195102 Malandain Aug 2006 A1
20060195103 Padget et al. Aug 2006 A1
20060195191 Sweeney et al. Aug 2006 A1
20060200139 Michelson Sep 2006 A1
20060200164 Michelson Sep 2006 A1
20060200239 Rothman et al. Sep 2006 A1
20060200240 Rothman et al. Sep 2006 A1
20060200241 Rothman et al. Sep 2006 A1
20060200242 Rothman et al. Sep 2006 A1
20060200243 Rothman et al. Sep 2006 A1
20060206116 Yeung Sep 2006 A1
20060206207 Dryer et al. Sep 2006 A1
20060212118 Abernathie Sep 2006 A1
20060217711 Stevens et al. Sep 2006 A1
20060229627 Hunt et al. Oct 2006 A1
20060229629 Manzi et al. Oct 2006 A1
20060235403 Blain Oct 2006 A1
20060235412 Blain Oct 2006 A1
20060235423 Cantu Oct 2006 A1
20060235521 Zucherman et al. Oct 2006 A1
20060235531 Buettner-Janz Oct 2006 A1
20060241643 Lim et al. Oct 2006 A1
20060241663 Rice et al. Oct 2006 A1
20060241770 Rhoda et al. Oct 2006 A1
20060247634 Warner et al. Nov 2006 A1
20060247770 Peterman Nov 2006 A1
20060247771 Peterman et al. Nov 2006 A1
20060247781 Francis Nov 2006 A1
20060253120 Anderson et al. Nov 2006 A1
20060253201 McLuen Nov 2006 A1
20060254784 Hartmann et al. Nov 2006 A1
20060264896 Palmer Nov 2006 A1
20060264939 Zucherman et al. Nov 2006 A1
20060264945 Edidin et al. Nov 2006 A1
20060265067 Zucherman et al. Nov 2006 A1
20060265075 Baumgartner et al. Nov 2006 A1
20060265077 Zwirkoski Nov 2006 A1
20060271049 Zucherman et al. Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060276897 Winslow et al. Dec 2006 A1
20060276899 Zipnick et al. Dec 2006 A1
20060276901 Zipnick et al. Dec 2006 A1
20060276902 Zipnick et al. Dec 2006 A1
20060282167 Lambrecht et al. Dec 2006 A1
20060287726 Segal et al. Dec 2006 A1
20060287727 Segal et al. Dec 2006 A1
20060293662 Boyer et al. Dec 2006 A1
20060293663 Walkenhorst et al. Dec 2006 A1
20060293753 Thramann Dec 2006 A1
20070006692 Phan Jan 2007 A1
20070010716 Malandain et al. Jan 2007 A1
20070010717 Cragg Jan 2007 A1
20070010824 Malandain et al. Jan 2007 A1
20070010826 Rhoda et al. Jan 2007 A1
20070010844 Gong et al. Jan 2007 A1
20070010845 Gong et al. Jan 2007 A1
20070010846 Leung et al. Jan 2007 A1
20070010848 Leung et al. Jan 2007 A1
20070010886 Banick et al. Jan 2007 A1
20070010889 Francis Jan 2007 A1
20070016191 Culbert et al. Jan 2007 A1
20070032703 Sankaran et al. Feb 2007 A1
20070032790 Aschmann et al. Feb 2007 A1
20070032791 Greenhalgh Feb 2007 A1
20070043361 Malandain et al. Feb 2007 A1
20070043362 Malandain et al. Feb 2007 A1
20070043363 Malandain et al. Feb 2007 A1
20070043440 William et al. Feb 2007 A1
20070048382 Meyer et al. Mar 2007 A1
20070049849 Schwardt et al. Mar 2007 A1
20070049934 Edidin et al. Mar 2007 A1
20070049935 Edidin et al. Mar 2007 A1
20070050034 Schwardt et al. Mar 2007 A1
20070050035 Schwardt et al. Mar 2007 A1
20070055201 Seto et al. Mar 2007 A1
20070055236 Hudgins et al. Mar 2007 A1
20070055237 Edidin et al. Mar 2007 A1
20070055246 Zucherman et al. Mar 2007 A1
20070055264 Parmigiani Mar 2007 A1
20070055265 Schaller Mar 2007 A1
20070055266 Osorio et al. Mar 2007 A1
20070055267 Osorio et al. Mar 2007 A1
20070055271 Schaller Mar 2007 A1
20070055272 Schaller Mar 2007 A1
20070055273 Schaller Mar 2007 A1
20070055274 Appenzeller et al. Mar 2007 A1
20070055275 Schaller Mar 2007 A1
20070055276 Edidin Mar 2007 A1
20070055277 Osorio et al. Mar 2007 A1
20070055278 Osorio et al. Mar 2007 A1
20070055281 Osorio et al. Mar 2007 A1
20070055284 Osorio et al. Mar 2007 A1
20070055300 Osorio et al. Mar 2007 A1
20070055377 Hanson et al. Mar 2007 A1
20070060933 Sankaran et al. Mar 2007 A1
20070060935 Schwardt et al. Mar 2007 A1
20070067034 Chirico et al. Mar 2007 A1
20070067035 Falahee Mar 2007 A1
20070068329 Phan et al. Mar 2007 A1
20070073292 Kohm et al. Mar 2007 A1
20070073399 Zipnick et al. Mar 2007 A1
20070078436 Leung et al. Apr 2007 A1
20070078463 Malandain Apr 2007 A1
20070093689 Steinberg Apr 2007 A1
20070093897 Gerbec et al. Apr 2007 A1
20070093899 Dutoit et al. Apr 2007 A1
20070093901 Grotz et al. Apr 2007 A1
20070093906 Hudgins et al. Apr 2007 A1
20070118132 Culbert et al. May 2007 A1
20070118222 Lang May 2007 A1
20070118223 Allard et al. May 2007 A1
20070123868 Culbert et al. May 2007 A1
20070123891 Ries et al. May 2007 A1
20070123892 Ries et al. May 2007 A1
20070123986 Schaller May 2007 A1
20070129730 Woods et al. Jun 2007 A1
20070135922 Trieu Jun 2007 A1
20070142843 Dye Jun 2007 A1
20070149978 Shezifi et al. Jun 2007 A1
20070150059 Ruberte et al. Jun 2007 A1
20070150060 Trieu Jun 2007 A1
20070150061 Trieu Jun 2007 A1
20070150063 Ruberte et al. Jun 2007 A1
20070150064 Ruberte et al. Jun 2007 A1
20070161992 Kwak et al. Jul 2007 A1
20070162005 Peterson et al. Jul 2007 A1
20070162127 Peterman et al. Jul 2007 A1
20070162132 Messerli Jul 2007 A1
20070162138 Heinz Jul 2007 A1
20070167945 Lange et al. Jul 2007 A1
20070168036 Ainsworth et al. Jul 2007 A1
20070168038 Trieu Jul 2007 A1
20070173939 Kim et al. Jul 2007 A1
20070173940 Hestad et al. Jul 2007 A1
20070178222 Storey et al. Aug 2007 A1
20070179612 Johnson et al. Aug 2007 A1
20070179615 Heinz et al. Aug 2007 A1
20070179616 Braddock et al. Aug 2007 A1
20070179618 Trieu et al. Aug 2007 A1
20070185578 O'Neil et al. Aug 2007 A1
20070191953 Trieu Aug 2007 A1
20070191954 Hansell et al. Aug 2007 A1
20070191959 Hartmann et al. Aug 2007 A1
20070197935 Reiley et al. Aug 2007 A1
20070198023 Sand et al. Aug 2007 A1
20070198025 Trieu et al. Aug 2007 A1
20070198089 Moskowitz et al. Aug 2007 A1
20070203491 Pasquet et al. Aug 2007 A1
20070208423 Messerli et al. Sep 2007 A1
20070208426 Trieu Sep 2007 A1
20070213717 Trieu et al. Sep 2007 A1
20070213737 Schermerhorn et al. Sep 2007 A1
20070213826 Smith et al. Sep 2007 A1
20070219634 Greenhalgh et al. Sep 2007 A1
20070225706 Clark et al. Sep 2007 A1
20070225726 Dye et al. Sep 2007 A1
20070225807 Phan et al. Sep 2007 A1
20070225815 Keith et al. Sep 2007 A1
20070233074 Anderson et al. Oct 2007 A1
20070233076 Trieu Oct 2007 A1
20070233083 Abdou Oct 2007 A1
20070233089 Dipoto et al. Oct 2007 A1
20070233130 Suddaby Oct 2007 A1
20070233244 Lopez et al. Oct 2007 A1
20070260245 Malandain et al. Nov 2007 A1
20070260255 Haddock et al. Nov 2007 A1
20070260314 Biyani Nov 2007 A1
20070270823 Trieu et al. Nov 2007 A1
20070270954 Wu Nov 2007 A1
20070270957 Heinz Nov 2007 A1
20070270968 Baynham et al. Nov 2007 A1
20070276373 Malandain Nov 2007 A1
20070276375 Rapp Nov 2007 A1
20070276497 Anderson Nov 2007 A1
20070282443 Globerman et al. Dec 2007 A1
20070282449 De et al. Dec 2007 A1
20070288091 Braddock et al. Dec 2007 A1
20070299521 Glenn et al. Dec 2007 A1
20080009877 Sankaran et al. Jan 2008 A1
20080015694 Tribus Jan 2008 A1
20080015701 Garcia et al. Jan 2008 A1
20080021556 Edie Jan 2008 A1
20080021557 Trieu Jan 2008 A1
20080021558 Thramann Jan 2008 A1
20080021559 Thramann Jan 2008 A1
20080027437 Johnson et al. Jan 2008 A1
20080027438 Abdou Jan 2008 A1
20080027453 Johnson et al. Jan 2008 A1
20080027454 Johnson et al. Jan 2008 A1
20080027544 Melkent Jan 2008 A1
20080027550 Link et al. Jan 2008 A1
20080033440 Moskowitz et al. Feb 2008 A1
20080045966 Buttermann et al. Feb 2008 A1
20080051890 Waugh et al. Feb 2008 A1
20080051897 Lopez et al. Feb 2008 A1
20080051902 Dwyer Feb 2008 A1
20080058598 Ries et al. Mar 2008 A1
20080058937 Malandain et al. Mar 2008 A1
20080058944 Duplessis et al. Mar 2008 A1
20080065082 Chang et al. Mar 2008 A1
20080065219 Dye Mar 2008 A1
20080071356 Greenhalgh et al. Mar 2008 A1
20080071380 Sweeney Mar 2008 A1
20080077148 Ries et al. Mar 2008 A1
20080077150 Nguyen Mar 2008 A1
20080077241 Nguyen Mar 2008 A1
20080082172 Jackson Apr 2008 A1
20080082173 Delurio et al. Apr 2008 A1
20080097436 Culbert et al. Apr 2008 A1
20080097454 Deridder et al. Apr 2008 A1
20080097611 Mastrorio et al. Apr 2008 A1
20080103601 Biro et al. May 2008 A1
20080108990 Mitchell et al. May 2008 A1
20080108996 Padget et al. May 2008 A1
20080119935 Alvarez May 2008 A1
20080125865 Abdelgany May 2008 A1
20080132934 Reiley et al. Jun 2008 A1
20080133017 Beyar et al. Jun 2008 A1
20080140085 Gately et al. Jun 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20080147129 Biedermann et al. Jun 2008 A1
20080147193 Matthis et al. Jun 2008 A1
20080154379 Steiner et al. Jun 2008 A1
20080161927 Savage et al. Jul 2008 A1
20080167657 Greenhalgh Jul 2008 A1
20080177306 Lamborne et al. Jul 2008 A1
20080177312 Perez-Cruet et al. Jul 2008 A1
20080177388 Patterson et al. Jul 2008 A1
20080183204 Greenhalgh et al. Jul 2008 A1
20080188945 Boyce et al. Aug 2008 A1
20080195096 Frei Aug 2008 A1
20080195209 Garcia et al. Aug 2008 A1
20080195210 Milijasevic et al. Aug 2008 A1
20080208255 Siegal Aug 2008 A1
20080208344 Kilpela et al. Aug 2008 A1
20080221586 Garcia-Bengochea et al. Sep 2008 A1
20080221687 Viker Sep 2008 A1
20080228225 Trautwein et al. Sep 2008 A1
20080229597 Malandain Sep 2008 A1
20080234732 Landry et al. Sep 2008 A1
20080234733 Scrantz et al. Sep 2008 A1
20080243126 Gutierrez et al. Oct 2008 A1
20080243251 Stad et al. Oct 2008 A1
20080243254 Butler Oct 2008 A1
20080249622 Gray Oct 2008 A1
20080249628 Altarac et al. Oct 2008 A1
20080255563 Farr et al. Oct 2008 A1
20080255574 Dye Oct 2008 A1
20080255618 Fisher et al. Oct 2008 A1
20080262619 Ray Oct 2008 A1
20080269904 Voorhies Oct 2008 A1
20080281346 Greenhalgh et al. Nov 2008 A1
20080281364 Chirico et al. Nov 2008 A1
20080281425 Thalgott et al. Nov 2008 A1
20080287981 Culbert et al. Nov 2008 A1
20080287997 Altarac et al. Nov 2008 A1
20080300685 Carls et al. Dec 2008 A1
20080306537 Culbert Dec 2008 A1
20080312743 Vila et al. Dec 2008 A1
20080319477 Justis et al. Dec 2008 A1
20090005870 Hawkins et al. Jan 2009 A1
20090005873 Slivka et al. Jan 2009 A1
20090018524 Greenhalgh et al. Jan 2009 A1
20090030423 Puno Jan 2009 A1
20090048631 Bhatnagar et al. Feb 2009 A1
20090048678 Saal et al. Feb 2009 A1
20090054898 Gleason Feb 2009 A1
20090054911 Mueller et al. Feb 2009 A1
20090054988 Hess Feb 2009 A1
20090054991 Biyani et al. Feb 2009 A1
20090062807 Song Mar 2009 A1
20090069813 Von et al. Mar 2009 A1
20090069895 Gittings et al. Mar 2009 A1
20090076607 Aalsma et al. Mar 2009 A1
20090076610 Afzal Mar 2009 A1
20090088789 O'Neil et al. Apr 2009 A1
20090099568 Lowry et al. Apr 2009 A1
20090105745 Culbert Apr 2009 A1
20090112217 Hester Apr 2009 A1
20090112320 Kraus Apr 2009 A1
20090112324 Refai et al. Apr 2009 A1
20090131986 Lee et al. May 2009 A1
20090149857 Culbert et al. Jun 2009 A1
20090164020 Janowski et al. Jun 2009 A1
20090177281 Swanson et al. Jul 2009 A1
20090177284 Rogers et al. Jul 2009 A1
20090182429 Humphreys et al. Jul 2009 A1
20090192613 Wing et al. Jul 2009 A1
20090192614 Beger et al. Jul 2009 A1
20090216234 Farr et al. Aug 2009 A1
20090221967 Thommen et al. Sep 2009 A1
20090222043 Altarac et al. Sep 2009 A1
20090222096 Trieu Sep 2009 A1
20090222099 Liu et al. Sep 2009 A1
20090222100 Cipoletti et al. Sep 2009 A1
20090234389 Chuang et al. Sep 2009 A1
20090234398 Chirico et al. Sep 2009 A1
20090240333 Trudeau et al. Sep 2009 A1
20090240334 Richelsoph Sep 2009 A1
20090240335 Arcenio et al. Sep 2009 A1
20090248159 Aflatoon Oct 2009 A1
20090248163 King et al. Oct 2009 A1
20090275890 Leibowitz et al. Nov 2009 A1
20090276049 Weiland Nov 2009 A1
20090276051 Arramon et al. Nov 2009 A1
20090292361 Lopez Nov 2009 A1
20090299479 Jones et al. Dec 2009 A1
20100016905 Greenhalgh et al. Jan 2010 A1
20100016968 Moore Jan 2010 A1
20100030217 Mitusina Feb 2010 A1
20100040332 Van et al. Feb 2010 A1
20100042218 Nebosky et al. Feb 2010 A1
20100049324 Valdevit et al. Feb 2010 A1
20100070036 Implicito Mar 2010 A1
20100076492 Warner et al. Mar 2010 A1
20100076502 Guyer et al. Mar 2010 A1
20100076559 Bagga et al. Mar 2010 A1
20100082109 Greenhalgh et al. Apr 2010 A1
20100094422 Hansell et al. Apr 2010 A1
20100094424 Woodburn et al. Apr 2010 A1
20100094426 Grohowski et al. Apr 2010 A1
20100100098 Norton et al. Apr 2010 A1
20100100183 Prewett et al. Apr 2010 A1
20100106191 Yue et al. Apr 2010 A1
20100114147 Biyani May 2010 A1
20100125334 Krueger May 2010 A1
20100174314 Mirkovic et al. Jul 2010 A1
20100179594 Theofilos et al. Jul 2010 A1
20100185290 Compton et al. Jul 2010 A1
20100185292 Hochschuler et al. Jul 2010 A1
20100191241 McCormack et al. Jul 2010 A1
20100191334 Keller Jul 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100204795 Greenhalgh Aug 2010 A1
20100204796 Bae et al. Aug 2010 A1
20100211107 Muhanna Aug 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100211182 Zimmermann Aug 2010 A1
20100217269 Landes Aug 2010 A1
20100222884 Greenhalgh Sep 2010 A1
20100234849 Bouadi Sep 2010 A1
20100234956 Attia et al. Sep 2010 A1
20100241231 Marino et al. Sep 2010 A1
20100256768 Lim et al. Oct 2010 A1
20100262240 Chavatte et al. Oct 2010 A1
20100268231 Kuslich et al. Oct 2010 A1
20100274358 Mueller et al. Oct 2010 A1
20100286777 Errico et al. Nov 2010 A1
20100286783 Lechmann et al. Nov 2010 A1
20100292700 Ries Nov 2010 A1
20100292796 Greenhalgh et al. Nov 2010 A1
20100298938 Humphreys et al. Nov 2010 A1
20100305700 Ben-Arye et al. Dec 2010 A1
20100305704 Messerli et al. Dec 2010 A1
20100324607 Davis Dec 2010 A1
20100324683 Reichen et al. Dec 2010 A1
20100331845 Foley et al. Dec 2010 A1
20100331891 Culbert et al. Dec 2010 A1
20110004216 Amendola et al. Jan 2011 A1
20110004308 Marino et al. Jan 2011 A1
20110004310 Michelson Jan 2011 A1
20110009970 Puno Jan 2011 A1
20110015747 McManus et al. Jan 2011 A1
20110029082 Hall Feb 2011 A1
20110029083 Hynes et al. Feb 2011 A1
20110029085 Hynes et al. Feb 2011 A1
20110029086 Glazer et al. Feb 2011 A1
20110035011 Cain Feb 2011 A1
20110040332 Culbert et al. Feb 2011 A1
20110046674 Calvosa et al. Feb 2011 A1
20110054538 Zehavi et al. Mar 2011 A1
20110066186 Boyer et al. Mar 2011 A1
20110071527 Nelson et al. Mar 2011 A1
20110082552 Wistrom et al. Apr 2011 A1
20110093074 Glerum et al. Apr 2011 A1
20110093076 Reo et al. Apr 2011 A1
20110098531 To Apr 2011 A1
20110098628 Yeung et al. Apr 2011 A1
20110098818 Brodke et al. Apr 2011 A1
20110112586 Guyer et al. May 2011 A1
20110130835 Ashley et al. Jun 2011 A1
20110130838 Morgenstern Lopez Jun 2011 A1
20110144692 Saladin et al. Jun 2011 A1
20110144753 Marchek et al. Jun 2011 A1
20110153020 Abdelgany et al. Jun 2011 A1
20110159070 Jin et al. Jun 2011 A1
20110160773 Aschmann et al. Jun 2011 A1
20110160861 Jimenez Jun 2011 A1
20110160866 Laurence et al. Jun 2011 A1
20110172716 Glerum Jul 2011 A1
20110172774 Varela Jul 2011 A1
20110190816 Sheffer et al. Aug 2011 A1
20110190891 Suh et al. Aug 2011 A1
20110230971 Donner et al. Sep 2011 A1
20110238072 Tyndall Sep 2011 A1
20110251690 Berger et al. Oct 2011 A1
20110270261 Mast et al. Nov 2011 A1
20110270401 Mckay Nov 2011 A1
20110276142 Niemiec et al. Nov 2011 A1
20110282453 Greenhalgh et al. Nov 2011 A1
20110282459 McClellan et al. Nov 2011 A1
20110301711 Palmatier et al. Dec 2011 A1
20110301712 Palmatier et al. Dec 2011 A1
20110307010 Pradhan Dec 2011 A1
20110313465 Warren et al. Dec 2011 A1
20110319899 O'Neil et al. Dec 2011 A1
20110319997 Glerum Dec 2011 A1
20110319998 O'Neil et al. Dec 2011 A1
20110320000 O'Neil Dec 2011 A1
20120004726 Greenhalgh et al. Jan 2012 A1
20120004732 Goel et al. Jan 2012 A1
20120006361 Miyagi et al. Jan 2012 A1
20120010715 Spann Jan 2012 A1
20120022654 Farris et al. Jan 2012 A1
20120029636 Ragab et al. Feb 2012 A1
20120029637 Ragab et al. Feb 2012 A1
20120029639 Blackwell et al. Feb 2012 A1
20120035730 Spann Feb 2012 A1
20120059474 Weiman Mar 2012 A1
20120059475 Weiman Mar 2012 A1
20120071977 Oglaza et al. Mar 2012 A1
20120071980 Purcell et al. Mar 2012 A1
20120083887 Purcell et al. Apr 2012 A1
20120083889 Purcell et al. Apr 2012 A1
20120109319 Perisic May 2012 A1
20120123546 Medina May 2012 A1
20120136443 Wenzel May 2012 A1
20120150304 Glerum et al. Jun 2012 A1
20120150305 Glerum et al. Jun 2012 A1
20120158146 Glerum et al. Jun 2012 A1
20120158147 Glerum et al. Jun 2012 A1
20120158148 Glerum et al. Jun 2012 A1
20120185049 Varela Jul 2012 A1
20120191204 Bae et al. Jul 2012 A1
20120197299 Fabian, Jr. Aug 2012 A1
20120197403 Merves Aug 2012 A1
20120197405 Cuevas et al. Aug 2012 A1
20120203290 Warren et al. Aug 2012 A1
20120203347 Glerum et al. Aug 2012 A1
20120209383 Tsuang et al. Aug 2012 A1
20120215262 Culbert et al. Aug 2012 A1
20120215315 Hochschuler et al. Aug 2012 A1
20120215316 Mohr et al. Aug 2012 A1
20120226357 Varela Sep 2012 A1
20120232552 Morgenstern et al. Sep 2012 A1
20120232658 Morgenstern et al. Sep 2012 A1
20120253395 Linares Oct 2012 A1
20120253406 Bae et al. Oct 2012 A1
20120265309 Glerum et al. Oct 2012 A1
20120277795 Von et al. Nov 2012 A1
20120277869 Siccardi et al. Nov 2012 A1
20120277877 Smith et al. Nov 2012 A1
20120290090 Glerum et al. Nov 2012 A1
20120290097 Cipoletti et al. Nov 2012 A1
20120310350 Farris et al. Dec 2012 A1
20120310352 Dimauro et al. Dec 2012 A1
20120323327 McAfee Dec 2012 A1
20120323328 Weiman Dec 2012 A1
20120323329 Jimenez Dec 2012 A1
20120330421 Weiman Dec 2012 A1
20120330422 Weiman Dec 2012 A1
20130006361 Glerum et al. Jan 2013 A1
20130006362 Biedermann et al. Jan 2013 A1
20130023937 Biedermann et al. Jan 2013 A1
20130023993 Weiman Jan 2013 A1
20130023994 Glerum Jan 2013 A1
20130030536 Rhoda et al. Jan 2013 A1
20130030544 Studer Jan 2013 A1
20130053966 Jimenez et al. Feb 2013 A1
20130060337 Petersheim et al. Mar 2013 A1
20130073044 Gamache Mar 2013 A1
20130079790 Stein et al. Mar 2013 A1
20130085572 Glerum et al. Apr 2013 A1
20130085574 Sledge Apr 2013 A1
20130109925 Horton et al. May 2013 A1
20130110240 Hansell et al. May 2013 A1
20130116791 Theofilos May 2013 A1
20130123924 Butler et al. May 2013 A1
20130123927 Malandain May 2013 A1
20130138214 Greenhalgh et al. May 2013 A1
20130144387 Walker et al. Jun 2013 A1
20130144388 Emery et al. Jun 2013 A1
20130144391 Siegal et al. Jun 2013 A1
20130150906 Kerboul Jun 2013 A1
20130158663 Miller et al. Jun 2013 A1
20130158664 Palmatier et al. Jun 2013 A1
20130158667 Tabor et al. Jun 2013 A1
20130158668 Nichols et al. Jun 2013 A1
20130158669 Sungarian et al. Jun 2013 A1
20130173004 Greenhalgh et al. Jul 2013 A1
20130190875 Shulock et al. Jul 2013 A1
20130190876 Drochner et al. Jul 2013 A1
20130190877 Medina Jul 2013 A1
20130197642 Ernst Aug 2013 A1
20130197647 Wolters et al. Aug 2013 A1
20130204371 McLuen et al. Aug 2013 A1
20130211525 McLuen et al. Aug 2013 A1
20130211526 Alheidt et al. Aug 2013 A1
20130218276 Fiechter et al. Aug 2013 A1
20130231747 Olmos et al. Sep 2013 A1
20130238006 O'Neil et al. Sep 2013 A1
20130253585 Garcia et al. Sep 2013 A1
20130261746 Linares et al. Oct 2013 A1
20130261747 Geisert Oct 2013 A1
20130268077 You et al. Oct 2013 A1
20130274883 McLuen et al. Oct 2013 A1
20130310937 Pimenta Nov 2013 A1
20130310939 Fabian et al. Nov 2013 A1
20130325128 Perloff et al. Dec 2013 A1
20140018816 Fenn et al. Jan 2014 A1
20140025169 Lechmann et al. Jan 2014 A1
20140039622 Glerum et al. Feb 2014 A1
20140039626 Mitchell Feb 2014 A1
20140046333 Johnson et al. Feb 2014 A1
20140046446 Robinson Feb 2014 A1
20140052259 Garner et al. Feb 2014 A1
20140058512 Petersheim Feb 2014 A1
20140058513 Gahman et al. Feb 2014 A1
20140067073 Hauck Mar 2014 A1
20140081267 Orsak et al. Mar 2014 A1
20140086962 Jin et al. Mar 2014 A1
20140094916 Glerum et al. Apr 2014 A1
20140094917 Salerni Apr 2014 A1
20140100662 Patterson Apr 2014 A1
20140107790 Combrowski Apr 2014 A1
20140114414 Abdou et al. Apr 2014 A1
20140114423 Suedkamp et al. Apr 2014 A1
20140121774 Glerum et al. May 2014 A1
20140128977 Glerum et al. May 2014 A1
20140128980 Kirschman May 2014 A1
20140135934 Hansell et al. May 2014 A1
20140142706 Hansell et al. May 2014 A1
20140148904 Robinson May 2014 A1
20140163682 Lott et al. Jun 2014 A1
20140163683 Seifert et al. Jun 2014 A1
20140172105 Frasier et al. Jun 2014 A1
20140172106 To et al. Jun 2014 A1
20140180421 Glerum et al. Jun 2014 A1
20140188225 Dmuschewsky Jul 2014 A1
20140228959 Niemiec et al. Aug 2014 A1
20140236296 Wagner et al. Aug 2014 A1
20140243892 Choinski Aug 2014 A1
20140243981 Davenport et al. Aug 2014 A1
20140243982 Miller Aug 2014 A1
20140249629 Moskowitz et al. Sep 2014 A1
20140249630 Weiman Sep 2014 A1
20140257484 Flower et al. Sep 2014 A1
20140257486 Alheidt Sep 2014 A1
20140257494 Thorwarth et al. Sep 2014 A1
20140277139 Vrionis et al. Sep 2014 A1
20140277204 Sandhu Sep 2014 A1
20140277464 Richter et al. Sep 2014 A1
20140277473 Perrow Sep 2014 A1
20140277474 Robinson et al. Sep 2014 A1
20140277476 McLean et al. Sep 2014 A1
20140277481 Lee et al. Sep 2014 A1
20140277507 Baynham Sep 2014 A1
20140296983 Fauth et al. Oct 2014 A1
20140303731 Glerum Oct 2014 A1
20140303732 Rhoda et al. Oct 2014 A1
20140324171 Glerum et al. Oct 2014 A1
20140336764 Masson et al. Nov 2014 A1
20140336771 Zambiasi et al. Nov 2014 A1
20140343678 Suddaby et al. Nov 2014 A1
20150012097 Ibarra et al. Jan 2015 A1
20150012098 Eastlack et al. Jan 2015 A1
20150045894 Hawkins et al. Feb 2015 A1
20150057755 Suddaby et al. Feb 2015 A1
20150066145 Rogers et al. Mar 2015 A1
20150088256 Ballard Mar 2015 A1
20150094610 Morgenstern et al. Apr 2015 A1
20150094812 Cain Apr 2015 A1
20150094813 Lechmann et al. Apr 2015 A1
20150094814 Emerick et al. Apr 2015 A1
20150100128 Glerum et al. Apr 2015 A1
20150112398 Morgenstern et al. Apr 2015 A1
20150112437 Davis et al. Apr 2015 A1
20150112438 McLean Apr 2015 A1
20150164655 Dimauro Jun 2015 A1
20150173914 Dimauro et al. Jun 2015 A1
20150173916 Cain Jun 2015 A1
20150182347 Robinson Jul 2015 A1
20150190242 Blain et al. Jul 2015 A1
20150196400 Dace Jul 2015 A1
20150196401 Dimauro et al. Jul 2015 A1
20150202052 Dimauro Jul 2015 A1
20150216671 Cain Aug 2015 A1
20150216672 Cain Aug 2015 A1
20150216673 Dimauro Aug 2015 A1
20150223946 Weiman Aug 2015 A1
20150230929 Lorio Aug 2015 A1
20150230932 Schaller Aug 2015 A1
20150238324 Nebosky et al. Aug 2015 A1
20150250606 McLean Sep 2015 A1
20150272743 Jimenez et al. Oct 2015 A1
20150305881 Bal et al. Oct 2015 A1
20150320571 Lechmann et al. Nov 2015 A1
20160000577 Dimauro Jan 2016 A1
20160016309 Swift et al. Jan 2016 A1
20160022437 Kelly et al. Jan 2016 A1
20160022438 Lamborne et al. Jan 2016 A1
20160038301 Wickham Feb 2016 A1
20160038304 Aquino et al. Feb 2016 A1
20160045333 Baynham Feb 2016 A1
20160051373 Faulhaber Feb 2016 A1
20160051374 Faulhaber Feb 2016 A1
20160051376 Serhan et al. Feb 2016 A1
20160058573 Dimauro et al. Mar 2016 A1
20160067055 Hawkins et al. Mar 2016 A1
20160074170 Rogers et al. Mar 2016 A1
20160074175 O'Neil Mar 2016 A1
20160081814 Baynham Mar 2016 A1
20160089247 Nichols et al. Mar 2016 A1
20160100954 Rumi et al. Apr 2016 A1
20160106551 Grimberg et al. Apr 2016 A1
20160113776 Capote Apr 2016 A1
20160120660 Melkent et al. May 2016 A1
20160120662 Schaller May 2016 A1
20160128843 Tsau et al. May 2016 A1
20160199195 Hauck et al. Jul 2016 A1
20160199196 Serhan et al. Jul 2016 A1
20160206440 Deridder et al. Jul 2016 A1
20160228258 Schaller et al. Aug 2016 A1
20160235455 Wahl Aug 2016 A1
20160242929 Voellmicke et al. Aug 2016 A1
20160256291 Miller Sep 2016 A1
20160310296 Dimauro et al. Oct 2016 A1
20160317313 Dimauro Nov 2016 A1
20160317317 Marchek et al. Nov 2016 A1
20160317714 Dimauro et al. Nov 2016 A1
20160331541 Dimauro et al. Nov 2016 A1
20160331546 Lechmann et al. Nov 2016 A1
20160331548 Dimauro et al. Nov 2016 A1
20160338854 Serhan et al. Nov 2016 A1
20160367265 Morgenstern Lopez Dec 2016 A1
20160367380 Dimauro Dec 2016 A1
20160374821 Dimauro et al. Dec 2016 A1
20170000622 Thommen et al. Jan 2017 A1
20170035578 Dimauro et al. Feb 2017 A1
20170056179 Lorio Mar 2017 A1
20170071756 Slivka et al. Mar 2017 A1
20170100177 Kim Apr 2017 A1
20170100255 Hleihil Apr 2017 A1
20170100260 Duffield et al. Apr 2017 A1
20170119542 Logan et al. May 2017 A1
20170128226 Faulhaber May 2017 A1
20170209284 Overes et al. Jul 2017 A1
20170216045 Dewey et al. Aug 2017 A1
20170266015 Overes et al. Sep 2017 A1
20170290674 Olmos et al. Oct 2017 A1
20170290675 Olmos et al. Oct 2017 A1
20170290677 Olmos et al. Oct 2017 A1
20170296352 Richerme et al. Oct 2017 A1
20170304074 Dimauro et al. Oct 2017 A1
20170367843 Eisen et al. Dec 2017 A1
20170367844 Eisen et al. Dec 2017 A1
20170367845 Eisen et al. Dec 2017 A1
20180028200 O'Neil et al. Feb 2018 A1
20180036141 Oneil et al. Feb 2018 A1
20180055649 Kelly et al. Mar 2018 A1
20180071111 Sharifi-Mehr et al. Mar 2018 A1
20180078379 Serhan et al. Mar 2018 A1
20180116811 Bernard et al. May 2018 A1
20180161171 Frasier et al. Jun 2018 A1
20180161175 Frasier et al. Jun 2018 A1
20180193164 Shoshtaev Jul 2018 A1
20180256360 Cain Sep 2018 A1
20180256362 Slivka et al. Sep 2018 A1
20190008654 Thommen Jan 2019 A1
20190021868 Ludwig et al. Jan 2019 A1
20190083276 Dimauro Mar 2019 A1
20190105171 Rogers et al. Apr 2019 A1
20190117409 Shoshtaev Apr 2019 A1
20190133785 Georges May 2019 A1
20190142602 Olmos et al. May 2019 A1
20190269521 Shoshtaev Sep 2019 A1
20190336301 Engstrom Nov 2019 A1
20190388238 Lechmann et al. Dec 2019 A1
20200008950 Serhan et al. Jan 2020 A1
20200015982 O'Neil Jan 2020 A1
20200030114 Cain Jan 2020 A1
20200060843 Evans et al. Feb 2020 A1
20200078192 Marchek et al. Mar 2020 A1
20200129308 Suedkamp et al. Apr 2020 A1
20200297506 Olmos et al. Sep 2020 A1
20200375754 Cain Dec 2020 A1
20200375755 Cain Dec 2020 A1
20200383799 Cain Dec 2020 A1
20200405497 Olmos et al. Dec 2020 A1
20200405500 Cain Dec 2020 A1
20210000160 Olmos et al. Jan 2021 A1
20210177619 Voellmicke et al. Jun 2021 A1
20210353427 Butler et al. Nov 2021 A1
Foreign Referenced Citations (296)
Number Date Country
2006279558 Feb 2007 AU
2005314079 Jul 2012 AU
2617872 Feb 2007 CA
1177918 Apr 1998 CN
1383790 Dec 2002 CN
1819805 Aug 2006 CN
101031260 Sep 2007 CN
101087566 Dec 2007 CN
101185594 May 2008 CN
101631516 Jan 2010 CN
101909548 Dec 2010 CN
102164552 Aug 2011 CN
103620249 Mar 2014 CN
104023674 Sep 2014 CN
104023675 Sep 2014 CN
104042366 Sep 2014 CN
104822332 Aug 2015 CN
104921848 Sep 2015 CN
104939876 Sep 2015 CN
105025846 Nov 2015 CN
105188582 Dec 2015 CN
204971722 Jan 2016 CN
105769391 Jul 2016 CN
105769392 Jul 2016 CN
107205829 Sep 2017 CN
2804936 Aug 1979 DE
3023353 Apr 1981 DE
3801459 Aug 1989 DE
3911610 Oct 1990 DE
4012622 Jul 1991 DE
9407806 Jul 1994 DE
19710392 Jul 1999 DE
19832798 Nov 1999 DE
20101793 May 2001 DE
202006005868 Jun 2006 DE
202008001079 Mar 2008 DE
10357960 Sep 2015 DE
0077159 Apr 1983 EP
0260044 Mar 1988 EP
0270704 Jun 1988 EP
0282161 Sep 1988 EP
0433717 Jun 1991 EP
0509084 Oct 1992 EP
0525352 Feb 1993 EP
0529275 Mar 1993 EP
0609084 Aug 1994 EP
0611557 Aug 1994 EP
0621020 Oct 1994 EP
0625336 Nov 1994 EP
0678489 Oct 1995 EP
0743045 Nov 1996 EP
0853929 Jul 1998 EP
1046376 Oct 2000 EP
1157676 Nov 2001 EP
1283026 Feb 2003 EP
1290985 Mar 2003 EP
1308132 May 2003 EP
1374784 Jan 2004 EP
1378205 Jan 2004 EP
1405602 Apr 2004 EP
1532949 May 2005 EP
1541096 Jun 2005 EP
1605836 Dec 2005 EP
1385449 Jul 2006 EP
1683593 Jul 2006 EP
1698305 Sep 2006 EP
1829486 Sep 2007 EP
1843723 Oct 2007 EP
1845874 Oct 2007 EP
1924227 May 2008 EP
1925272 May 2008 EP
2331023 Jun 2011 EP
2368529 Sep 2011 EP
2237748 Sep 2012 EP
2641571 Sep 2013 EP
2705809 Mar 2014 EP
2764851 Aug 2014 EP
2777633 Sep 2014 EP
2645965 Aug 2016 EP
3263072 Jan 2018 EP
3366263 Aug 2018 EP
2649311 Jan 1991 FR
2699065 Jun 1994 FR
2712486 May 1995 FR
2718635 Oct 1995 FR
2728778 Jul 1996 FR
2730159 Aug 1996 FR
2745709 Sep 1997 FR
2800601 May 2001 FR
2801189 May 2001 FR
2808182 Nov 2001 FR
2874814 Mar 2006 FR
2913331 Sep 2008 FR
2948277 Jan 2011 FR
3026294 Apr 2016 FR
2157788 Oct 1985 GB
2173565 Oct 1986 GB
64-052439 Feb 1989 JP
06-500039 Jan 1994 JP
06-319742 Nov 1994 JP
07-502419 Mar 1995 JP
07-184922 Jul 1995 JP
07-213533 Aug 1995 JP
10-085232 Apr 1998 JP
11-089854 Apr 1999 JP
2003-010197 Jan 2003 JP
2003-126266 May 2003 JP
2003-526457 Sep 2003 JP
2006-501901 Jan 2006 JP
2006-516456 Jul 2006 JP
2007-054666 Mar 2007 JP
2007-530243 Nov 2007 JP
2008-507363 Mar 2008 JP
2008-126085 Jun 2008 JP
2011-509766 Mar 2011 JP
2011-520580 Jul 2011 JP
2012-020153 Feb 2012 JP
2012-508048 Apr 2012 JP
4988203 Aug 2012 JP
2013-508031 Mar 2013 JP
5164571 Mar 2013 JP
2013-516206 May 2013 JP
2014-502867 Feb 2014 JP
2015-500707 Jan 2015 JP
2015-525652 Sep 2015 JP
2017-505196 Feb 2017 JP
9109572 Jul 1991 WO
9204423 Mar 1992 WO
9207594 May 1992 WO
9214423 Sep 1992 WO
9304634 Mar 1993 WO
9304652 Mar 1993 WO
9317669 Sep 1993 WO
9404100 Mar 1994 WO
9531158 Nov 1995 WO
9628100 Sep 1996 WO
9700054 Jan 1997 WO
9726847 Jul 1997 WO
9834552 Aug 1998 WO
9834568 Aug 1998 WO
9902214 Jan 1999 WO
9926562 Jun 1999 WO
9942062 Aug 1999 WO
9952478 Oct 1999 WO
9953871 Oct 1999 WO
9960956 Dec 1999 WO
9962417 Dec 1999 WO
0012033 Mar 2000 WO
0013620 Mar 2000 WO
0024343 May 2000 WO
0067652 May 2000 WO
0044288 Aug 2000 WO
0053127 Sep 2000 WO
0067650 Nov 2000 WO
0067651 Nov 2000 WO
0074605 Dec 2000 WO
0076409 Dec 2000 WO
0101893 Jan 2001 WO
0101895 Jan 2001 WO
0110316 Feb 2001 WO
0112054 Feb 2001 WO
0117464 Mar 2001 WO
0180751 Nov 2001 WO
0195838 Dec 2001 WO
0203870 Jan 2002 WO
0217824 Mar 2002 WO
0217825 Mar 2002 WO
0230338 Apr 2002 WO
0243601 Jun 2002 WO
0243628 Jun 2002 WO
0245627 Jun 2002 WO
0247563 Jun 2002 WO
0271921 Sep 2002 WO
0285250 Oct 2002 WO
0302021 Jan 2003 WO
0305937 Jan 2003 WO
0307854 Jan 2003 WO
0320169 Mar 2003 WO
0321308 Mar 2003 WO
0322165 Mar 2003 WO
0328587 Apr 2003 WO
0343488 May 2003 WO
0303951 Jun 2003 WO
2003101308 Dec 2003 WO
2004008949 Jan 2004 WO
0359180 Mar 2004 WO
2004030582 Apr 2004 WO
2004034924 Apr 2004 WO
2004062505 Jul 2004 WO
2004064603 Aug 2004 WO
2004069033 Aug 2004 WO
2004073563 Sep 2004 WO
2004078220 Sep 2004 WO
2004078221 Sep 2004 WO
2004080316 Sep 2004 WO
2004082526 Sep 2004 WO
2004098420 Nov 2004 WO
2004098453 Nov 2004 WO
2004108022 Dec 2004 WO
2005027734 Mar 2005 WO
2005032433 Apr 2005 WO
2005039455 May 2005 WO
2005051246 Jun 2005 WO
2005081877 Sep 2005 WO
2005094297 Oct 2005 WO
2005112834 Dec 2005 WO
2005112835 Dec 2005 WO
2005115261 Dec 2005 WO
2006017507 Feb 2006 WO
2006044920 Apr 2006 WO
2006047587 May 2006 WO
2006047645 May 2006 WO
2006058079 Jun 2006 WO
2006058281 Jun 2006 WO
2006060420 Jun 2006 WO
2006063083 Jun 2006 WO
2006065419 Jun 2006 WO
2006066228 Jun 2006 WO
2006072941 Jul 2006 WO
2006081843 Aug 2006 WO
2006108067 Oct 2006 WO
2006118944 Nov 2006 WO
2007009107 Jan 2007 WO
2007022194 Feb 2007 WO
2007028098 Mar 2007 WO
2007048012 Apr 2007 WO
2007067726 Jun 2007 WO
2007084427 Jul 2007 WO
2007119212 Oct 2007 WO
2007124130 Nov 2007 WO
2008005627 Jan 2008 WO
2008011378 Jan 2008 WO
2008044057 Apr 2008 WO
2008064842 Jun 2008 WO
2008070863 Jun 2008 WO
2008103781 Aug 2008 WO
2008103832 Aug 2008 WO
2009064787 May 2009 WO
2009092102 Jul 2009 WO
2009124269 Oct 2009 WO
2009143496 Nov 2009 WO
2009147527 Dec 2009 WO
2009152919 Dec 2009 WO
2010011348 Jan 2010 WO
2010068725 Jun 2010 WO
2010075451 Jul 2010 WO
2010075555 Jul 2010 WO
2010088766 Aug 2010 WO
2010121002 Oct 2010 WO
2010136170 Dec 2010 WO
2010148112 Dec 2010 WO
2011013047 Feb 2011 WO
2011046459 Apr 2011 WO
2011046460 Apr 2011 WO
2011060087 May 2011 WO
2011079910 Jul 2011 WO
2011119617 Sep 2011 WO
2011142761 Nov 2011 WO
2011150350 Dec 2011 WO
2012009152 Jan 2012 WO
2012027490 Mar 2012 WO
2012028182 Mar 2012 WO
2012030331 Mar 2012 WO
2012089317 Jul 2012 WO
2012103254 Aug 2012 WO
2012122294 Sep 2012 WO
2012129197 Sep 2012 WO
2012135764 Oct 2012 WO
2013006669 Jan 2013 WO
2013023096 Feb 2013 WO
2013025876 Feb 2013 WO
20131043850 Mar 2013 WO
2013062903 May 2013 WO
2013082184 Jun 2013 WO
2013148176 Oct 2013 WO
2013149611 Oct 2013 WO
2013158294 Oct 2013 WO
2013173767 Nov 2013 WO
2013184946 Dec 2013 WO
2014014610 Jan 2014 WO
2014018098 Jan 2014 WO
2014026007 Feb 2014 WO
2014035962 Mar 2014 WO
2014088521 Jun 2014 WO
2014116891 Jul 2014 WO
2014144696 Sep 2014 WO
2015004660 Jan 2015 WO
2015013479 Jan 2015 WO
2015022039 Feb 2015 WO
2015048997 Apr 2015 WO
2016069796 May 2016 WO
2016118246 Jul 2016 WO
2016127139 Aug 2016 WO
2017040881 Mar 2017 WO
2017136620 Aug 2017 WO
2018078148 May 2018 WO
Non-Patent Literature Citations (87)
Entry
Zucherman, “A Multicenter, Prospective, Randomized Trial Evaluating the X STOP Interspinous Process Decompression System for the Treatment of Neurogenic Intermittent Claudication”, Spine, vol. 30, No. 12, pp. 1351-1358, 2005.
U.S. Appl. No. 60/942,998, Method and Apparatus for Spinal Stabilization, filed Jun. 8, 2007.
U.S. Appl. No. 61/675,975, Expandable Implant, filed Jul. 26, 2012.
U.S. Appl. No. 60/397,588, Method and apparatus for spinal fixation, filed Jul. 19, 2002.
U.S. Appl. No. 60/794,171, Method and apparatus for spinal fixation, filed Apr. 21, 2006.
U.S. Appl. No. 60/424,055, filed Nov. 5, 2002, entitled Method and apparatus for spinal fixation.
Talwar “Insertion loads of the X STOP interspinous process distraction system designed to treat neurogenic intermittent claudication”, Eur Spine J. (2006) 15: pp. 908-912.
Spine Solutions Brochure—Prodisc 2001, 16 pages.
Siddiqui, “The Positional Magnetic Resonance Imaging Changes in the Lumbar Spine Following Insertion of a Novel Interspinous Process Distraction Device”, Spine, vol. 30, No. 23, pp. 2677-2682, 2005.
Shin, “Posterior Lumbar Interbody Fusion via a Unilateral Approach”, Yonsei Medical Journal, 2006, pp. 319-325, vol. 47(3).
ProMap TM EMG Navigation Probe. Technical Brochure Spineology Inc, Dated May 2009.
Polikeit, “The Importance of the Endplate for Interbody Cages in the Lumbar Spine”, Eur. Spine J., 2003, pp. 556-561, vol. 12.
Paul D. Fuchs, “The use of an interspinous implant in conjunction with a graded facetectomy procedure”, Spine vol. 30, No. 11, pp. 1266-1272, 2005.
Niosi, “Biomechanical Characterization of the three-dimentional kinematic behavior of the dynesys dynamic stabilization system: an in vitro study”, Eur Spine J. (2006), 15: pp. 913-922.
Morgenstern R; “Transforaminal Endoscopic Stenosis Surgery—A Comparative Study of Laser and Reamed Foraminoplasty”, in European Musculoskeletal Review, Issue 1, 2009.
Medco Forum, “Percutaneous Lumbar Fixation via PERPOS System From Interventional Spine”, Oct. 2007, vol. 14, No. 49.
Medco Forum, “Percutaneous Lumbar Fixation Via PERPOS PLS System Interventional Spine”, Sep. 2008, vol. 15, No. 37.
Mahar et al., “Biomechanical Comparison of Novel Percutaneous Transfacet Device and a Traditional Posterior System for Single Level Fusion”, Journal of Spinal Disorders & Techniques, Dec. 2006, vol. 19, No. 8, pp. 591-594.
Link SB Charite Brochure—Intervertebral Prosthesis 1988, 29 pages.
Krbec, “Replacement of the Vertebral Body with an Expansion Implant (Synex)”, Acta Chir Orthop Traumatol Cech, 2002, pp. 158-162, vol. 69(3).
King, M.D., Don, “Internal Fixation for Lumbosacral Fusion”, The Journal of Bone and Joint Surgery, J. Bone Joint Surg Am., 1948; 30: 560-578.
Kambin et al., “Percutaneous Lateral Discectomy of the Lumbar Spine: A Preliminary Report”, Clin. Orthop,: 1983, 174: 127-132.
Iprenburg et al., “Transforaminal Endocopic Surgery in Lumbar Disc Herniation in an Economic crises—The Tessys Method”, US Musculoskeletal, 2008, pp. 47-49.
Hunt, “Expandable Cage Placement Via a Posterolateral Approach in Lumbar Spine Reconstructions”, Journal of Neurosurgery: Spine, Sep. 2006, pp. 271-274, vol. 5.
Hoogland et al., “Total Lumar Intervertebral Disc Replacement: Testing a New Articulating Space in Human Cadaver Spines—241”, Annual ORS, Dallas, TX, Feb. 21-23, 1978, 8 pages.
Grays Anatomy, Crown Publishers, Inc., 1977, pp. 33-54.
Gore, “Technique of Cervical Interbody Fusion”, Clinical Orthopaedics and Related Research, Sep. 1984, pp. 191-195, No. 188.
Folman, Posterior Lumbar Interbody Fusion for Degenerative Disc Disease Using a Minimally Invasive B-Twin Expandable Spinal Spacer, Journal of Spinal Disorders & Techniques, 2003, pp. 455-460, vol. 16(5).
Chin, “Early Results of the Triage Medical Percutaneous Transfacet Pedicular BONE-LOK Compression Device for Lumbar Fusion”, Accessed online Jul. 10, 2017, 10 pages.
Chiang, “Biomechanical Comparison of Instrumented Posterior Lumbar Interbody Fusion with One or Two Cages by Finite Element Analysis”, Spine, Sep. 2006, pp. E682-E689, vol. 31(19), Lippincott Williams & Wilkins, Inc.
Brooks et al., “Efficacy of Supplemental Posterior Transfacet Pedicle Device Fixation in the Setting of One- or Two-Level Anterior Lumbar Interbody Fusion”, Retrieved Jun. 19, 2017, 6 pages.
Brochure for PERPOS PLS System Surgical Technique by Interventional Spine, 2008, 8 pages.
Alfen et al., “Developments in the area of Endoscopic Spine Surgery”, European Musculoskeletal Review 2006, pp. 23-24, Thessys(Trademark), Transforaminal Endoscopic Spine Systems, joi max Medical Solutions.
Barakat et al., Macromolecular engineering of polylactone and polylactide. XXI. Controlled synthesis of low molecular weight polylactide macromonomers. J Polym Sci Polym Chem 34:497-502, 1996.
Bruder et al., Identification and characterization of a cell surface differentiation antigen on human osteoprogenitor cells. 42nd Annual Meeting of the Orthopaedic Research Society. p. 574, Feb. 19-22, 1996, Atlanta, Georgia.
Bruder et al., Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone. Sep. 1997;21 (3):225-235.
Burkoth et al., A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials. Dec. 2000; 21 (23): 2395-2404.
Cambridge Scientific News, FDA Approves Cambridge Scientific, Inc.'s Orthopedic WISORB (TM) Malleolar Screw [online], Jul. 30, 2002 [retrieved on Oct. 14, 2003]. Retrieved from the Internet <URL: http://www.cambridgescientificinc.com>.
Carrino, John A., Roxanne Chan and Alexander R. Vaccaro, “Vertebral Augmentation: Vertebroplasty and Kyphoplasty”, Seminars in Roentgenology, vol. 39, No. 1 Jan. 2004: pp. 68-84.
Cheng, B.C., Ph.D., Biomechanical pullout strength and histology of Plasmapore Registered XP coated implants: Ovine multi time point survival study. Aesculap Implant Systems, LLC, 2013, 12 pages.
Domb, Biodegradable bone cement compositions based on acrylate and epoxide terminated poly(propylene fumarate) oligomers and calcium salt compositions, Biomaterials 17, 1996, 411-417.
Edeland, H.G., “Some Additional Suggestions for an Intervertebral Disc Prosthesis”, J of Bio Medical Engr., vol. 7(1) pp. 57-62, Jan. 1985.
European Search Report EP03253921 dated Nov. 13, 2003, 4 pages.
Flemming et al., Monoclonal anitbody against adult marrow-derived mesenchymal stem cells recognizes developing vasculature in embryonic human skin. Developmental Dynamics. 1998;212:119-132.
Ha et al. (Topographical characterization and microstructural interface analysis of vacuum-plasma-sprayed titanium and hydroxyapatite coatings on carbon fiber-reinforced poly(etheretherketone), Journal of Materials Science: Materials in Science 9 (1997), pp. 891-896.
Haas, Norbert P., New Products from AO Development [online], May 2002 [retrieved on Oct. 14, 2003]. Retrieved from the Internet <URL: http://www.ao.asif.ch/development/pdf_tk_news_02_pdf>.
Hao et al., Investigation of nanocomposites based on semi-interpenetrating network of [L-poly (epsilon-caprolactone)]/[net-poly (epsilon-caprolactone)] and hydroxyapatite nanocrystals. Biomaterials. Apr. 2003;24(9): 1531-9.
Harsha et al., Tribo performance of polyaryletherketone composites, Polymer Testing (21) (2002) pp. 697-709.
Haynesworth et al., Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992;13(1):69-80.
Hitchon et al., Comparison of the biomechanics of hydroxyapatite and polymethylmethacrylate vertebroplasty in a cadaveric spinal compression fracture model. J Neurosurg. Oct. 2001;95(2 Suppl):215-20.
International Patent Application No. PCT /US2013/029014, International Search Report dated Jul. 1, 2013, 7 pages.
Joshi, Ajeya P., M.D. and Paul A. Glazer, M.D., “Vertebroplasty: Current Concepts and Outlook for the Future”, 2003, (5 pages), From: http://www.orthojournalhms.org/html/pdfs/manuscript-15.pdf.
Kandziora, Frank, et al., “Biomechanical Analysis of Biodegradable Interbody Fusion Cages Augmented with Poly (propylene Glycol-co-Fumaric Acid),” Spine, 27(15): 1644-1651 (2002).
Kotsias, A., Clinical trial of titanium-coated PEEL cages anterior cervical discectomy and fusion. [Klinishe Untersuching zum Einsatz von titanbeschichteten Polyetheretherketon—Implantaten bei der cervikalen interkorporalen fusion]. Doctoral thesis. Department of Medicine, Charite, University of Medicine Berlin, 2014, 73 pages. (German language document/Engl. summary).
Kricheldorf et al., Polylactides—synthesis, characterization and medical applications. Macromol Symp 103:85-102, 1996.
Kroschwitz et al., eds., Hydrogels. Concise Encyclopedia of Polymer Science and Engineering. Wiley and Sons, pp. 458-459, 1990.
Lendlein et al., AB-polymer networks based on oligo(epsilon-caprolactone) segments showing shape-memory properties. Proc Natl Acad Sci US A. Jan. 30, 2001;98(3):842-7. Epub Jan. 23, 2001.
Malberg. M.I., MD; Pimenta, L., MD; Millan, M.M., MD, 9th International Meeting on Advanced Spine Techniques, May 23-25, 2002, Montreux, Switzerland. Paper #54, Paper #60, and E-Poster #54, 5 pages.
Massia et al, An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol 114:1089-1100, 1991.
McAfee et al., Minimally invasive anterior retroperitoneal approach to the lumbar spine: Emphasis on the lateral BAK. Spine. 1998;23(13):1476-84.
Mendez et al., Self-curing acrylic formulations containing PMMA/PCL composites: properties and antibiotic release behavior. J Biomed Mater Res. Jul. 2002;61 (1 ):66-74.
Nguyen et al., Poly(Aryl-Ether-Ether-Ketone) and its Advanced Composites: A Review, Polymer Composites, Apr. 1987, vol. 8, No. 2, pp. 57-73.
OSTEOSET Registered DBM Pellets (Important Medical Information) [online], Nov. 2002 [retrieved on Oct. 14, 2003]. Retrieved from the Internet <URL: http://www.wmt.com/Literature>.
POROCOAT(R) Porous Coating, 1 Page, https://emea.depuysynthese.com/hcp/hip/products/qs/porocoat-porous-coatingemea Accessed on Jul. 31, 2017.
Regan et al., Endoscopic thoracic fusion cage. Atlas of Endoscopic Spine Surgery. Quality Medical Publishing, Inc. 1995;350-354.
Slivka et al., In vitro compression testing of fiber-reinforced, bioabsorbable, porous implants. Synthetic Bioabsorbable Polymers for Implants. STP1396, pp. 124-135, ATSM International, Jul. 2000.
Sonic Accelerated Fracture Healing System/Exogen 3000. Premarket Approval. U.S. Food & Drug Administration. Date believed to be May 10, 2000. Retrieved Jul. 23, 2012 from <http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=14736#>. 4 pages, 2012.
Stewart et al., Co-expression of the stro-1 anitgen and alkaline phosphatase in cultures of human bone and marrow cells. ASBMR 18th Annual Meeting. Bath Institute for Rheumatic Diseases, Bath, Avon, UK. Abstract No. P208, p. S142, 1996.
Timmer et al., In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate. Biomaterials. Feb. 2003;24(4 ):571-7.
United States Disctrict Court, Central District of California, Case No. 1 :10-CV-00849-LPS, Nuvasive, Inc., vs., Globus Medical, Inc., Videotaped Deposition of: Luiz Pimenta, M.D., May 9, 2012, 20 pages.
Walsh et al., Preparation of porous composite implant materials by in situ polymerization of porous apatite containing epsilon-caprolactone or methyl methacrylate. Biomaterials. Jun. 2001;22( 11):1205-12.
Zimmer.com, Longer BAK/L Sterile Interbody Fusion Devices. Date believed to be 1997. Product Data Sheet.Zimmer. Retrieved Jul. 23, 2012 from <http:/ catalog.zimmer.com/contenUzpc/products/600/600/620/S20/S045. html>, 2 pages.
CN Office Action dated Apr. 24, 2020 for CN Application No. 201780040910.
U.S. Appl. No. 09/558,057, filed Apr. 26, 2000, entitled Bone Fixation System.
Allcock, “Polyphosphazenes”; The Encyclopedia of Polymer Science; 1988; pp. 31-41; vol. 13; Wiley Intersciences, John Wiley & Sons.
Cohn, “Biodegradable PEO/PLA Block Copolymers”; Journal of Biomedical Materials Research; 1988; pp. 993-1009 vol. 22; John Wiley & Sons, Inc.
Cohn, “Polymer Preprints”; Journal of Biomaterials Research; 1989; p. 498; Biomaterials Research Labortatory, Casal Institute of Applied Chemistry, Israel.
Heller, “Poly (Otrho Esters)”; Handbook of Biodegradable Polymers; edited by Domb; et al.; Hardwood Academic Press; 1997; pp. 99-118.
Japanese Office Action for Application No. 2013-542047, dated Sep. 8, 2015 (12 pages).
Japanese Office Action for Application No. 2016-135826, dated Jun. 6, 2017, (7 pages).
Kemnitzer, “Degradable Polymers Derived From the Amino Acid L-Tyrosine”; 1997; pp. 251-272; edited by Domb, et al., Hardwood Academic Press.
Khoo, “Minimally Invasive Correction of Grade I and II Isthmic Spondylolisthesis using AxiaLIF for L5/S1 Fusion”, pp. 1-7, Rev B Sep. 15, 2008.
Khoo, Axilif address spongy from the caudal approach. Minimally Invasive Correction of Grage I and II Isthmic Spondylolisthesis using AsiaLiF for L5/S1 Fusion, pp. 45-0123 Rev B Sep. 15, 2008.
U.S. Appl. No. 61/009,546, filed Dec. 28, 2007 Rodgers.
U.S. Appl. No. 61/140,926, filed Dec. 26, 2008 Spann.
U.S. Appl. No. 61/178,315, filed May 14, 2009 Spann.
Vandorpe, “Biodegradable Polyphosphazenes for Biomedical Applications”; Handbook of Biodegradable Polymers 1997; pp. 161-182; Hardwood Academic Press.
Related Publications (1)
Number Date Country
20180360616 A1 Dec 2018 US
Provisional Applications (1)
Number Date Country
62519470 Jun 2017 US